<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Oncotarget</journal-id>
<journal-id journal-id-type="iso-abbrev">Oncotarget</journal-id>
<journal-id journal-id-type="publisher-id">Oncotarget</journal-id>
<journal-id journal-id-type="publisher-id">ImpactJ</journal-id>
<journal-title-group>
<journal-title>Oncotarget</journal-title>
</journal-title-group>
<issn pub-type="epub">1949-2553</issn>
<publisher>
<publisher-name>Impact Journals LLC</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29108258</article-id>
<article-id pub-id-type="pmc">5667991</article-id>
<article-id pub-id-type="publisher-id">20219</article-id>
<article-id pub-id-type="doi">10.18632/oncotarget.20219</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Paper</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Transcriptional signature of lymphoblastoid cell lines of <italic>BRCA1</italic>, <italic>BRCA2</italic> and non-<italic>BRCA1/2</italic> high risk breast cancer families</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Pouliot</surname>
<given-names>Marie-Christine</given-names>
</name>
<xref ref-type="aff" rid="A1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kothari</surname>
<given-names>Charu</given-names>
</name>
<xref ref-type="aff" rid="A1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Joly-Beauparlant</surname>
<given-names>Charles</given-names>
</name>
<xref ref-type="aff" rid="A1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Labrie</surname>
<given-names>Yvan</given-names>
</name>
<xref ref-type="aff" rid="A1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ouellette</surname>
<given-names>Geneviève</given-names>
</name>
<xref ref-type="aff" rid="A1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Simard</surname>
<given-names>Jacques</given-names>
</name>
<xref ref-type="aff" rid="A1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Droit</surname>
<given-names>Arnaud</given-names>
</name>
<xref ref-type="aff" rid="A1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Durocher</surname>
<given-names>Francine</given-names>
</name>
<xref ref-type="aff" rid="A1">
<sup>1</sup>
</xref>
</contrib>
<aff id="A1"><sup>1</sup> CHU de Québec Research Centre-Université Laval, Department of Molecular Medicine, Québec, Canada</aff>
</contrib-group>
<author-notes>
<corresp id="cor1">
<bold>
<italic>Correspondence to:</italic>
</bold>
<italic>Francine Durocher,</italic>
<email>Francine.Durocher@crchudequebec.ulaval.ca</email>
</corresp>
</author-notes>
<pub-date pub-type="collection">
<day>3</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>12</day>
<month>8</month>
<year>2017</year>
</pub-date>
<volume>8</volume>
<issue>45</issue>
<fpage>78691</fpage>
<lpage>78712</lpage>
<history>
<date date-type="received">
<day>28</day>
<month>9</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>7</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright: © 2017 Pouliot et al.</copyright-statement>
<copyright-year>2017</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/">
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">Creative Commons Attribution License</ext-link> 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<abstract>
<p>Approximately 25% of hereditary breast cancer cases are associated with a strong familial history which can be explained by mutations in <italic>BRCA1</italic> or <italic>BRCA2</italic> and other lower penetrance genes. The remaining high-risk families could be classified as BRCAX (non-<italic>BRCA1/2</italic>) families.</p>
<p>Gene expression involving alternative splicing represents a well-known mechanism regulating the expression of multiple transcripts, which could be involved in cancer development. Thus using RNA-seq methodology, the analysis of transcriptome was undertaken to potentially reveal transcripts implicated in breast cancer susceptibility and development.</p>
<p>RNA was extracted from immortalized lymphoblastoid cell lines of 117 women (affected and unaffected) coming from <italic>BRCA1</italic>, <italic>BRCA2</italic> and BRCAX families. Anova analysis revealed a total of 95 transcripts corresponding to 85 different genes differentially expressed (Bonferroni corrected p-value &lt;0.01) between those groups. Hierarchical clustering allowed distinctive subgrouping of <italic>BRCA1/2</italic> subgroups from BRCAX individuals. We found 67 transcripts, which could discriminate BRCAX from <italic>BRCA1/BRCA2</italic> individuals while 28 transcripts discriminate affected from unaffected BRCAX individuals.</p>
<p>To our knowledge, this represents the first study identifying transcripts differentially expressed in lymphoblastoid cell lines from major classes of mutation-related breast cancer subgroups, namely <italic>BRCA1</italic>, <italic>BRCA2</italic> and BRCAX. Moreover, some transcripts could discriminate affected from unaffected BRCAX individuals, which could represent potential therapeutic targets for breast cancer treatment.</p>
</abstract>
<kwd-group>
<kwd>hereditary breast cancer</kwd>
<kwd>high-risk <italic>BRCA1/2</italic>/X families</kwd>
<kwd>gene expression</kwd>
<kwd>RNA-seq</kwd>
<kwd>lymphoblastoid cell lines</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>INTRODUCTION</title>
<p>In 2015, breast cancer represented 26% of all cancer cases among Canadian women and was the second leading cause of cancer death constituting 14% of overall death due to cancer [<xref ref-type="bibr" rid="R1">1</xref>]. Like every common cancer, breast cancer shows some degree of familial clustering [<xref ref-type="bibr" rid="R2">2</xref>]. High-risk families having multiple cases of breast or ovarian cancer are associated with a higher risk of developing breast cancer during their lifetime than other families [<xref ref-type="bibr" rid="R3">3</xref>]. It is thought that approximately 10-15% of breast cancer cases are hereditary and associated with mutations in <italic>BRCA1</italic> or <italic>BRCA2</italic> genes and some other genes having high to moderate penetrance such as <italic>TP53</italic>, <italic>PTEN</italic>, <italic>ATM</italic>, <italic>CHEK2</italic>, <italic>PALB2</italic> and <italic>BRIP1</italic> and <italic>ATR</italic>, which account for approximately 5% of the risk [<xref ref-type="bibr" rid="R4">4</xref>-<xref ref-type="bibr" rid="R10">10</xref>]. Common variants have also been identified in additional susceptibility loci and would explain a further ∼16% of the 2-fold familial risk of breast cancer [<xref ref-type="bibr" rid="R11">11</xref>]. Among our French Canadian cohort, 24% of high-risk breast cancer families were found to be carriers of a deleterious <italic>BRCA1</italic> or <italic>BRCA2</italic> mutation [<xref ref-type="bibr" rid="R12">12</xref>].</p>
<p>Therefore, susceptibility alleles for more than half of the high-risk families remain unknown. A portion of these remnant breast cancer families could be explained by modulation of gene expression, which is mainly regulated through methylation or alternative splicing (AS) mechanisms. Indeed, more than 90% of human genes undergo alternative splicing and it is now becoming clear that AS plays an important role in human cancer development [<xref ref-type="bibr" rid="R13">13</xref>-<xref ref-type="bibr" rid="R14">14</xref>]. RNA sequencing allows a genome-wide expression study of the transcriptome and can likely detect and quantify all coding and non-coding transcripts [<xref ref-type="bibr" rid="R15">15</xref>]. The use of RNA sequencing greatly enhanced our understanding of gene expression in cells [<xref ref-type="bibr" rid="R16">16</xref>].</p>
<p>Human immortalized lymphoblastoid cell lines (LCLs) provide information on gene expression without having to consider tissue specific expression [<xref ref-type="bibr" rid="R17">17</xref>]. LCLs used for the establishment of gene expression or splicing signatures are recognized as a reliable biological material to study a given disease [<xref ref-type="bibr" rid="R18">18</xref>-<xref ref-type="bibr" rid="R28">28</xref>], and some studies recently showed the heritability of splicing, as some exons were spliced in an allele-specific manner [<xref ref-type="bibr" rid="R18">18</xref>, <xref ref-type="bibr" rid="R29">29</xref>, <xref ref-type="bibr" rid="R30">30</xref>]. Moreover, it has been demonstrated that LCLs can be used to study life-course environmental epigenetics [<xref ref-type="bibr" rid="R31">31</xref>].</p>
<p>Previous studies attempted to discriminate <italic>BRCA1/2</italic>, non-<italic>BRCA1/2</italic> (BRCAX) and sporadic breast cancers were based on gene expression levels and histological tests performed on breast tumor tissue [<xref ref-type="bibr" rid="R32">32</xref>-<xref ref-type="bibr" rid="R37">37</xref>]. In another study, although several genes or spliced transcripts were identified as differentially expressed in familial cases, they did not allow clusterization of <italic>BRCA1</italic>, <italic>BRCA2</italic> and BRCAX tumor tissues [<xref ref-type="bibr" rid="R38">38</xref>].</p>
<p>In this study, we performed RNA sequencing on LCLs isolated from <italic>BRCA1/2</italic> and BRCAX affected and unaffected individuals coming from high-risk breast cancer families in an attempt to distinguish breast cancer subgroups based on their transcriptome profile. This study revealed several transcripts involved in regulation of translation, apoptosis, cell cycle as well as cell growth and proliferation, which could discriminate BRCAX individuals from <italic>BRCA1/2</italic> subgroups.</p>
</sec>
<sec id="s2">
<title>RESULTS</title>
<p>Our French Canadian cohort comprised three major familial breast cancer subgroups namely <italic>BRCA1</italic> and <italic>BRCA2</italic> carriers as well as BRCAX individuals, i.e. non <italic>BRCA1/2</italic> (affected and unaffected). The <italic>BRCA1</italic> cases included 25 individuals (ind) affected with breast cancer and 11 unaffected women, who were carriers of <italic>BRCA1</italic> mutations namely R1443X (22 ind), 3705insA (2 ind), 2244insA (7 ind), 2953del3+C (2 ind) and three individuals carrying E352X, 4160delAG or 1723del9ins13 mutation, respectively. The <italic>BRCA2</italic> subgroup was composed of 31 affected and 18 unaffected individuals carrying 8765delAG (44 ind), E3002K (2 ind), 6503delTT (1 ind), R3128X (1 ind) or 3036del4 mutation (1 ind). The BRCAX subgroup included 16 affected and 16 unaffected individuals, which represented 16 pairs of sisters (1 affected and 1 unaffected per family). It should be noted that the oldest unaffected sister available was purposely selected in BRCAX families. This subgroup of unaffected sisters was used as controls for comparison purpose in the analyses described below. The mutational profile and relationship status of <italic>BRCA1, BRCA2</italic> and <italic>BRCAX</italic> individuals are highlighted in <xref ref-type="supplementary-material" rid="SD1">Supplementary Table 1</xref>.</p>
<p>RNA-Seq analyses generated an average of 68 million reads per sample, and more than 85% of the reads were aligned to the hg19 human reference genome using TopHat (data not shown). As displayed in <xref ref-type="supplementary-material" rid="SD1">Supplementary Table 2</xref>, out of a total of 173 259 transcripts detected, 95 transcripts (0.05 % of all transcripts) were found to be significantly (p&lt;0.01) and differentially expressed based on the Bonferroni-corrected ANOVA analysis, when considering all four breast cancer subgroups (<italic>BRCA1</italic>, <italic>BRCA2</italic>, unaffected and affected BRCAX individuals). All these significant transcripts were encoded by 85 different genes. In addition to the main isoforms (one per gene), 10 mRNA isoforms were considered as alternatively spliced isoforms (11.8%). These significant transcripts included 54 gene isoforms showing a highly significant Bonferroni-corrected p-value (p &lt; 0.001).</p>
<p>Principal component analysis (PCA) of these 95 transcripts identified as differentially expressed among <italic>BRCA1</italic>-carriers (n=36), <italic>BRCA2</italic>-carriers (n=49), unaffected BRCAX (n=16) and affected BRCAX (n=16) individuals is presented in Figure <xref ref-type="fig" rid="F1">1</xref>. The first three principal components of transcriptional variation accounted for 59.6 % of the total variance. PCA on the full dataset showed that the PC1 component accounted for 46 % of the variance, which is highly informative, while PC2 was also informative compared to the variance explained in the randomized data set.</p>
<fig id="F1" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<title>Principal component analysis (PCA) on lymphoblastoid cell lines</title>
<p>Unsupervised classification of the groups using a combination of PC1, PC2 and PC3. Distance between dots is a dimensional measure for the similarity of the expression profiles of the samples (red: <italic>BRCA1</italic>, blue: <italic>BRCA2</italic>, green: BRCAX unaffected and purple: BRCAX affected).</p>
</caption>
<graphic xlink:href="oncotarget-08-78691-g001"></graphic>
</fig>
<p>Unsupervised hierarchical clustering of all <italic>BRCA1</italic>, <italic>BRCA2</italic> and BRCAX individuals was then performed using the 95 significant transcripts. As illustrated in Figure <xref ref-type="fig" rid="F2">2</xref>, gene expression levels of these significant transcripts allowed to discriminate distinctly <italic>BRCA1/2</italic> from BRCAX (unaffected and affected) individuals. However, it was not possible to segregate <italic>BRCA1</italic> from <italic>BRCA2</italic> individuals as well as affected from unaffected BRCAX individuals. In addition, when considering <italic>BRCA1</italic> and <italic>BRCA2</italic> individuals, no specific clustering could be observed based on gene mutation or the status of the disease. Intra-group variance analysis using gene expression data was performed by Principle component analysis (PCA) for patients with the BRCA1 R1443X mutation (22 patients) and BRCA2 8765delAG mutation (44 patients). We did not find significance of BRCA1 R1443X and BRCA2 8765delAG mutation from their respective BRCA1 and BRCA2 subgroup. Thus, grouping of different mutations in BRCA1 or BRCA2 subgroup is justified (data not shown).</p>
<fig id="F2" orientation="portrait" position="float">
<label>Figure 2</label>
<caption>
<title>Hierarchical clustering of the 95 transcripts differentially expressed</title>
<p>Unsupervised LCLs classification based on the significantly and differentially expressed transcripts measured by RNA-sequencing using bonferroni corrected p-value &lt;0.01. Color bar represents each of our groups (red: <italic>BRCA1</italic>, blue: <italic>BRCA2</italic>, Green: BRCAX) and status of disease (pink: affected and white: unaffected).</p>
</caption>
<graphic xlink:href="oncotarget-08-78691-g002"></graphic>
</fig>
<p>The ANOVA analysis followed by conservative post hoc Scheffé test, which is appropriate for comparing groups with unequal sample sizes, allowed to potentially identify transcripts discriminating <italic>BRCA1</italic>, <italic>BRCA2</italic> and affected BRCAX individuals from unaffected BRCAX individuals, which were used as controls in this analysis. This analysis revealed 69, 71 and 28 gene isoforms differentially expressed from BRCAX unaffected for <italic>BRCA1</italic>, <italic>BRCA2</italic> and affected BRCAX individuals, respectively (See <xref ref-type="supplementary-material" rid="SD1">Supplementary Table 2</xref>). It should be noted that the large majority of transcripts identified in <italic>BRCA1</italic>-carriers were also found in <italic>BRCA2</italic>-carriers.</p>
<p>As presented in Figure <xref ref-type="fig" rid="F3">3</xref>, these transcripts were then illustrated in Venn diagrams, which showed that 3 common transcripts (3.2%) were differentially expressed in all three subgroups, when compared to unaffected BRCAX individuals. In addition, a large portion of transcripts (65: 68.4%) was commonly identified in <italic>BRCA1</italic> and <italic>BRCA2</italic> subgroups, while only 1 transcript was specifically and exclusively associated with <italic>BRCA1</italic>, and another one different transcript with <italic>BRCA2</italic>. This illustrated the similarity between <italic>BRCA1</italic> and <italic>BRCA2</italic>-carrier individuals regarding their gene expression profile. On the other hand, 23 gene isoforms were exclusively associated with affected BRCAX individuals and are not different in <italic>BRCA1</italic> and <italic>BRCA2</italic> subgroups. The name of the transcripts is presented in <xref ref-type="supplementary-material" rid="SD1">Supplementary Table 3</xref>.</p>
<fig id="F3" orientation="portrait" position="float">
<label>Figure 3</label>
<caption>
<title>Venn diagram of significantly and differentially expressed transcripts compared with BRCAX unaffected individuals</title>
<p>An intersectional analysis of differentially expressed transcripts compared with BRCAX unaffected was performed. The cut-off value was Bonferroni corrected p-value ≤ 0.01.</p>
</caption>
<graphic xlink:href="oncotarget-08-78691-g003"></graphic>
</fig>
<p>In an attempt to further discriminate unaffected and affected BRCAX individuals, hierarchical clustering was then performed using the 28 gene isoforms discriminating both BRCAX subgroups (Figure <xref ref-type="fig" rid="F4">4</xref>). Although a much better clustering could be observed between both subgroups, these genes could not differentiate distinctly unaffected from affected BRCAX individuals, with 4 affected individuals being located among the unaffected individuals.</p>
<fig id="F4" orientation="portrait" position="float">
<label>Figure 4</label>
<caption>
<title>Hierarchical clustering of the 28 transcripts differentially expressed between BRCAX affected and BRCAX unaffected individuals</title>
<p>Heat map of the TPM (Transcripts Per Million) for 32 women using Euclidean distance with average linkage.</p>
</caption>
<graphic xlink:href="oncotarget-08-78691-g004"></graphic>
</fig>
<p>Further, we performed Scheffé analysis on all the 4 subgroups (<italic>BRCA1</italic>, <italic>BRCA2</italic>, unaffected and affected BRCAX) combined, this allowed us to identify specific transcripts, which are exclusively associated with each subgroup. As listed in Table <xref ref-type="table" rid="T1">1</xref>, although no specific transcripts were specifically associated with <italic>BRCA1</italic> or <italic>BRCA2</italic> individuals, we could identify 67 transcripts specifically associated with <italic>BRCA1/BRCA2</italic> following combination of both subgroups and compared to BRCAX individuals. In addition, 3 and 28 transcripts showed exclusive association with unaffected and affected BRCAX subgroups, respectively.</p>
<table-wrap id="T1" orientation="portrait" position="float">
<label>Table 1</label>
<caption>
<title>Transcripts specifically associated with each group and their corrected p-value</title>
</caption>
<table frame="box" rules="all">
<thead>
<tr>
<th align="center" colspan="4" rowspan="1" valign="middle">Transcript specifically associated with BRCA1/2 carriers when compared to BRCAX unaffected and affected individuals</th>
</tr>
<tr>
<th align="center" colspan="1" rowspan="1" valign="middle">Ensembl transcript ID</th>
<th align="center" colspan="1" rowspan="1" valign="middle">HGNC symbol</th>
<th align="center" colspan="1" rowspan="1" valign="middle">Bonferroni corrected p-value</th>
<th align="center" colspan="1" rowspan="1" valign="middle">Relevant biological process</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000598296</td>
<td align="center" colspan="1" rowspan="1" valign="middle">NOSIP</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.16 E-06</td>
<td align="center" colspan="1" rowspan="1" valign="middle">negative regulation of nitric-oxide synthase activity</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000580799</td>
<td align="center" colspan="1" rowspan="1" valign="middle">GGA3</td>
<td align="center" colspan="1" rowspan="1" valign="middle">4.03 E-04</td>
<td align="center" colspan="1" rowspan="1" valign="middle">positive regulation of protein catabolic process</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000430762</td>
<td align="center" colspan="1" rowspan="1" valign="middle">PPP3CB</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.11 E-03</td>
<td align="center" colspan="1" rowspan="1" valign="middle">positive regulation of transcription from RNA polymerase II promoter</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000486593</td>
<td align="center" colspan="1" rowspan="1" valign="middle">LAMP2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.05 E-03</td>
<td align="center" colspan="1" rowspan="1" valign="middle">regulation of protein stability</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000366726</td>
<td align="center" colspan="1" rowspan="1" valign="middle">GUK1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.18 E-03</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ATP metabolic process</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000438462</td>
<td align="center" colspan="1" rowspan="1" valign="middle">RTN4</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.62 E-03</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Regulation of apoptotic process, cell-cell adhesion, negative regulation of cell growth</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000588730</td>
<td align="center" colspan="1" rowspan="1" valign="middle">C18orf25</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2.76 E-03</td>
<td align="center" colspan="1" rowspan="1" valign="middle">protein ubiquitination involved in ubiquitin-dependent protein catabolic process</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000471658</td>
<td align="center" colspan="1" rowspan="1" valign="middle">PSPC1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">4.22 E-03</td>
<td align="center" colspan="1" rowspan="1" valign="middle">mRNA splicing, negative regulation of transcription</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000490523</td>
<td align="center" colspan="1" rowspan="1" valign="middle">EIF2AK1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">3.26 E-07</td>
<td align="center" colspan="1" rowspan="1" valign="middle">negative regulation of cell proliferation, regulation of translational initiation by eIF2 alpha phosphorylation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000586868</td>
<td align="center" colspan="1" rowspan="1" valign="middle">TBCB</td>
<td align="center" colspan="1" rowspan="1" valign="middle">4.69 E-07</td>
<td align="center" colspan="1" rowspan="1" valign="middle">cell differentiation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000572932</td>
<td align="center" colspan="1" rowspan="1" valign="middle">NOMO3</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.54 E-06</td>
<td align="center" colspan="1" rowspan="1" valign="middle">carbohydrate binding</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000596417</td>
<td align="center" colspan="1" rowspan="1" valign="middle">EEF2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.09 E-06</td>
<td align="center" colspan="1" rowspan="1" valign="middle">positive regulation of translation, cell-cell adhesion, response to estradiol</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000485280</td>
<td align="center" colspan="1" rowspan="1" valign="middle">RAB7A</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.99 E-06</td>
<td align="center" colspan="1" rowspan="1" valign="middle">positive regulation of protein catabolic process, regulation of autophagosome assembly</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000587393</td>
<td align="center" colspan="1" rowspan="1" valign="middle">AES</td>
<td align="center" colspan="1" rowspan="1" valign="middle">3.25 E-06</td>
<td align="center" colspan="1" rowspan="1" valign="middle">negative regulation of canonical Wnt signaling pathway, negative regulation of transcription and protein binding</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000593582</td>
<td align="center" colspan="1" rowspan="1" valign="middle">TRIM28</td>
<td align="center" colspan="1" rowspan="1" valign="middle">4.78 E-06</td>
<td align="center" colspan="1" rowspan="1" valign="middle">positive regulation of DNA repair, positive regulation of transcription, epithelial to mesenchymal transition, protein sumoylation and ubiquitination</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000463243</td>
<td align="center" colspan="1" rowspan="1" valign="middle">HLA-DPA1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.04 E-05</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Immune process, positive regulation of interferon-gamma production</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000476642</td>
<td align="center" colspan="1" rowspan="1" valign="middle">HLA-DPA1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.04 E-05</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Immune process, positive regulation of interferon-gamma production</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000480481</td>
<td align="center" colspan="1" rowspan="1" valign="middle">HLA-DPA1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.04 E-05</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Immune process, positive regulation of interferon-gamma production</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000483480</td>
<td align="center" colspan="1" rowspan="1" valign="middle">HLA-DPA1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.04 E-05</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Immune process, positive regulation of interferon-gamma production</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000486449</td>
<td align="center" colspan="1" rowspan="1" valign="middle">HLA-DPA1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.04 E-05</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Immune process, positive regulation of interferon-gamma production</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000493893</td>
<td align="center" colspan="1" rowspan="1" valign="middle">COMT</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.05 E-05</td>
<td align="center" colspan="1" rowspan="1" valign="middle">estrogen metabolic process, dopamine catabolic process</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000495074</td>
<td align="center" colspan="1" rowspan="1" valign="middle">HLA-DPA1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.04 E-05</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Immune process, positive regulation of interferon-gamma production</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000514979</td>
<td align="center" colspan="1" rowspan="1" valign="middle">HLA-DPA1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.04 E-05</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Immune process, positive regulation of interferon-gamma production</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000524786</td>
<td align="center" colspan="1" rowspan="1" valign="middle">DEAF1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">7.14 E-06</td>
<td align="center" colspan="1" rowspan="1" valign="middle">regulation of mammary gland epithelial cell proliferation, regulation of transcription</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000368439</td>
<td align="center" colspan="1" rowspan="1" valign="middle">CKS1B</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.40 E-05</td>
<td align="center" colspan="1" rowspan="1" valign="middle">regulation of mitotic cell cycle</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000524815</td>
<td align="center" colspan="1" rowspan="1" valign="middle">PACS1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.83 E-05</td>
<td align="center" colspan="1" rowspan="1" valign="middle">positive regulation of protein binding, protein targeting to Golgi</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000515540</td>
<td align="center" colspan="1" rowspan="1" valign="middle">BAX</td>
<td align="center" colspan="1" rowspan="1" valign="middle">3.35 E-05</td>
<td align="center" colspan="1" rowspan="1" valign="middle">DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest, apoptotic process</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000548861</td>
<td align="center" colspan="1" rowspan="1" valign="middle">RP11-603J24.9</td>
<td align="center" colspan="1" rowspan="1" valign="middle">4.07 E-05</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Unknown</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000529698</td>
<td align="center" colspan="1" rowspan="1" valign="middle">DGKZ</td>
<td align="center" colspan="1" rowspan="1" valign="middle">5.99 E-05</td>
<td align="center" colspan="1" rowspan="1" valign="middle">protein kinase C-activating G-protein coupled receptor signaling pathway, cell migration</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000372077</td>
<td align="center" colspan="1" rowspan="1" valign="middle">VEGFA</td>
<td align="center" colspan="1" rowspan="1" valign="middle">9.13 E-05</td>
<td align="center" colspan="1" rowspan="1" valign="middle">growth factor activity, cytokine activity</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000435720</td>
<td align="center" colspan="1" rowspan="1" valign="middle">PSMF1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.51 E-04</td>
<td align="center" colspan="1" rowspan="1" valign="middle">MAPK cascade, regulation of Wnt signaling pathway and ubiquitin-protein ligase activity involved in mitotic cell cycle</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000461760</td>
<td align="center" colspan="1" rowspan="1" valign="middle">STK25</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.53 E-04</td>
<td align="center" colspan="1" rowspan="1" valign="middle">positive regulation of stress-activated MAPK cascade, signal transduction by protein phosphorylation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000492277</td>
<td align="center" colspan="1" rowspan="1" valign="middle">RPL29</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.44 E-04</td>
<td align="center" colspan="1" rowspan="1" valign="middle">cell-cell adhesion, involved in nonsense-mediated decay</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000236957</td>
<td align="center" colspan="1" rowspan="1" valign="middle">EEF1B2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.68 E-04</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Involved in translational elongation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000308774</td>
<td align="center" colspan="1" rowspan="1" valign="middle">TRMT112</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2.13 E-04</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Involved in RNA methylation and translational termination</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000494862</td>
<td align="center" colspan="1" rowspan="1" valign="middle">HDLBP</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2.89 E-04</td>
<td align="center" colspan="1" rowspan="1" valign="middle">cell-cell adhesion and cholesterol metabolic process</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000473991</td>
<td align="center" colspan="1" rowspan="1" valign="middle">PSMD2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">3.14 E-04</td>
<td align="center" colspan="1" rowspan="1" valign="middle">MAPK cascade, regulation of Wnt signaling pathway and ubiquitin-protein ligase activity involved in mitotic cell cycle, tumor necrosis factor-mediated signaling pathway</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000394729</td>
<td align="center" colspan="1" rowspan="1" valign="middle">PRKCD</td>
<td align="center" colspan="1" rowspan="1" valign="middle">4.02 E-04</td>
<td align="center" colspan="1" rowspan="1" valign="middle">apoptotic process, cell cycle, negative regulation of inflammatory response</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000563039</td>
<td align="center" colspan="1" rowspan="1" valign="middle">SPN</td>
<td align="center" colspan="1" rowspan="1" valign="middle">3.96 E-04</td>
<td align="center" colspan="1" rowspan="1" valign="middle">apoptotic signaling pathway, immune response, signal transduction</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000406984</td>
<td align="center" colspan="1" rowspan="1" valign="middle">FTH1P15</td>
<td align="center" colspan="1" rowspan="1" valign="middle">6.76 E-04</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Unknown</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000585935</td>
<td align="center" colspan="1" rowspan="1" valign="middle">RAVER1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.000677355</td>
<td align="center" colspan="1" rowspan="1" valign="middle">mRNA splicing via spliceosome</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000528296</td>
<td align="center" colspan="1" rowspan="1" valign="middle">RPL8</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.000747246</td>
<td align="center" colspan="1" rowspan="1" valign="middle">cytoplasmic translation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000456311</td>
<td align="center" colspan="1" rowspan="1" valign="middle">CAD</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.000787707</td>
<td align="center" colspan="1" rowspan="1" valign="middle">cellular response to drug and epidermal growth factor stimulus</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000595355</td>
<td align="center" colspan="1" rowspan="1" valign="middle">GINS2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.000895068</td>
<td align="center" colspan="1" rowspan="1" valign="middle">double-strand break repair, mitotic DNA replication initiation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000620429</td>
<td align="center" colspan="1" rowspan="1" valign="middle">VPS11</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.000910435</td>
<td align="center" colspan="1" rowspan="1" valign="middle">positive regulation of cellular protein catabolic process, endosome to lysosome transport</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000630977</td>
<td align="center" colspan="1" rowspan="1" valign="middle">VPS11</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.000910435</td>
<td align="center" colspan="1" rowspan="1" valign="middle">positive regulation of cellular protein catabolic process, endosome to lysosome transport</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000352980</td>
<td align="center" colspan="1" rowspan="1" valign="middle">KAT5</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.000987787</td>
<td align="center" colspan="1" rowspan="1" valign="middle">double-strand break repair, regulation of growth and transcription</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000456818</td>
<td align="center" colspan="1" rowspan="1" valign="middle">TUBA4A</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.00110052</td>
<td align="center" colspan="1" rowspan="1" valign="middle">G2/M transition of mitotic cell cycle, cytoskeleton organization</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000517577</td>
<td align="center" colspan="1" rowspan="1" valign="middle">FTH1P11</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.001117274</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Unknown</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000591301</td>
<td align="center" colspan="1" rowspan="1" valign="middle">GNA11</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.00106912</td>
<td align="center" colspan="1" rowspan="1" valign="middle">G-protein coupled acetylcholine receptor signaling pathway, signal transduction</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000523037</td>
<td align="center" colspan="1" rowspan="1" valign="middle">MRPL22</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.001163245</td>
<td align="center" colspan="1" rowspan="1" valign="middle">mitochondrial translational elongation and termination</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000606722</td>
<td align="center" colspan="1" rowspan="1" valign="middle">NDUFA13</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.001321049</td>
<td align="center" colspan="1" rowspan="1" valign="middle">negative regulation of intrinsic apoptotic signaling pathway, of cell growth and transcription</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000381348</td>
<td align="center" colspan="1" rowspan="1" valign="middle">LINC00634</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.001422158</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Unknown</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000594493</td>
<td align="center" colspan="1" rowspan="1" valign="middle">RPS11</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.001903649</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Involved in nonsense-mediated decay and translation processes</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000568265</td>
<td align="center" colspan="1" rowspan="1" valign="middle">TAF1C</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.002079705</td>
<td align="center" colspan="1" rowspan="1" valign="middle">positive regulation of transcription, epigenetic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000597681</td>
<td align="center" colspan="1" rowspan="1" valign="middle">MAP1S</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.002292852</td>
<td align="center" colspan="1" rowspan="1" valign="middle">apoptotic process, microtubule bundle formation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000368436</td>
<td align="center" colspan="1" rowspan="1" valign="middle">CKS1B</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.002744271</td>
<td align="center" colspan="1" rowspan="1" valign="middle">regulation of mitotic cell cycle and transcription</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000537533</td>
<td align="center" colspan="1" rowspan="1" valign="middle">PTPN6</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.004221708</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Regulation of apoptotic process as well as cell differentiation and proliferation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000569760</td>
<td align="center" colspan="1" rowspan="1" valign="middle">FUS</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.004169852</td>
<td align="center" colspan="1" rowspan="1" valign="middle">mRNA splicing via spliceosome and regulation of nucleic acid-templated transcription</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000533397</td>
<td align="center" colspan="1" rowspan="1" valign="middle">RPL8</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.00427335</td>
<td align="center" colspan="1" rowspan="1" valign="middle">cytoplasmic translation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000443451</td>
<td align="center" colspan="1" rowspan="1" valign="middle">NCOR2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.005527765</td>
<td align="center" colspan="1" rowspan="1" valign="middle">negative regulation of transcription</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000487513</td>
<td align="center" colspan="1" rowspan="1" valign="middle">EHMT2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.006799918</td>
<td align="center" colspan="1" rowspan="1" valign="middle">DNA methylation, regulation of transcription and DNA replication</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000552600</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ESPL1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.008498519</td>
<td align="center" colspan="1" rowspan="1" valign="middle">apoptotic process, regulation of mitotic metaphase/anaphase transition and mitotic sister chromatid segregation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000543608</td>
<td align="center" colspan="1" rowspan="1" valign="middle">SPPL3</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.009823731</td>
<td align="center" colspan="1" rowspan="1" valign="middle">T cell receptor signaling pathway, positive regulation of protein dephosphorylation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000405878</td>
<td align="center" colspan="1" rowspan="1" valign="middle">XRCC6</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.10805E-07</td>
<td align="center" colspan="1" rowspan="1" valign="middle">double-strand break repair via classical nonhomologous end joining, regulation of transcription</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000427834</td>
<td align="center" colspan="1" rowspan="1" valign="middle">SGSM3</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.38595E-06</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Activates GTPase and binds to Rab GTPase</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000537739</td>
<td align="center" colspan="1" rowspan="1" valign="middle">HDGF</td>
<td align="center" colspan="1" rowspan="1" valign="middle">4.52676E-06</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Binds to the DNA and helps in cell proliferation and differentiation</td>
</tr>
<tr>
<td align="left" colspan="4" rowspan="1" valign="middle">
<bold>Transcript specifically associated with unaffected BRCAX when compared to BRCA1, BRCA2 and BRCAX affected individuals</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000405878</td>
<td align="center" colspan="1" rowspan="1" valign="middle">XRCC6</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.10805E-07</td>
<td align="center" colspan="1" rowspan="1" valign="middle">double-strand break repair via classical nonhomologous end joining, regulation of transcription</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000427834</td>
<td align="center" colspan="1" rowspan="1" valign="middle">SGSM3</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.38595E-06</td>
<td align="center" colspan="1" rowspan="1" valign="middle">cell cycle arrest, regulation of Rab protein signal transduction</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000537739</td>
<td align="center" colspan="1" rowspan="1" valign="middle">HDGF</td>
<td align="center" colspan="1" rowspan="1" valign="middle">4.52676E-06</td>
<td align="center" colspan="1" rowspan="1" valign="middle">cell proliferation, regulation of transcription and signal transduction</td>
</tr>
<tr>
<td align="left" colspan="4" rowspan="1" valign="middle">
<bold>Transcript specifically associated with affected BRCAX when compared to BRCA1, BRCA2 and BRCAX unaffected individuals</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000419477</td>
<td align="center" colspan="1" rowspan="1" valign="middle">YWHAZ</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.001164657</td>
<td align="center" colspan="1" rowspan="1" valign="middle">regulation of apoptotic process, cell-cell adhesion and establishment of Golgi localization</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000539269</td>
<td align="center" colspan="1" rowspan="1" valign="middle">CARS2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.002107185</td>
<td align="center" colspan="1" rowspan="1" valign="middle">cysteinyl-tRNA aminoacylation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000436614</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ZNF687</td>
<td align="center" colspan="1" rowspan="1" valign="middle">5.67433E-07</td>
<td align="center" colspan="1" rowspan="1" valign="middle">regulation of transcription</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000237837</td>
<td align="center" colspan="1" rowspan="1" valign="middle">FGF23</td>
<td align="center" colspan="1" rowspan="1" valign="middle">6.98876E-06</td>
<td align="center" colspan="1" rowspan="1" valign="middle">MAPK cascade, fibroblast growth factor receptor signaling pathway, regulation of transcription</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000452722</td>
<td align="center" colspan="1" rowspan="1" valign="middle">CADM1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">6.01183E-05</td>
<td align="center" colspan="1" rowspan="1" valign="middle">apoptotic process, regulation of cytokine secretion</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000459748</td>
<td align="center" colspan="1" rowspan="1" valign="middle">RP11-466H18.1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.000157558</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Unknown</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000460469</td>
<td align="center" colspan="1" rowspan="1" valign="middle">NMD3</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.000153464</td>
<td align="center" colspan="1" rowspan="1" valign="middle">protein transport</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000562465</td>
<td align="center" colspan="1" rowspan="1" valign="middle">CDAN1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.000146598</td>
<td align="center" colspan="1" rowspan="1" valign="middle">chromatin assembly, negative regulation of DNA replication</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000495645</td>
<td align="center" colspan="1" rowspan="1" valign="middle">CHPF2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.000410748</td>
<td align="center" colspan="1" rowspan="1" valign="middle">chondroitin sulfate biosynthetic process</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000377861</td>
<td align="center" colspan="1" rowspan="1" valign="middle">PCDH9</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.000632184</td>
<td align="center" colspan="1" rowspan="1" valign="middle">homophilic cell adhesion via plasma membrane adhesion molecules</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000415265</td>
<td align="center" colspan="1" rowspan="1" valign="middle">WDR6</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.000658126</td>
<td align="center" colspan="1" rowspan="1" valign="middle">cell cycle arrest, negative regulation of cell proliferation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000552588</td>
<td align="center" colspan="1" rowspan="1" valign="middle">RPL18</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.00085376</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Involved in nonsense-mediated decay and translational initiation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000374752</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ACAD8</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.001441532</td>
<td align="center" colspan="1" rowspan="1" valign="middle">lipid metabolic process, regulation of transcription</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000449683</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ATP5J2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.001764478</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ATP biosynthetic process</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000513391</td>
<td align="center" colspan="1" rowspan="1" valign="middle">OCIAD1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.001957078</td>
<td align="center" colspan="1" rowspan="1" valign="middle">protein binding</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000547276</td>
<td align="center" colspan="1" rowspan="1" valign="middle">HNRNPA1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.002375206</td>
<td align="center" colspan="1" rowspan="1" valign="middle">fibroblast growth factor receptor signaling pathway, gene expression, mRNA splicing</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000525085</td>
<td align="center" colspan="1" rowspan="1" valign="middle">NDUFC2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.003100189</td>
<td align="center" colspan="1" rowspan="1" valign="middle">mitochondrial electron transport, NADH to ubiquinone</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000500813</td>
<td align="center" colspan="1" rowspan="1" valign="middle">DCTD</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.003245736</td>
<td align="center" colspan="1" rowspan="1" valign="middle">nucleotide biosynthetic process</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000612832</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ARHGAP21</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.004173962</td>
<td align="center" colspan="1" rowspan="1" valign="middle">organelle transport along microtubule, Golgi organization</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000535413</td>
<td align="center" colspan="1" rowspan="1" valign="middle">MLEC</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.004822683</td>
<td align="center" colspan="1" rowspan="1" valign="middle">carbohydrate metabolic process, protein folding</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000498022</td>
<td align="center" colspan="1" rowspan="1" valign="middle">NAGK</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.004945162</td>
<td align="center" colspan="1" rowspan="1" valign="middle">UDP-N-acetylglucosamine biosynthetic process</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000444034</td>
<td align="center" colspan="1" rowspan="1" valign="middle">MED12</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.005486952</td>
<td align="center" colspan="1" rowspan="1" valign="middle">canonical Wnt signaling pathway, intracellular steroid hormone receptor signaling pathway, regulation of transcription</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000522754</td>
<td align="center" colspan="1" rowspan="1" valign="middle">NCALD</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.006089983</td>
<td align="center" colspan="1" rowspan="1" valign="middle">calcium-mediated signaling</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000552819</td>
<td align="center" colspan="1" rowspan="1" valign="middle">PCBP2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.002187131</td>
<td align="center" colspan="1" rowspan="1" valign="middle">mRNA metabolic process, mRNA splicing, defense response to virus</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000528413</td>
<td align="center" colspan="1" rowspan="1" valign="middle">IRF7</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.002697978</td>
<td align="center" colspan="1" rowspan="1" valign="middle">cellular response to DNA damage stimulus, interferon-gamma-mediated signaling pathway, regulation of transcription and immune response</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000405878</td>
<td align="center" colspan="1" rowspan="1" valign="middle">XRCC6</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.10805E-07</td>
<td align="center" colspan="1" rowspan="1" valign="middle">double-strand break repair via classical nonhomologous end joining, regulation of transcription</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000427834</td>
<td align="center" colspan="1" rowspan="1" valign="middle">SGSM3</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.38595E-06</td>
<td align="center" colspan="1" rowspan="1" valign="middle">cell cycle arrest, regulation of Rab protein signal transduction</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ENST00000537739</td>
<td align="center" colspan="1" rowspan="1" valign="middle">HDGF</td>
<td align="center" colspan="1" rowspan="1" valign="middle">4.52676E-06</td>
<td align="center" colspan="1" rowspan="1" valign="middle">IRE1-mediated unfolded protein response, cell proliferation, regulation of transcription and signal transduction</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Of interest, out of 67 transcripts specifically associated with <italic>BRCA1/BRCA2</italic> subgroups combined, 19 transcripts (28%) were involved in DNA repair, cell proliferation, apoptosis and cell cycle, 32 (48%) different transcripts exert an action in transcription, translation as well as mRNA and protein metabolic processes, while 10 transcripts (15%) were involved in immune processes. Regarding the 28 transcripts exclusively associated with BRCAX affected individuals, more than 28% were involved in DNA repair/proliferation/apoptosis/cell cycle mechanisms, and approximately 43% (12 transcripts) were implicated in transcription and translation-related processes. It should be noted that <italic>XRCC6</italic>, <italic>SGSM3</italic> and <italic>HDGF</italic> transcripts were associated with <italic>BRCA1/BRCA2</italic>, BRCAX unaffected and BRCAX affected individuals given that their expression was differentially expressed between all three subgroups. The expression of <italic>SGSM3</italic> and <italic>HDGF</italic> was validated by qPCR in BRCAX subgroup to differentiate affected from non-affected patients (<xref ref-type="supplementary-material" rid="SD2">Supplementary Figure 1</xref>). The expression level of these genes was also checked in different mammalian breast cancer cell lines. Further, ANOVA analysis highlighted that <italic>H3F3B</italic> was differentially expressed in <italic>BRCA1</italic> and <italic>BRCA2</italic> subgroups, which was also evaluated by qPCR (<xref ref-type="supplementary-material" rid="SD2">Supplementary Figure 1</xref>).</p>
<p>The 85 genes associated with the 95 significant transcripts identified as differentially expressed between <italic>BRCA1</italic>, <italic>BRCA2</italic> and BRCAX (unaffected or affected) individuals were then submitted for pathway and molecular function analyses. Using Ingenuity Pathway analysis, enrichment of several canonical pathways and functions were identified. It should be noted that mapped genes can be classified in more than one biological process or metabolic process.</p>
<p>Moreover, as described in Table <xref ref-type="table" rid="T2">2</xref>, cell death and survival (top p-value: 2.46 × 10<sup>−5</sup> with 34 molecules), cellular function and maintenance (top p-value: 6.77 × 10<sup>−5</sup> with 25 molecules), cell cycle (top p-value: 7.41 × 10<sup>−5</sup> with 15 molecules), post-translational modification (top p-value: 2.03 × 10<sup>−4</sup> with 11 molecules) as well as cell morphology (top p-value: 2.07 × 10<sup>−4</sup> with 17 molecules) represent the top overrepresented functions associated with these 85 genes. In addition, organismal injury, cell signaling, cell cycle and cell death represent the top networks associated with the whole gene set. Of great interest, these genes were also associated with Cancer and Organismal Injury and Abnormalities (Table <xref ref-type="table" rid="T2">2</xref>).</p>
<table-wrap id="T2" orientation="portrait" position="float">
<label>Table 2</label>
<caption>
<title>Overrepresented functions, network and diseases for significantly and differentially expressed transcripts</title>
</caption>
<table frame="box" rules="all">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" valign="middle">Molecular and cellular functions</th>
<th align="center" colspan="1" rowspan="1" valign="middle">Top p-value*</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Cell Death and Suvival [<xref ref-type="bibr" rid="R34">34</xref>]</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2.46E-05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Cellular Function and Maintenance [<xref ref-type="bibr" rid="R25">25</xref>]</td>
<td align="center" colspan="1" rowspan="1" valign="middle">6.77E-05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Cell Cycle [<xref ref-type="bibr" rid="R15">15</xref>]</td>
<td align="center" colspan="1" rowspan="1" valign="middle">7.41E-05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Post-Translational Modification [<xref ref-type="bibr" rid="R11">11</xref>]</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2.03E-04</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Cell Morphology [<xref ref-type="bibr" rid="R17">17</xref>]</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2.07E-04</td>
</tr>
</tbody>
</table>
<table frame="box" rules="all">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="middle">Top Networks</th>
<th align="center" colspan="1" rowspan="1" valign="middle">Score</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Organismal Injury and Abnormalities, Renal and Urological Disease, Embryonic Development</td>
<td align="center" colspan="1" rowspan="1" valign="middle">61</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Psychological Disorders, Cancer, Cell Cycle</td>
<td align="center" colspan="1" rowspan="1" valign="middle">29</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Cell Signaling, Cell-To-Cell Signaling and Interaction, Cell Death and Survival</td>
<td align="center" colspan="1" rowspan="1" valign="middle">25</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Cell Cycle, Cancer, Organismal Injury and Abnormalities</td>
<td align="center" colspan="1" rowspan="1" valign="middle">22</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Cell Death and Survival, Cancer, Gastrointestinal Disease</td>
<td align="center" colspan="1" rowspan="1" valign="middle">15</td>
</tr>
</tbody>
</table>
<table frame="box" rules="all">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="middle">Diseases and disorders</th>
<th align="center" colspan="1" rowspan="1" valign="middle">Top p-value*</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Cancer [<xref ref-type="bibr" rid="R71">71</xref>]</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.45E-05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Organismal Injury and Abnormalities [<xref ref-type="bibr" rid="R73">73</xref>]</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.45E-05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Renal and Urological Disease [<xref ref-type="bibr" rid="R27">27</xref>]</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.45E-05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Neurological Disease [<xref ref-type="bibr" rid="R27">27</xref>]</td>
<td align="center" colspan="1" rowspan="1" valign="middle">4.17E-05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Hematological Disease [<xref ref-type="bibr" rid="R34">34</xref>]</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.86E-04</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>*Top P-value of the p-value range.</p>
</table-wrap-foot>
</table-wrap>
<p>The IPA analysis was also performed using the 28 genes discriminating unaffected from affected BRCAX individuals. As presented in Table <xref ref-type="table" rid="T3">3</xref>, BRCAX-related genes were particularly associated with Telomere Extension by Telomerase, DNA Double-Strand Break Repair by Non-Homologous End Joining as well as specific molecule degradation and biosynthesis (p-value ranging from 1.66 × 10<sup>−4</sup> to 0.05). The top system development and functions represented by these genes were tissue development (top p-value: 1.28 × 10<sup>−3</sup> with 5 molecules), embryonic development (top p-value: 1.28 × 10<sup>−3</sup>) and Immune Cell Trafficking (top p-value: 1.28 × 10<sup>−3</sup>) (data not shown).</p>
<table-wrap id="T3" orientation="portrait" position="float">
<label>Table 3</label>
<caption>
<title>The most significant canonical pathways enriched for significantly and differentially expressed transcripts between BRCAX affected and BRCAX unaffected</title>
</caption>
<table frame="box" rules="all">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" valign="middle">IPA canonical enriched pathways</th>
<th align="center" colspan="1" rowspan="1" valign="middle">Number of gene in pathways</th>
<th align="center" colspan="1" rowspan="1" valign="middle">p-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Telomere Extension by Telomerase</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.66E-04</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">N-acetylglucosamine Degradation II</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">5.13E-03</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">CMP-N-acetylneuraminate Biosynthesis I (Eukaryotes)</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">6.46E-03</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Chondroitin and Dermatan Biosynthesis</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">7.76E-03</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">DNA Double-Strand Break Repair by Non-Homologous End Joining</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.78E-02</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Isoleucine Degradation I</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.78E-02</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Valine Degradation I</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2.29E-02</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">tRNA Charging</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">4.90E-02</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>Analyses were performed using genes associated with significantly and differentially expressed transcripts between BRCAX affected and BRCAX unaffected using bonferroni correct p-value &lt;0.01.</p>
</table-wrap-foot>
</table-wrap>
<p>In addition, cell-to-cell signaling and interaction, cellular development, cellular growth and proliferation, cellular movement and lipid metabolism (top p-value at 1.28 × 10<sup>−3</sup>) represented the enriched functions (Table <xref ref-type="table" rid="T4">4</xref>). As also described in this table, IPA analysis revealed that these genes were involved in networks such as “Cell death and survival” as well as “Connective tissue disorders and metabolic diseases” with 38 and 26 molecules, respectively.</p>
<table-wrap id="T4" orientation="portrait" position="float">
<label>Table 4</label>
<caption>
<title>Overrepresented functions, network and diseases for significantly and differentially expressed transcripts between BRCAX affected and BRCAX unaffected</title>
</caption>
<table frame="box" rules="all">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" valign="middle">Molecular and cellular functions</th>
<th align="center" colspan="1" rowspan="1" valign="middle">Top p-value*</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Cell-To-Cell Signaling and Interaction [<xref ref-type="bibr" rid="R4">4</xref>]</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.28E-03</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Cellular Development [<xref ref-type="bibr" rid="R7">7</xref>]</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.28E-03</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Cellular Growth and Proliferation [<xref ref-type="bibr" rid="R4">4</xref>]</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.28E-03</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Cellular Movement [<xref ref-type="bibr" rid="R2">2</xref>]</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.28E-03</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Lipid Metabolism [<xref ref-type="bibr" rid="R1">1</xref>]</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.28E-03</td>
</tr>
</tbody>
</table>
<table frame="box" rules="all">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="middle">Top networks</th>
<th align="center" colspan="1" rowspan="1" valign="middle">Score</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Cell Death and Survival, Cell Morphology, Hair and Skin Development and Function</td>
<td align="center" colspan="1" rowspan="1" valign="middle">38</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Connective Tissue Disorders, Metabolic Disease, Nutritional Disease</td>
<td align="center" colspan="1" rowspan="1" valign="middle">26</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Cellular Assembly and Organization, DNA Replication, Recombination, and Repair, Nucleic Acid Metabolism</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2</td>
</tr>
</tbody>
</table>
<table frame="box" rules="all">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="middle">Diseases and disorders</th>
<th align="center" colspan="1" rowspan="1" valign="middle">Top p-value*</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Connective Tissue Disorders [<xref ref-type="bibr" rid="R3">3</xref>]</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2.37E-05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Metabolic Disease [<xref ref-type="bibr" rid="R3">3</xref>]</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2.37E-05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Nutritional Disease [<xref ref-type="bibr" rid="R2">2</xref>]</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2.37E-05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Skeletal and Muscular Disorders [<xref ref-type="bibr" rid="R4">4</xref>]</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2.37E-05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Cancer [<xref ref-type="bibr" rid="R26">26</xref>]</td>
<td align="center" colspan="1" rowspan="1" valign="middle">5.46E-04</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><bold>*</bold> Top P-value of the p-value range.</p>
<p>The number of genes involved in the process is given in parentheses.</p>
<p>Analyses were performed using genes associated with significantly and differentially expressed transcripts between BRCAX affected and BRCAX unaffected using bonferroni correct p-value &lt;0.01.</p>
</table-wrap-foot>
</table-wrap>
<p>Moreover, “cancer” (top p-value: 5.46 × 10<sup>−4</sup> with 26 molecules) represented the disease associated with the highest number of molecules. Altogether, these analyses revealed enrichment of several pathways and functions involved in key mechanisms required for carcinogenesis development.</p>
</sec>
<sec id="s3">
<title>DISCUSSION</title>
<p>In this study, we analyzed the genome-wide transcription profile observed in LCLs immortalized from high-risk breast cancer families. To our knowledge, this is the first study describing clustering of <italic>BRCA1</italic>, <italic>BRCA2</italic> and unaffected/affected BRCAX individuals based on their whole gene expression profile observed in corresponding LCLs.</p>
<p>The reliability of using LCLs from affected individuals for a given disease with regard to expression studies or splicing signatures has already been established [<xref ref-type="bibr" rid="R18">18</xref>-<xref ref-type="bibr" rid="R28">28</xref>]. A particular study conducted by Hussain and colleague concluded that LCLs were a good reflection of isolated lymphocytes given their close resemblance at the genetic and phenotypic levels to parent lymphocytes and were a valuable resource for studies regarding genotype-phenotype interactions [<xref ref-type="bibr" rid="R39">39</xref>] and inter-individual variations associated with various diseases and disorders such as cancer or infectious disease [<xref ref-type="bibr" rid="R40">40</xref>-<xref ref-type="bibr" rid="R42">42</xref>]. In addition, peripheral blood mononuclear cells (PBMCs) have also been used to investigate the links between DNA damage response, immunity and cancer [<xref ref-type="bibr" rid="R43">43</xref>] and to study the early stages of breast cancer development on gene expression patterns [<xref ref-type="bibr" rid="R44">44</xref>].</p>
<p>As described in other studies [<xref ref-type="bibr" rid="R45">45</xref>-<xref ref-type="bibr" rid="R47">47</xref>], we used ANOVA analysis of variance with the Scheffé multiple post-hoc test to identify transcripts specifically regulated in <italic>BRCA1</italic>, <italic>BRCA2</italic> as well as in unaffected and affected BRCAX individuals. Using gene expression data of the 95 significant gene isoforms, our clustering results allowed discrimination of <italic>BRCA</italic> subgroups, particularly <italic>BRCA1/2</italic> from BRCAX individuals.</p>
<p>This is in agreement with other studies in which gene expression in LCLs was successfully used for clustering analysis in several diseases including autism spectrum disorders and spinocerebellar ataxia (<italic>SCA28</italic>) [<xref ref-type="bibr" rid="R48">48</xref>, <xref ref-type="bibr" rid="R49">49</xref>]. Moreover, LCLs served as a model system to assess genotype–phenotype relationships in human cells, including studies for quantitative trait loci influencing levels of individual mRNAs and responses to drugs and radiation [<xref ref-type="bibr" rid="R50">50</xref>-<xref ref-type="bibr" rid="R53">53</xref>], as well as regarding the haploinsufficiency effects of various <italic>BRCA1</italic> mutation [<xref ref-type="bibr" rid="R54">54</xref>].</p>
<p>Over the last decade, several investigations clustered breast tumors based on single gene expression levels as well as their gene/splicing expression profile or molecular and clinical characteristics. The first correlation between the tumor phenotypic diversity (histopathological and clinical characteristics) and gene expression patterns was demonstrated in 2000 by Perou and colleague [<xref ref-type="bibr" rid="R55">55</xref>-<xref ref-type="bibr" rid="R58">58</xref>]. Van’t Veer et al. conducted clustering analyses of breast tumors based on their gene expression profile and determined a predictive signature of metastases development (poor prognosis) in patients without tumoral cells in local lymph node at diagnosis and established a specific signature of <italic>BRCA1</italic> tumors [<xref ref-type="bibr" rid="R56">56</xref>]. Clustering analyses of breast tumors based on whole gene expression revealed familial aggregation of BRCA-related tumors and of specific molecular subtypes including Basal, <italic>HER2</italic>-enriched, Luminal A and B as well as Normal-like and sporadic tumors [<xref ref-type="bibr" rid="R38">38</xref>, <xref ref-type="bibr" rid="R55">55</xref>-<xref ref-type="bibr" rid="R57">57</xref>, <xref ref-type="bibr" rid="R59">59</xref>-<xref ref-type="bibr" rid="R70">70</xref>]. In addition, alternative splicing expression profile was also successfully used in several studies aiming to discriminate subtypes of breast tumors [<xref ref-type="bibr" rid="R71">71</xref>-<xref ref-type="bibr" rid="R73">73</xref>], and specific gene expression profiles have also been identified for <italic>BRCA1</italic>, <italic>BRCA2</italic> and <italic>CHEK2</italic>-associated breast tumors [<xref ref-type="bibr" rid="R62">62</xref>, <xref ref-type="bibr" rid="R74">74</xref>].</p>
<p>To our knowledge, the only clustering analysis involving LCLs in breast cancer classification distinguished BRCA1 carrier from non-carrier individuals [<xref ref-type="bibr" rid="R75">75</xref>], in which 133 genes were found to be differentially expressed between <italic>BRCA1</italic>-mutated and non-carriers. However, hierarchical clustering of these genes did not result in an accurate discrimination between both subgroups. Of these 133 genes identified by Vuillaume <italic>et al.</italic> [<xref ref-type="bibr" rid="R75">75</xref>], the <italic>RPL29</italic> and <italic>PSMF1</italic> genes have also been identified in our comparison between <italic>BRCA1/2</italic> and BRCAX individuals. <italic>RPL29</italic> is a ribosomal protein, involved in RNA interaction and protein synthesis, while <italic>PSMF1</italic> gene encodes a proteasome inhibitor protein involved in protein folding and degradation [<xref ref-type="bibr" rid="R76">76</xref>, <xref ref-type="bibr" rid="R77">77</xref>].</p>
<p>We then compared our results with GTEx Portal database, which contains normalized expression data from RNA sequencing for each gene and transcripts for different types of tissues. The normalization of expression was done by similar method for all databases. The expression values for genes from EBV transformed lymphocytes are available, and the normalized expression values in this database are similar with the ones we obtained [<xref ref-type="bibr" rid="R78">78</xref>]. In addition, we performed correlation between TPM value and FPKM value by doing a regression analysis using the values for each sample in the analysis and we found significant correlation between both of them.</p>
<p>We also compared our gene lists with the lists for up and down regulated genes associated with breast cancer using BioXpress, a curated gene expression and disease association database using RNA sequencing from TCGA database [<xref ref-type="bibr" rid="R79">79</xref>]. A certain number of our significant genes were common. Indeed, there were 5 genes that were present in our list and in the up regulated list for breast cancer (<italic>RAP2C</italic>, <italic>SPN</italic>, <italic>GINS2</italic>, <italic>ESPL1</italic> and <italic>IRF7</italic>). Regarding the list for down regulated genes associated with breast cancer, 3 genes were also present in our list (<italic>HLA-DPA1</italic>, <italic>PCDH9</italic> and <italic>NCALD</italic>).</p>
<p>Among the highest significant genes associated with <italic>BRCA1/2</italic> subgroups, some of them (p-values ranging from 1.1 × 10<sup>−7</sup> to 4.5 × 10<sup>−6</sup>) namely <italic>NOSIP</italic>, <italic>EIF2AK1</italic>, <italic>TBCB</italic>, <italic>XRCC6</italic>, <italic>SGSM3</italic> and <italic>HDGF</italic> are involved in key mechanisms implicated in carcinogenesis susceptibility.</p>
<p>The expression of the <italic>NOSIP</italic> gene was upregulated and <italic>EIF2AK1</italic> and <italic>TBCB</italic> were downregulated in <italic>BRCA1/2</italic> individuals when compared to BRCAX subgroups. The eNOS Interacting Protein <italic>NOSIP</italic> was identified as an interacting protein of the endothelial isoform of nitric oxide synthase (eNOS) to enhance its translocation to intracellular membrane [<xref ref-type="bibr" rid="R80">80</xref>].</p>
<p>The <italic>EIF2AK1</italic> gene is involved in the modulation of the basal hepatic endoplasmic reticulum stress tone [<xref ref-type="bibr" rid="R81">81</xref>]. Although no information links this gene to breast cancer, it has been demonstrated in a mouse xenograft model of human breast cancer that an activator of <italic>EIF2AK1</italic> protein was associated with tumor growth inhibition compared with vehicle [<xref ref-type="bibr" rid="R82">82</xref>]. Thus, its downregulation in <italic>BRCA1/2</italic> individuals could promote tumor development.</p>
<p>Regarding <italic>TBCB</italic>, this protein is involved in regulation of axonal growth and microtubule functional diversity and dynamics [<xref ref-type="bibr" rid="R83">83</xref>]. This protein was shown to be overexpressed and phosphorylated in breast tumors [<xref ref-type="bibr" rid="R84">84</xref>]. Therefore the effect of its decreased expression in <italic>BRCA1/2</italic> individuals remains to be investigated.</p>
<p>Of great interest, specific expression levels of <italic>XRCC6</italic>, <italic>SGSM3</italic> and <italic>HDGF</italic> genes were also associated with BRCAX individuals (unaffected and affected). These genes are involved in DNA repair as well as in the regulation of cell cycle, cell proliferation and transcription, and were differentially expressed between <italic>BRCA1/2</italic>, unaffected BRCAX and affected BRCAX individual. These genes showed the highest expression in affected BRCAX and the lowest expression in <italic>BRCA1</italic> and <italic>BRCA2</italic> subgroups. Indeed, a similar and progressive pattern of expression values for all three genes was observed between subgroups (BRCAX affected &gt; BRCAX unaffected &gt; <italic>BRCA1/2</italic> individuals) as presented in <xref ref-type="supplementary-material" rid="SD1">Supplementary Table 2</xref>. Futhermore, the study highlighted few genes which could discriminate <italic>BRCA1</italic> from <italic>BRCA2</italic> subgroup, amongst them the highest difference was depicted by <italic>H3F3B.</italic></p>
<p><italic>XRCC6</italic> gene encodes the Ku70 protein, which is a component of the non-homologous end joining (NHEJ) DNA repair pathway. This pathway is an alternative mechanism to homologous recombination (HR) repair pathway involved in double-strand break (DSB) repair in mammalian cells [<xref ref-type="bibr" rid="R85">85</xref>]. Defect or variation of expression of <italic>NHEJ</italic> genes such as <italic>XRCC6</italic>, might escape cell cycle checkpoint surveillance and could lead to suboptimal DNA repair and subsequently to accumulation of DNA damage and carcinogenesis initiation [<xref ref-type="bibr" rid="R86">86</xref>-<xref ref-type="bibr" rid="R88">88</xref>]. Given the key roles of BRCA1/2 in HR repair pathway [<xref ref-type="bibr" rid="R89">89</xref>], defective activity of BRCA1/2 proteins found in some individuals combined with low expression of <italic>NHEJ</italic>-associated genes could likely increase the accumulation of DNA damage in BRCA1/2 individuals. Indeed, this low expression of Ku70 was previously observed in BRCA1-deficient cell lines [<xref ref-type="bibr" rid="R90">90</xref>]. On the other hand, the high expression of <italic>XRCC6</italic> in BRCAX individuals affected with breast cancer remains to be elucidated. Moreover, polymorphisms in <italic>XRCC6</italic> gene have been shown to increase breast cancer susceptibility as well as other types of cancer [<xref ref-type="bibr" rid="R91">91</xref>-<xref ref-type="bibr" rid="R96">96</xref>].</p>
<p>SGSM3 is a member of the small G protein signaling modulators, which is associated with small G protein coupled receptor signal transduction pathway [<xref ref-type="bibr" rid="R97">97</xref>]. The human SGSM3 proteins were demonstrated to coprecipitate with RAP and RAB subfamily members of the small G protein superfamily. Therefore it has been suggested that the SGSM family members exert a role as modulators of the small G protein RAP and RAB-mediated neuronal signal transduction and vesicular transportation pathways [<xref ref-type="bibr" rid="R97">97</xref>]. The only information in the literature associating this protein with breast cancer described a decrease of <italic>SGSM3</italic> mRNA in breast cancer tissue compared to normal tissue [<xref ref-type="bibr" rid="R98">98</xref>], which is in contrast with the significant increase of expression in LCLs of BRCAX affected individuals observed in our study. However, in the study performed by Nourashrafeddin <italic>et al.</italic> using basic RT-PCR method and visualization on agarose gel [<xref ref-type="bibr" rid="R98">98</xref>], <italic>SGSM3</italic> was not detected in normal and cancerous tissues, illustrating the very low expression of this gene in breast tissues. It should be noted that a polymorphism (rs17001868) found in the <italic>SGSM3</italic> gene has been associated with mammographic dense areas of the breast [<xref ref-type="bibr" rid="R99">99</xref>], which represents a factor of breast cancer risk [<xref ref-type="bibr" rid="R100">100</xref>-<xref ref-type="bibr" rid="R102">102</xref>]. <italic>SGSM3</italic> has also been associated with hepatocellular carcinoma [<xref ref-type="bibr" rid="R103">103</xref>].</p>
<p>The Hepatoma-derived growth factor (<italic>HDGF</italic>) is now recognized as a breast cancer-associated gene and promotes the epithelial-mesenchymal transition (EMT) [<xref ref-type="bibr" rid="R104">104</xref>]. EMT is a hallmark of many cancers characterized by an increased cell invasion, which enhances the initial phase of metastatic progression [<xref ref-type="bibr" rid="R105">105</xref>, <xref ref-type="bibr" rid="R106">106</xref>]. HDGF is overexpressed in several types of cancers including breast cancer cell lines and tissues and correlates with poor prognosis [<xref ref-type="bibr" rid="R104">104</xref>, <xref ref-type="bibr" rid="R107">107</xref>-<xref ref-type="bibr" rid="R112">112</xref>]. Blockade of HDGF using a specific antibody results in the inhibition of malignant features and EMT of breast cancer cells [<xref ref-type="bibr" rid="R104">104</xref>]. Thus, its overexpression in breast cancer tissues is in concordance with our results demonstrating the overexpression of <italic>HDGF</italic> in LCLs of BRCAX individuals affected with breast cancer. Hence, this protein could be considered as a prognostic factor for tumor metastasis and recurrence.</p>
<p>H3 Histone Family Member 3B (<italic>H3F3B</italic>) is part of core histone molecule and has a role in gene regulation, DNA repair, DNA replication and chromosomal stability. Mutations in <italic>H3F3B</italic> gene have been associated with several cancers including brain cancer, giant cell tumor of bone and colorectal cancer [<xref ref-type="bibr" rid="R113">113</xref>-<xref ref-type="bibr" rid="R115">115</xref>]. Overexpression of this gene is also associated with colorectal cancer. In breast cancer, the copy number of the chromosome carrying this gene is significantly high [<xref ref-type="bibr" rid="R116">116</xref>], which is further confirmed by the data from the human protein atlas data.</p>
<p>In addition to <italic>XRCC6</italic>, <italic>SGSM3</italic> and <italic>HDGF</italic> genes as described above, <italic>ZNF687</italic> and <italic>FGF23</italic> genes were also associated with and upregulated in BRCAX affected individuals when compared to unaffected individuals.</p>
<p><italic>ZNF687</italic> encodes a zinc finger protein and represents an important regulator of skeletal development and maintenance [<xref ref-type="bibr" rid="R117">117</xref>]. Overexpression of <italic>ZNF687</italic> has been observed in tumor tissue of individual giant cell tumor of bone associated with Paget disease of bone, and this high expression is also observed in the peripheral blood of patients affected with Paget disease [<xref ref-type="bibr" rid="R118">118</xref>]. The role of <italic>ZNF687</italic> in breast cancer is unknown.</p>
<p>As to fibroblast growth factor 23 (FGF23), it is a binding partner of Klotho proteins for endocrine signaling through the action of FGFRs. These FGFR receptors are involved in several mechanisms such as regulation of cell survival, proliferation, differentiation and motility during embryogenesis as well as tissue homeostasis and carcinogenesis [<xref ref-type="bibr" rid="R119">119</xref>-<xref ref-type="bibr" rid="R122">122</xref>]. Indeed, FGF23 signaling promotes proliferation in myeloma cells [<xref ref-type="bibr" rid="R123">123</xref>], while increase of FGF23 levels in serum were observed in cancer patients, and were also elevated in patients with non-cancerous diseases, such as hypophosphatemic rickets and chronic kidney diseases [<xref ref-type="bibr" rid="R124">124</xref>].</p>
<p>Considering all significant genes identified following ANOVA analysis of gene expression data observed in four <italic>BRCA</italic> subgroups, several interesting pathways seem to be affected by the regulation of specific genes. Among these pathways, <italic>EIF2</italic> signaling, <italic>14-3-3</italic>-mediated pathway and <italic>mTOR</italic> signaling are particularly significant and relevant to breast cancer. Moreover, both the <italic>EIF2</italic> (through the activation of the <italic>PI3K</italic> pathway) and 14-3-3-mediated signaling cascades regulate the <italic>mTOR</italic> pathway [<xref ref-type="bibr" rid="R125">125</xref>, <xref ref-type="bibr" rid="R126">126</xref>], which is involved in the response to hormones and growth factor stimulation and is well known to exert a significant role in tumor cell growth and proliferation as well as in breast cancer development [<xref ref-type="bibr" rid="R127">127</xref>] and references therein.</p>
<p>On the other hand, cell death and survival, cellular function and maintenance as well as cell cycle represent the highest enriched functions, while cancer remains among the diseases/disorders having the highest p-value, which is associated with a high number of genes involved in cancer-related pathways.</p>
<p>Taken together, in the present study, we compared gene expression profiles in lymphoblastoid cell lines in <italic>BRCA1</italic>- and <italic>BRCA2</italic>- carriers as well as BRCAX affected and unaffected individuals from high-risk breast cancer families in order to determine specific markers which could be of great relevance for further studies. Indeed, several transcripts have been identified as potential valuable markers of interest for breast cancer, and deserve further analysis.</p>
</sec>
<sec id="s4">
<title>MATERIALS AND METHODS</title>
<sec id="s4_1">
<title>Ascertainment of high-risk families</title>
<p>Recruitment of high-risk French Canadian breast and ovarian cancer families started in 1996 as a large interdisciplinary research program designated INHERIT BRCAs [<xref ref-type="bibr" rid="R12">12</xref>]. The High risk group is defined as families with a history of breast cancer with at least 3 cases in 1<sup>st</sup> degree relative or 4 cases in 2<sup>nd</sup> degree relative, the full selection criteria have been published previously [<xref ref-type="bibr" rid="R12">12</xref>]. Patients were screened for deleterious mutations in <italic>BRCA1</italic> and <italic>BRCA2</italic> genes. The <italic>BRCA</italic> testing was done by complete sequencing of the <italic>BRCA1/2</italic> gene by using primers in both directions (forward and reverse). Confirmation was done by Myriad Laboratories. A subset of 96 high-risk families with no deleterious mutation in <italic>BRCA1</italic> or <italic>BRCA2</italic> were recruited (BRCAX families) as described elsewhere [<xref ref-type="bibr" rid="R128">128</xref>, <xref ref-type="bibr" rid="R129">129</xref>]. For the purpose of this study, carriers of a <italic>BRCA1</italic> or <italic>BRCA2</italic> mutation were selected. As for the BRCAX families, the youngest available breast cancer case in the family was selected, along with the oldest non-affected sister. All unaffected women were post-menopausal. All individuals provided their written informed consent in order for their genetic material to be part of a biobank (Dr J. Simard, director). The age range of affected <italic>BRCA1, BRCA2</italic> and BRCAX were 23-65, 29-72 and 35-70 respectively. For unaffected <italic>BRCA1, BRCA2</italic> and BRCAX the age range was 35-66, 37-77 and 41-86 respectively.</p>
<sec id="s4_1_1">
<title>Cell line immortalization and RNA extraction</title>
<p>Lymphocytes (LCLs) were isolated and immortalized from 7 to 9 mL of blood samples from breast cancer individuals using Epstein-Barr virus in 15% RPMI medium as previously described [<xref ref-type="bibr" rid="R128">128</xref>, <xref ref-type="bibr" rid="R130">130</xref>, <xref ref-type="bibr" rid="R131">131</xref>]. Total RNA was extracted from LCLs using TRI Reagent (Molecular Reasearch Center Inc, Cincinnati, OH, USA) according to the manufacturer’s instructions as described previously [<xref ref-type="bibr" rid="R128">128</xref>]. The viral strain, number of passage and conditions for cell lines were kept identical to avoid bias in gene expression [<xref ref-type="bibr" rid="R133">133</xref>].</p>
</sec>
<sec id="s4_1_2">
<title>RNA-seq experiments</title>
<p>The quality of RNA samples was evaluated with an Agilent Bioanalyzer 2100 to determine the RIN (RNA Integrity) score using the Agilent RNA 6000 Nano chip and reagents. Samples with a RIN score &gt;7 were retained and converted to cDNA with the Illumina RNA seq kit for sequence library preparation based on the Illumina TruSeq RNA Sample Preparation protocol. The final libraries were pooled in triplicate and then sequenced on an Illumina HiSeq 2000 at the McGill University and Génome Québec Innovation Centre.</p>
<p>Raw reads were trimmed for length (n&gt;=32), quality (phred33 score &gt;= 30) and adaptor sequence using fastxv0.0.13.1. Trimmed paired-end reads (read length: 100 bp) were aligned to the hg19 human reference genome using Tophat version v1.4.0 [<xref ref-type="bibr" rid="R132">132</xref>]. The resulting alignment file was indexed using samtools v0.1.18. Raw, trimmed and aligned read numbers were retrieved after alignment to determine the quality of the sequence data. GATK (v1.0.5777) [<xref ref-type="bibr" rid="R134">134</xref>] was then used to compute the coding sequence coverage for each sample. Raw read counts and normalized read counts (in transcript per million, TPM) were obtained using the Kallisto v0.43.0 quant command [<xref ref-type="bibr" rid="R135">135</xref>] with the default parameter on the GRCh38.rel79 version of the human transcriptome, while Pearson correlation values were obtained pairwise for each sample using R v2.12.0. Differential gene expression was determined using edgeRv2.2.6 [<xref ref-type="bibr" rid="R136">136</xref>] on R v2.12.0 and DESeqv1.6.1 [<xref ref-type="bibr" rid="R137">137</xref>] on R v2.14.0. Transcript differential expression was performed using cuffdiff v1.3.0. A gene ontology analysis was then launched on gene and transcript differential expression results using goseqv1.2.1 [<xref ref-type="bibr" rid="R138">138</xref>] on R v2.12.0. Finally, UCSC compatible wiggle tracks were generated using FindPeaks v4.0.16.</p>
</sec>
<sec id="s4_1_3">
<title>Statistical analysis</title>
<p>Statistical analyses were carried out using the R Package v3.3. In regard to mRNA levels, One-factor analysis of variance (ANOVA) was performed to compare the breast cancer subgroups. First a model was fitted using the lm function from the stats package then the ANOVA analysis was performed with the Anova command from the car package [<xref ref-type="bibr" rid="R139">139</xref>-<xref ref-type="bibr" rid="R140">140</xref>]. Bonferroni correction was performed with the p.adjust function from the stats package using “BH”, “BY” and “bonferroni” methods and statistically significant differences were considered at p &lt; 0.01 for the “bonferroni” method [<xref ref-type="bibr" rid="R140">140</xref>]. The Scheffé test was carried out with the scheffé test function from the agricolae R package for post-hoc analysis for comparisons between two of the multiple groups [<xref ref-type="bibr" rid="R141">141</xref>]. We performed intra-group variance analysis using gene expression data of patients with the <italic>BRCA1</italic> R1443X mutation and <italic>BRCA2</italic> 8765delAG mutation by Principle component analysis (PCA).</p>
</sec>
<sec id="s4_1_4">
<title>Pathways, network and clustering analyses</title>
<p>Partek Genomics Suites® software package (copyright © 2009 Partek Incorporated. St. Louis, MO) was used for hierarchical clustering using the default setting (Euclidean dissimilarity and average linkage method) as well as for Principal component analysis (PCA).</p>
<p>Identification of overrepresented pathways, functions and gene-associated diseases were performed using QIAGEN’s Ingenuity® Pathway Analysis (IPA®, QIAGEN Redwood City, <ext-link ext-link-type="uri" xlink:href="http://www.qiagen.com/ingenuity">www.qiagen.com/ingenuity</ext-link>) software. Default settings in IPA for expression dataset analyses were used for gene list functional analysis. Gene lists were uploaded using NCBI Entrez gene IDs or gene symbols and submitted for IPA Core Analysis. IPA calculates <italic>p</italic>-values that reflect the statistical significance of association between the genes and the networks by the Fisher’s exact test. <italic>P</italic>-value ≤ 0.05 were considered significant.</p>
</sec>
</sec>
</sec>
<sec id="s5" sec-type="supplementary-material">
<title>SUPPLEMENTARY MATERIALS FIGURES AND TABLES</title>
<supplementary-material content-type="local-data" id="SD1">
<media id="d35e2636" mime-subtype="pdf" mimetype="application" orientation="portrait" position="anchor" xlink:href="oncotarget-08-78691-s001.pdf"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD2">
<media id="d35e2638" mime-subtype="docx" mimetype="application" orientation="portrait" position="anchor" xlink:href="oncotarget-08-78691-s002.docx"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD3">
<media id="d35e2640" mime-subtype="docx" mimetype="application" orientation="portrait" position="anchor" xlink:href="oncotarget-08-78691-s003.docx"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD4">
<media id="d35e2642" mime-subtype="docx" mimetype="application" orientation="portrait" position="anchor" xlink:href="oncotarget-08-78691-s004.docx"></media>
</supplementary-material>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="con">
<p>
<bold>Author contributions</bold>
</p>
<p>FD designed the research protocol. MCP, CK and GO conducted experiments. JS and AD contributed samples and analytic tools. MCP, CK, CJB and YL performed data analysis. MCP, CK, CJB, YL, FD drafted manuscript. Critical revision of the manuscript was done by all the authors.</p>
</fn>
</fn-group>
<ack>
<p>The authors are indebted to the participants and their families for their generosity and providing DNA samples.</p>
</ack>
<fn-group>
<fn fn-type="COI-statement">
<p>
<bold>CONFLICTS OF INTEREST</bold>
</p>
<p>The authors declare that there are no conflicts of interest.</p>
</fn>
<fn fn-type="supported-by">
<p>
<bold>GRANT SUPPORT</bold>
</p>
<p>This study was supported by research grant from the Canadian Cancer Society and Quebec Breast Cancer Foundation. MCP holds a studentship from Laval University, Cancer Research Center at Laval University, Fondation CHU de Quebec and Fondation René Bussières. CK holds a Bourse de recrutement au doctorat- Pierre J. Durand. CJB holds a Fond de Recherche du Québec - Santé (FRQS) Doctoral award. AD is chairholder of the L’Oreal Research Chair in Digital Biology. JS is chairholder of the Canada Research Chair in Oncogenetics.</p>
</fn>
</fn-group>
<ref-list>
<title>REFERENCES</title>
<ref id="R1">
<label>1</label>
<mixed-citation publication-type="other">
<comment>Canadian Cancer Society’s Advisory Committee on Cancer Statistics. Canadian Cancer Statistics 2014. Toronto, ON; 2014. 1 p</comment>
</mixed-citation>
</ref>
<ref id="R2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Peto</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Houlston</surname>
<given-names>RS</given-names>
</name>
</person-group>
<article-title>Genetics and the common cancers</article-title>
<source/>Eur J Cancer
          <year>2001</year>
<volume>37</volume>
<fpage>S88</fpage>
<lpage>96</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0959-8049(01)00255-6">https://doi.org/10.1016/S0959-8049(01)00255-6</ext-link>
</comment>
<pub-id pub-id-type="pmid">11602375</pub-id>
</element-citation>
</ref>
<ref id="R3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>Collaborative Group on Hormonal Factors in Breast Cancer</collab>
</person-group>
<article-title>Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53297 women with breast cancer and 100239 women without breast cancer from 54 epidemiological studies</article-title>
<source/>Lancet
          <year>1996</year>
<volume>347</volume>
<fpage>1713</fpage>
<lpage>27</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0140-6736(96)90806-5">https://doi.org/10.1016/S0140-6736(96)90806-5</ext-link>
</comment>
<pub-id pub-id-type="pmid">8656904</pub-id>
</element-citation>
</ref>
<ref id="R4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Aloraifi</surname>
<given-names>F</given-names>
</name>
<name name-style="western">
<surname>McCartan</surname>
<given-names>D</given-names>
</name>
<name name-style="western">
<surname>McDevitt</surname>
<given-names>T</given-names>
</name>
<name name-style="western">
<surname>Green</surname>
<given-names>AJ</given-names>
</name>
<name name-style="western">
<surname>Bracken</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Geraghty</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Protein-truncating variants in moderate-risk breast cancer susceptibility genes: a meta-analysis of high-risk case-control screening studies</article-title>
<source/>Cancer Genet
          <year>2015</year>
<volume>208</volume>
<fpage>455</fpage>
<lpage>63</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cancergen.2015.06.001">https://doi.org/10.1016/j.cancergen.2015.06.001</ext-link>
</comment>
<pub-id pub-id-type="pmid">26250988</pub-id>
</element-citation>
</ref>
<ref id="R5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Easton</surname>
<given-names>DF</given-names>
</name>
</person-group>
<article-title>How many more breast cancer predisposition genes are there?</article-title>
<source/>Breast Cancer Res
          <year>1999</year>
<volume>1</volume>
<fpage>14</fpage>
<lpage>7</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.116:bcr6">https://doi.org/10.116:bcr6</ext-link>
</comment>
<pub-id pub-id-type="pmid">11250676</pub-id>
</element-citation>
</ref>
<ref id="R6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Stadler</surname>
<given-names>ZK</given-names>
</name>
<name name-style="western">
<surname>Thom</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Robson</surname>
<given-names>ME</given-names>
</name>
<name name-style="western">
<surname>Weitzel</surname>
<given-names>JN</given-names>
</name>
<name name-style="western">
<surname>Kauff</surname>
<given-names>ND</given-names>
</name>
<name name-style="western">
<surname>Hurley</surname>
<given-names>KE</given-names>
</name>
<name name-style="western">
<surname>Devlin</surname>
<given-names>V</given-names>
</name>
<name name-style="western">
<surname>Gold</surname>
<given-names>B</given-names>
</name>
<name name-style="western">
<surname>Klein</surname>
<given-names>RJ</given-names>
</name>
<name name-style="western">
<surname>Offit</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Genome-wide association studies of cancer</article-title>
<source/>J Clin Oncol
          <year>2010</year>
<volume>28</volume>
<fpage>4255</fpage>
<lpage>67</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1200/JCO.2009.25.7816">https://doi.org/10.1200/JCO.2009.25.7816</ext-link>
</comment>
<pub-id pub-id-type="pmid">20585100</pub-id>
</element-citation>
</ref>
<ref id="R7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Meijers-Heijboer</surname>
<given-names>H</given-names>
</name>
<name name-style="western">
<surname>van den Ouweland</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Klijn</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Wasielewski</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>de Snoo</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Oldenburg</surname>
<given-names>R</given-names>
</name>
<name name-style="western">
<surname>Hollestelle</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Houben</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Crepin</surname>
<given-names>E</given-names>
</name>
<name name-style="western">
<surname>van Veghel-Plandsoen</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Elstrodt</surname>
<given-names>F</given-names>
</name>
<name name-style="western">
<surname>van Duijn</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Bartels</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in non-carriers of BRCA1 or BRCA2 mutations</article-title>
<source/>Nat Genet
          <year>2002</year>
<volume>31</volume>
<fpage>55</fpage>
<lpage>9</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ng879">https://doi.org/10.1038/ng879</ext-link>
</comment>
<pub-id pub-id-type="pmid">11967536</pub-id>
</element-citation>
</ref>
<ref id="R8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Renwick</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Thompson</surname>
<given-names>D</given-names>
</name>
<name name-style="western">
<surname>Seal</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Kelly</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Chagtai</surname>
<given-names>T</given-names>
</name>
<name name-style="western">
<surname>Ahmed</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>North</surname>
<given-names>B</given-names>
</name>
<name name-style="western">
<surname>Jayatilake</surname>
<given-names>H</given-names>
</name>
<name name-style="western">
<surname>Barfoot</surname>
<given-names>R</given-names>
</name>
<name name-style="western">
<surname>Spanova</surname>
<given-names>K</given-names>
</name>
<name name-style="western">
<surname>McGuffog</surname>
<given-names>L</given-names>
</name>
<name name-style="western">
<surname>Evans</surname>
<given-names>DG</given-names>
</name>
<name name-style="western">
<surname>Eccles</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles</article-title>
<source/>Nat Genet
          <year>2006</year>
<volume>38</volume>
<fpage>873</fpage>
<lpage>5</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ng1837">https://doi.org/10.1038/ng1837</ext-link>
</comment>
<pub-id pub-id-type="pmid">16832357</pub-id>
</element-citation>
</ref>
<ref id="R9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Rahman</surname>
<given-names>N</given-names>
</name>
<name name-style="western">
<surname>Seal</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Thompson</surname>
<given-names>D</given-names>
</name>
<name name-style="western">
<surname>Kelly</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Renwick</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Elliott</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Reid</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Spanova</surname>
<given-names>K</given-names>
</name>
<name name-style="western">
<surname>Barfoot</surname>
<given-names>R</given-names>
</name>
<name name-style="western">
<surname>Chagtai</surname>
<given-names>T</given-names>
</name>
<name name-style="western">
<surname>Jayatilake</surname>
<given-names>H</given-names>
</name>
<name name-style="western">
<surname>McGuffog</surname>
<given-names>L</given-names>
</name>
<name name-style="western">
<surname>Hanks</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene</article-title>
<source/>Nat Genet
          <year>2007</year>
<volume>39</volume>
<fpage>165</fpage>
<lpage>7</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038:ng1959">https://doi.org/10.1038:ng1959</ext-link>
</comment>
<pub-id pub-id-type="pmid">17200668</pub-id>
</element-citation>
</ref>
<ref id="R10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Malkin</surname>
<given-names>D</given-names>
</name>
<name name-style="western">
<surname>Li</surname>
<given-names>FP</given-names>
</name>
<name name-style="western">
<surname>Strong</surname>
<given-names>LC</given-names>
</name>
<name name-style="western">
<surname>Fraumeni</surname>
<given-names>JF</given-names>
</name>
<name name-style="western">
<surname>Nelson</surname>
<given-names>CE</given-names>
</name>
<name name-style="western">
<surname>Kim</surname>
<given-names>DH</given-names>
</name>
<name name-style="western">
<surname>Kassel</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Gryka</surname>
<given-names>MA</given-names>
</name>
<name name-style="western">
<surname>Bischoff</surname>
<given-names>FZ</given-names>
</name>
<name name-style="western">
<surname>Tainsky</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms</article-title>
<source/>Science
          <year>1990</year>
<volume>250</volume>
<fpage>1233</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">1978757</pub-id>
</element-citation>
</ref>
<ref id="R11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Michailidou</surname>
<given-names>K</given-names>
</name>
<name name-style="western">
<surname>Beesley</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Lindstrom</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Canisius</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Dennis</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Lush</surname>
<given-names>MJ</given-names>
</name>
<name name-style="western">
<surname>Maranian</surname>
<given-names>MJ</given-names>
</name>
<name name-style="western">
<surname>Bolla</surname>
<given-names>MK</given-names>
</name>
<name name-style="western">
<surname>Wang</surname>
<given-names>Q</given-names>
</name>
<name name-style="western">
<surname>Shah</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Perkins</surname>
<given-names>BJ</given-names>
</name>
<name name-style="western">
<surname>Czenz</surname>
<given-names>K</given-names>
</name>
<name name-style="western">
<surname>Eriksson</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer</article-title>
<source/>Nat Genet
          <year>2015</year>
<volume>47</volume>
<fpage>373</fpage>
<lpage>80</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038:ng.3242">https://doi.org/10.1038:ng.3242</ext-link>
</comment>
<pub-id pub-id-type="pmid">25751625</pub-id>
</element-citation>
</ref>
<ref id="R12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Simard</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Dumont</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Moisan</surname>
<given-names>AM</given-names>
</name>
<name name-style="western">
<surname>Gaborieau</surname>
<given-names>V</given-names>
</name>
<name name-style="western">
<surname>Vézina</surname>
<given-names>H</given-names>
</name>
<name name-style="western">
<surname>Durocher</surname>
<given-names>F</given-names>
</name>
<name name-style="western">
<surname>Chiquette</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Plante</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Avard</surname>
<given-names>D</given-names>
</name>
<name name-style="western">
<surname>Bessette</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Brousseau</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Dorval</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Godard</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer</article-title>
<source/>J Med Genet
          <year>2007</year>
<volume>44</volume>
<fpage>107</fpage>
<lpage>21</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/jmg.2006.044388">https://doi.org/10.1136/jmg.2006.044388</ext-link>
</comment>
<pub-id pub-id-type="pmid">16905680</pub-id>
</element-citation>
</ref>
<ref id="R13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Wang</surname>
<given-names>ET</given-names>
</name>
<name name-style="western">
<surname>Sandberg</surname>
<given-names>R</given-names>
</name>
<name name-style="western">
<surname>Luo</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Khrebtukova</surname>
<given-names>I</given-names>
</name>
<name name-style="western">
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name name-style="western">
<surname>Mayr</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Kingsmore</surname>
<given-names>SF</given-names>
</name>
<name name-style="western">
<surname>Schroth</surname>
<given-names>GP</given-names>
</name>
<name name-style="western">
<surname>Burge</surname>
<given-names>BC</given-names>
</name>
</person-group>
<article-title>Alternative isoform regulation in human tissue transcriptomes</article-title>
<source/>Nature
          <year>2008</year>
<volume>456</volume>
<fpage>470</fpage>
<lpage>6</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature07509">https://doi.org/10.1038/nature07509</ext-link>
</comment>
<pub-id pub-id-type="pmid">18978772</pub-id>
</element-citation>
</ref>
<ref id="R14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Venables</surname>
<given-names>JP</given-names>
</name>
</person-group>
<article-title>Aberrant and alternative splicing in cancer</article-title>
<source/>Cancer Res
          <year>2004</year>
<volume>64</volume>
<fpage>7647</fpage>
<lpage>54</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1158:0008-5472.CAN-04-1910">https://doi.org/10.1158:0008-5472.CAN-04-1910</ext-link>
</comment>
<pub-id pub-id-type="pmid">15520162</pub-id>
</element-citation>
</ref>
<ref id="R15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Hoen</surname>
<given-names>PA</given-names>
</name>
<name name-style="western">
<surname>Friedländer</surname>
<given-names>MR</given-names>
</name>
<name name-style="western">
<surname>Almlöf</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Sammeth</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Pulyakhina</surname>
<given-names>I</given-names>
</name>
<name name-style="western">
<surname>Anvar</surname>
<given-names>SY</given-names>
</name>
<name name-style="western">
<surname>Laros</surname>
<given-names>JF</given-names>
</name>
<name name-style="western">
<surname>Buermans</surname>
<given-names>HP</given-names>
</name>
<name name-style="western">
<surname>Karlberg</surname>
<given-names>O</given-names>
</name>
<name name-style="western">
<surname>Brännvall</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Dunnen den</surname>
<given-names>JT</given-names>
</name>
<name name-style="western">
<surname>van Ommen</surname>
<given-names>GJ</given-names>
</name>
<name name-style="western">
<surname>Guigo</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Reproducibility of high-throughput mRNA ans small RNA sequencing across laboratories</article-title>
<source/>Nat Biotechnol
          <year>2013</year>
<volume>31</volume>
<fpage>1015</fpage>
<lpage>22</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nbt.2702">https://doi.org/10.1038/nbt.2702</ext-link>
</comment>
<pub-id pub-id-type="pmid">24037425</pub-id>
</element-citation>
</ref>
<ref id="R16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Ching</surname>
<given-names>T</given-names>
</name>
<name name-style="western">
<surname>Huang</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Garmire</surname>
<given-names>LX</given-names>
</name>
</person-group>
<article-title>Power analysis and sample size estimation for RNA-Seq differential expression</article-title>
<source/>RNA
          <year>2014</year>
<volume>20</volume>
<fpage>1684</fpage>
<lpage>96</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1261/rna.046011.114">https://doi.org/10.1261/rna.046011.114</ext-link>
</comment>
<pub-id pub-id-type="pmid">25246651</pub-id>
</element-citation>
</ref>
<ref id="R17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Cheung</surname>
<given-names>VG</given-names>
</name>
<name name-style="western">
<surname>Conlin</surname>
<given-names>LK</given-names>
</name>
<name name-style="western">
<surname>Weber</surname>
<given-names>TM</given-names>
</name>
<name name-style="western">
<surname>Arcaro</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Jen</surname>
<given-names>KY</given-names>
</name>
<name name-style="western">
<surname>Morley</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Spielman</surname>
<given-names>RS</given-names>
</name>
</person-group>
<article-title>Natural variation in human gene expression assessed in lymphoblastoid cells</article-title>
<source/>Nat Genet
          <year>2003</year>
<volume>33</volume>
<fpage>422</fpage>
<lpage>5</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ng1094">https://doi.org/10.1038/ng1094</ext-link>
</comment>
<pub-id pub-id-type="pmid">12567189</pub-id>
</element-citation>
</ref>
<ref id="R18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Hull</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Campino</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Rowlands</surname>
<given-names>K</given-names>
</name>
<name name-style="western">
<surname>Chan</surname>
<given-names>MS</given-names>
</name>
<name name-style="western">
<surname>Copley</surname>
<given-names>RR</given-names>
</name>
<name name-style="western">
<surname>Taylor</surname>
<given-names>MS</given-names>
</name>
<name name-style="western">
<surname>Rockett</surname>
<given-names>K</given-names>
</name>
<name name-style="western">
<surname>Elvidge</surname>
<given-names>G</given-names>
</name>
<name name-style="western">
<surname>Keating</surname>
<given-names>B</given-names>
</name>
<name name-style="western">
<surname>Knight</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Kwiatkowski</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Identification of common genetic variation that modulates alternative splicing</article-title>
<source/>PLoS Genet
          <year>2007</year>
<volume>3</volume>
<fpage>e99</fpage>
<lpage>9</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pgen.0030099">https://doi.org/10.1371/journal.pgen.0030099</ext-link>
</comment>
<pub-id pub-id-type="pmid">17571926</pub-id>
</element-citation>
</ref>
<ref id="R19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Cheung</surname>
<given-names>HC</given-names>
</name>
<name name-style="western">
<surname>Baggerly</surname>
<given-names>KA</given-names>
</name>
<name name-style="western">
<surname>Tsavachidis</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Bachinski</surname>
<given-names>LL</given-names>
</name>
<name name-style="western">
<surname>Neubauer</surname>
<given-names>VL</given-names>
</name>
<name name-style="western">
<surname>Nixon</surname>
<given-names>TJ</given-names>
</name>
<name name-style="western">
<surname>Aldape</surname>
<given-names>KD</given-names>
</name>
<name name-style="western">
<surname>Cote</surname>
<given-names>GJ</given-names>
</name>
<name name-style="western">
<surname>Krahe</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Global analysis of aberrant pre-mRNA splicing in glioblastoma using exon expression arrays</article-title>
<source/>BMC Genomics
          <year>2008</year>
<volume>9</volume>
<fpage>216</fpage>
<lpage>6</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186:1471-2164-9-216">https://doi.org/10.1186:1471-2164-9-216</ext-link>
</comment>
<pub-id pub-id-type="pmid">18474104</pub-id>
</element-citation>
</ref>
<ref id="R20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Gardina</surname>
<given-names>PJ</given-names>
</name>
<name name-style="western">
<surname>Clark</surname>
<given-names>TA</given-names>
</name>
<name name-style="western">
<surname>Shimada</surname>
<given-names>B</given-names>
</name>
<name name-style="western">
<surname>Staples</surname>
<given-names>MK</given-names>
</name>
<name name-style="western">
<surname>Yang</surname>
<given-names>Q</given-names>
</name>
<name name-style="western">
<surname>Veitch</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Schweitzer</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Awad</surname>
<given-names>T</given-names>
</name>
<name name-style="western">
<surname>Sugnet</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Dee</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Davies</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Williams</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Turpaz</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array</article-title>
<source/>BMC Genomics
          <year>2006</year>
<volume>7</volume>
<fpage>325</fpage>
<lpage>5</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1471-2164-7-325">https://doi.org/10.1186/1471-2164-7-325</ext-link>
</comment>
<pub-id pub-id-type="pmid">17192196</pub-id>
</element-citation>
</ref>
<ref id="R21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Tuthill</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Semple</surname>
<given-names>RK</given-names>
</name>
<name name-style="western">
<surname>Day</surname>
<given-names>R</given-names>
</name>
<name name-style="western">
<surname>Soos</surname>
<given-names>MA</given-names>
</name>
<name name-style="western">
<surname>Sweeney</surname>
<given-names>E</given-names>
</name>
<name name-style="western">
<surname>Seymour</surname>
<given-names>PJ</given-names>
</name>
<name name-style="western">
<surname>Didi</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>O’Rahilly</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Functional characterization of a novel insulin receptor mutation contributing to Rabson-Mendenhall syndrome</article-title>
<source/>Clin Endocrinol (Oxf)
          <year>2007</year>
<volume>66</volume>
<fpage>21</fpage>
<lpage>6</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1365-2265.2006.02678.x">https://doi.org/10.1111/j.1365-2265.2006.02678.x</ext-link>
</comment>
<pub-id pub-id-type="pmid">17201797</pub-id>
</element-citation>
</ref>
<ref id="R22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Rivolta</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>McGee</surname>
<given-names>TL</given-names>
</name>
<name name-style="western">
<surname>Rio Frio</surname>
<given-names>T</given-names>
</name>
<name name-style="western">
<surname>Jensen</surname>
<given-names>RV</given-names>
</name>
<name name-style="western">
<surname>Berson</surname>
<given-names>EL</given-names>
</name>
<name name-style="western">
<surname>Dryja</surname>
<given-names>TP</given-names>
</name>
</person-group>
<article-title>Variation in retinitis pigmentosa-11 (PRPF31 or RP11) gene expression between symptomatic and asymptomatic patients with domain RP11 mutations</article-title>
<source/>Hum Mutat
          <year>2006</year>
<volume>27</volume>
<fpage>644</fpage>
<lpage>53</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/humu.20325">https://doi.org/10.1002/humu.20325</ext-link>
</comment>
<pub-id pub-id-type="pmid">16708387</pub-id>
</element-citation>
</ref>
<ref id="R23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Philibert</surname>
<given-names>RA</given-names>
</name>
<name name-style="western">
<surname>Crowe</surname>
<given-names>R</given-names>
</name>
<name name-style="western">
<surname>Ryu</surname>
<given-names>GY</given-names>
</name>
<name name-style="western">
<surname>Yoon</surname>
<given-names>JG</given-names>
</name>
<name name-style="western">
<surname>Secrest</surname>
<given-names>D</given-names>
</name>
<name name-style="western">
<surname>Sandhu</surname>
<given-names>H</given-names>
</name>
<name name-style="western">
<surname>Madan</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Transcriptional profiling of lymphoblast cell lines from subjects with panic disorder</article-title>
<source/>Am J Med Genet B Neuropsychiatr Genet
          <year>2007</year>
<volume>144B</volume>
<fpage>674</fpage>
<lpage>82</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/ajmg.b.30502">https://doi.org/10.1002/ajmg.b.30502</ext-link>
</comment>
<pub-id pub-id-type="pmid">17342723</pub-id>
</element-citation>
</ref>
<ref id="R24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Morley</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Molony</surname>
<given-names>CM</given-names>
</name>
<name name-style="western">
<surname>Weber</surname>
<given-names>TM</given-names>
</name>
<name name-style="western">
<surname>Devlin</surname>
<given-names>JL</given-names>
</name>
<name name-style="western">
<surname>Ewens</surname>
<given-names>KG</given-names>
</name>
<name name-style="western">
<surname>Spielman</surname>
<given-names>RS</given-names>
</name>
<name name-style="western">
<surname>Cheung</surname>
<given-names>VG</given-names>
</name>
</person-group>
<article-title>Genetic analysis of genome-wide variation in human gene expression</article-title>
<source/>Nature
          <year>2004</year>
<volume>430</volume>
<fpage>743</fpage>
<lpage>7</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature02797">https://doi.org/10.1038/nature02797</ext-link>
</comment>
<pub-id pub-id-type="pmid">15269782</pub-id>
</element-citation>
</ref>
<ref id="R25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Morello</surname>
<given-names>F</given-names>
</name>
<name name-style="western">
<surname>de Bruin</surname>
<given-names>TW</given-names>
</name>
<name name-style="western">
<surname>Rotter</surname>
<given-names>JI</given-names>
</name>
<name name-style="western">
<surname>Pratt</surname>
<given-names>RE</given-names>
</name>
<name name-style="western">
<surname>van der Kallen</surname>
<given-names>CJ</given-names>
</name>
<name name-style="western">
<surname>Hladik</surname>
<given-names>GA</given-names>
</name>
<name name-style="western">
<surname>Dzau</surname>
<given-names>VJ</given-names>
</name>
<name name-style="western">
<surname>Liew</surname>
<given-names>CC</given-names>
</name>
<name name-style="western">
<surname>Chen</surname>
<given-names>YD</given-names>
</name>
</person-group>
<article-title>Differential gene expression of blood-derived cell lines in familial combined hyperlipidemia</article-title>
<source/>Arterioscler Throm Vasc Biol
          <year>2004</year>
<volume>24</volume>
<fpage>2149</fpage>
<lpage>54</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/01.ATV.0000145978.70872.63">https://doi.org/10.1161/01.ATV.0000145978.70872.63</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Dixon</surname>
<given-names>AL</given-names>
</name>
<name name-style="western">
<surname>Liang</surname>
<given-names>L</given-names>
</name>
<name name-style="western">
<surname>Moffatt</surname>
<given-names>MF</given-names>
</name>
<name name-style="western">
<surname>Chen</surname>
<given-names>W</given-names>
</name>
<name name-style="western">
<surname>Heath</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Wong</surname>
<given-names>KC</given-names>
</name>
<name name-style="western">
<surname>Taylor</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Burnett</surname>
<given-names>E</given-names>
</name>
<name name-style="western">
<surname>Gut</surname>
<given-names>I</given-names>
</name>
<name name-style="western">
<surname>Farall</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Lathrop</surname>
<given-names>GM</given-names>
</name>
<name name-style="western">
<surname>Abecasis</surname>
<given-names>GR</given-names>
</name>
<name name-style="western">
<surname>Cookson</surname>
<given-names>WO</given-names>
</name>
</person-group>
<article-title>A genome-wide association study of global gene expression</article-title>
<source/>Nat Genet
          <year>2007</year>
<volume>39</volume>
<fpage>1202</fpage>
<lpage>7</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ng2109">https://doi.org/10.1038/ng2109</ext-link>
</comment>
<pub-id pub-id-type="pmid">17873877</pub-id>
</element-citation>
</ref>
<ref id="R27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Kwan</surname>
<given-names>T</given-names>
</name>
<name name-style="western">
<surname>Benovoy</surname>
<given-names>D</given-names>
</name>
<name name-style="western">
<surname>Dias</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Gurd</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Provencher</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Beaulieu</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Hudson</surname>
<given-names>TJ</given-names>
</name>
<name name-style="western">
<surname>Sladek</surname>
<given-names>R</given-names>
</name>
<name name-style="western">
<surname>Majewski</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Genome-wide analysis of transcript isoform variation in humans</article-title>
<source/>Nat Genet
          <year>2008</year>
<volume>40</volume>
<fpage>225</fpage>
<lpage>31</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ng.2007.57">https://doi.org/10.1038/ng.2007.57</ext-link>
</comment>
<pub-id pub-id-type="pmid">18193047</pub-id>
</element-citation>
</ref>
<ref id="R28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Thorsen</surname>
<given-names>K</given-names>
</name>
<name name-style="western">
<surname>Sørensen</surname>
<given-names>KD</given-names>
</name>
<name name-style="western">
<surname>Brems-Eskildsen</surname>
<given-names>AS</given-names>
</name>
<name name-style="western">
<surname>Modin</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Gaustadnes</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Hein</surname>
<given-names>AM</given-names>
</name>
<name name-style="western">
<surname>Kruhøffer</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Laurberg</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Borre</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Wang</surname>
<given-names>K</given-names>
</name>
<name name-style="western">
<surname>Brunak</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Krainer</surname>
<given-names>AR</given-names>
</name>
<name name-style="western">
<surname>Tørring</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis</article-title>
<source/>Mol Cell Proteomics
          <year>2008</year>
<volume>7</volume>
<fpage>1214</fpage>
<lpage>24</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/mcp.M700590-MCP200">https://doi.org/10.1074/mcp.M700590-MCP200</ext-link>
</comment>
<pub-id pub-id-type="pmid">18353764</pub-id>
</element-citation>
</ref>
<ref id="R29">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Kwan</surname>
<given-names>T</given-names>
</name>
<name name-style="western">
<surname>Benovoy</surname>
<given-names>D</given-names>
</name>
<name name-style="western">
<surname>Dias</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Gurd</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Serre</surname>
<given-names>D</given-names>
</name>
<name name-style="western">
<surname>Zuzan</surname>
<given-names>H</given-names>
</name>
<name name-style="western">
<surname>Clark</surname>
<given-names>TA</given-names>
</name>
<name name-style="western">
<surname>Schweitzer</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Staples</surname>
<given-names>MK</given-names>
</name>
<name name-style="western">
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<name name-style="western">
<surname>Blume</surname>
<given-names>JE</given-names>
</name>
<name name-style="western">
<surname>Husdon</surname>
<given-names>TJ</given-names>
</name>
<name name-style="western">
<surname>Sladek</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Heritability of alternative splicing in the human genome</article-title>
<source/>Genome Res
          <year>2007</year>
<volume>17</volume>
<fpage>1210</fpage>
<lpage>8</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/gr.6281007">https://doi.org/10.1101/gr.6281007</ext-link>
</comment>
<pub-id pub-id-type="pmid">17671095</pub-id>
</element-citation>
</ref>
<ref id="R30">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Stranger</surname>
<given-names>BE</given-names>
</name>
<name name-style="western">
<surname>Nica</surname>
<given-names>AC</given-names>
</name>
<name name-style="western">
<surname>Forrest</surname>
<given-names>MS</given-names>
</name>
<name name-style="western">
<surname>Dimas</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Bird</surname>
<given-names>CP</given-names>
</name>
<name name-style="western">
<surname>Beazley</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Ingle</surname>
<given-names>CE</given-names>
</name>
<name name-style="western">
<surname>Dunning</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Flicek</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Koller</surname>
<given-names>D</given-names>
</name>
<name name-style="western">
<surname>Montgomery</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Tavaré</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Deloukas</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Population genomics of human gene expression</article-title>
<source/>Nat Genet
          <year>2007</year>
<volume>39</volume>
<fpage>1217</fpage>
<lpage>24</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ng2142">https://doi.org/10.1038/ng2142</ext-link>
</comment>
<pub-id pub-id-type="pmid">17873874</pub-id>
</element-citation>
</ref>
<ref id="R31">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Suderman</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Pappas</surname>
<given-names>JP</given-names>
</name>
<name name-style="western">
<surname>Borghol</surname>
<given-names>N</given-names>
</name>
<name name-style="western">
<surname>Buxton</surname>
<given-names>JL</given-names>
</name>
<name name-style="western">
<surname>McArdle</surname>
<given-names>WL</given-names>
</name>
<name name-style="western">
<surname>Ring</surname>
<given-names>SM</given-names>
</name>
<name name-style="western">
<surname>Hertzman</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Power</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Szyf</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Pembrey</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Lymbhoblastoid cell lines reveal associations of adult DNA methylation with childhood and current adversity that are distinct from whole blood associations</article-title>
<source/>Int J Epidemiol
          <year>2015</year>
<volume>44</volume>
<fpage>1331</fpage>
<lpage>40</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/ije/dyv168">https://doi.org/10.1093/ije/dyv168</ext-link>
</comment>
<pub-id pub-id-type="pmid">26351305</pub-id>
</element-citation>
</ref>
<ref id="R32">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Aloraifi</surname>
<given-names>F</given-names>
</name>
<name name-style="western">
<surname>Alshehhi</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>McDevitt</surname>
<given-names>T</given-names>
</name>
<name name-style="western">
<surname>Cody</surname>
<given-names>N</given-names>
</name>
<name name-style="western">
<surname>Meany</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>O’Doherty</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Quinn</surname>
<given-names>CM</given-names>
</name>
<name name-style="western">
<surname>Green</surname>
<given-names>AJ</given-names>
</name>
<name name-style="western">
<surname>Bracken</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Geraghty</surname>
<given-names>JG</given-names>
</name>
</person-group>
<article-title>Phenotypic analysis of familial breast cancer: comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancer</article-title>
<source/>Eur J Surg Oncol
          <year>2015</year>
<volume>41</volume>
<fpage>641</fpage>
<lpage>6</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ejso.2015.01.021">https://doi.org/10.1016/j.ejso.2015.01.021</ext-link>
</comment>
<pub-id pub-id-type="pmid">25736863</pub-id>
</element-citation>
</ref>
<ref id="R33">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Hedenfalk</surname>
<given-names>I</given-names>
</name>
<name name-style="western">
<surname>Duggan</surname>
<given-names>D</given-names>
</name>
<name name-style="western">
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name name-style="western">
<surname>Radmacher</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Bittner</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Simon</surname>
<given-names>R</given-names>
</name>
<name name-style="western">
<surname>Meltzer</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Gusterson</surname>
<given-names>B</given-names>
</name>
<name name-style="western">
<surname>Esteller</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Kallioniemi</surname>
<given-names>OP</given-names>
</name>
<name name-style="western">
<surname>Wilfond</surname>
<given-names>B</given-names>
</name>
<name name-style="western">
<surname>Borg</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Trent</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gene-expression profiles in hereditary breast cancer</article-title>
<source/>N Engl J Med
          <year>2001</year>
<volume>344</volume>
<fpage>539</fpage>
<lpage>48</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1056/NEJM200102223440801">https://doi.org/10.1056/NEJM200102223440801</ext-link>
</comment>
<pub-id pub-id-type="pmid">11207349</pub-id>
</element-citation>
</ref>
<ref id="R34">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Honrado</surname>
<given-names>E</given-names>
</name>
<name name-style="western">
<surname>Osorio</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Milne</surname>
<given-names>RL</given-names>
</name>
<name name-style="western">
<surname>Paz</surname>
<given-names>MF</given-names>
</name>
<name name-style="western">
<surname>Melchor</surname>
<given-names>L</given-names>
</name>
<name name-style="western">
<surname>Cascón</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Urioste</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Cazorla</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Díez</surname>
<given-names>O</given-names>
</name>
<name name-style="western">
<surname>Lerma</surname>
<given-names>E</given-names>
</name>
<name name-style="western">
<surname>Esteller</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Palacios</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Benítez</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Immunohistochemical classification of non-<italic>BRCA1/2</italic> tumors identifies different groups that demonstrate the heterogeneity of <italic>BRCAX</italic> families</article-title>
<source/>Modern Pathol
          <year>2007</year>
<volume>20</volume>
<fpage>1298</fpage>
<lpage>306</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/modpathol.3800969">https://doi.org/10.1038/modpathol.3800969</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R35">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Hedenfalk</surname>
<given-names>I</given-names>
</name>
<name name-style="western">
<surname>Ringner</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Ben-Dor</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Yakhini</surname>
<given-names>Z</given-names>
</name>
<name name-style="western">
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name name-style="western">
<surname>Chebil</surname>
<given-names>G</given-names>
</name>
<name name-style="western">
<surname>Ach</surname>
<given-names>R</given-names>
</name>
<name name-style="western">
<surname>Loman</surname>
<given-names>N</given-names>
</name>
<name name-style="western">
<surname>Olsson</surname>
<given-names>H</given-names>
</name>
<name name-style="western">
<surname>Meltzer</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Borg</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Trent</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Molecular classification of familial non-BRCA1/BRCA2 breast cancer</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2003</year>
<volume>100</volume>
<fpage>2532</fpage>
<lpage>7</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073:pnas.0533805100">https://doi.org/10.1073:pnas.0533805100</ext-link>
</comment>
<pub-id pub-id-type="pmid">12610208</pub-id>
</element-citation>
</ref>
<ref id="R36">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Lakhani</surname>
<given-names>SR</given-names>
</name>
<name name-style="western">
<surname>Gusterson</surname>
<given-names>BA</given-names>
</name>
<name name-style="western">
<surname>Jacquemier</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Sloane</surname>
<given-names>JP</given-names>
</name>
<name name-style="western">
<surname>Anderson</surname>
<given-names>TJ</given-names>
</name>
<name name-style="western">
<surname>van de Vijver</surname>
<given-names>MJ</given-names>
</name>
<name name-style="western">
<surname>Venter</surname>
<given-names>D</given-names>
</name>
<name name-style="western">
<surname>Freeman</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Antoniou</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>McGuffog</surname>
<given-names>L</given-names>
</name>
<name name-style="western">
<surname>Smyth</surname>
<given-names>E</given-names>
</name>
<name name-style="western">
<surname>Steel</surname>
<given-names>CM</given-names>
</name>
<name name-style="western">
<surname>Haites</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2</article-title>
<source/>Clin Cancer Res
          <year>2000</year>
<volume>6</volume>
<fpage>782</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">10741697</pub-id>
</element-citation>
</ref>
<ref id="R37">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Fernández-Ramires</surname>
<given-names>R</given-names>
</name>
<name name-style="western">
<surname>Gómez</surname>
<given-names>G</given-names>
</name>
<name name-style="western">
<surname>Muñoz-Repeto</surname>
<given-names>I</given-names>
</name>
<name name-style="western">
<surname>de Cecco</surname>
<given-names>L</given-names>
</name>
<name name-style="western">
<surname>Llort</surname>
<given-names>G</given-names>
</name>
<name name-style="western">
<surname>Cazorla</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Blanco</surname>
<given-names>I</given-names>
</name>
<name name-style="western">
<surname>Gariboldi</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Pierotti</surname>
<given-names>MA</given-names>
</name>
<name name-style="western">
<surname>Benítez</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Osorio</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Transcriptional characteristics of familial non-BRCA1/BRCA2 breast tumors</article-title>
<source/>Int J Cancer
          <year>2011</year>
<volume>128</volume>
<fpage>2635</fpage>
<lpage>44</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/ijc.25603">https://doi.org/10.1002/ijc.25603</ext-link>
</comment>
<pub-id pub-id-type="pmid">20715112</pub-id>
</element-citation>
</ref>
<ref id="R38">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Larsen</surname>
<given-names>MJ</given-names>
</name>
<name name-style="western">
<surname>Thomassen</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Tan</surname>
<given-names>Q</given-names>
</name>
<name name-style="western">
<surname>Lænkholm</surname>
<given-names>AV</given-names>
</name>
<name name-style="western">
<surname>Bak</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Sørensen</surname>
<given-names>KP</given-names>
</name>
<name name-style="western">
<surname>Andersen</surname>
<given-names>MK</given-names>
</name>
<name name-style="western">
<surname>Kruse</surname>
<given-names>TA</given-names>
</name>
<name name-style="western">
<surname>Gerdes</surname>
<given-names>AM</given-names>
</name>
</person-group>
<article-title>RNA profiling reveals familial aggregation of molecular subtypes in non-BRCA1/2 breast cancer families</article-title>
<source/>BMC Med Genomics
          <year>2014</year>
<volume>7</volume>
<fpage>9</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1755-8794-7-9">https://doi.org/10.1186/1755-8794-7-9</ext-link>
</comment>
<pub-id pub-id-type="pmid">24479546</pub-id>
</element-citation>
</ref>
<ref id="R39">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Hussain</surname>
<given-names>T</given-names>
</name>
<name name-style="western">
<surname>Kotnis</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Sarin</surname>
<given-names>R</given-names>
</name>
<name name-style="western">
<surname>Mulherkar</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Establishment &amp; characterization of lymphoblastoid cell lines from patients with multiple primary neoplasms in the upper aero-digestive tract &amp; healthy individuals</article-title>
<source/>Indian J Med Res
          <year>2012</year>
<volume>135</volume>
<fpage>820</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">22825601</pub-id>
</element-citation>
</ref>
<ref id="R40">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Chaussabel</surname>
<given-names>D</given-names>
</name>
<name name-style="western">
<surname>Allman</surname>
<given-names>W</given-names>
</name>
<name name-style="western">
<surname>Mejias</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Chung</surname>
<given-names>W</given-names>
</name>
<name name-style="western">
<surname>Bennett</surname>
<given-names>L</given-names>
</name>
<name name-style="western">
<surname>Ramilo</surname>
<given-names>O</given-names>
</name>
<name name-style="western">
<surname>Pascual</surname>
<given-names>V</given-names>
</name>
<name name-style="western">
<surname>Palucka</surname>
<given-names>AK</given-names>
</name>
<name name-style="western">
<surname>Banchereau</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Analysis of significance patterns identifies ubiquitous and disease-specific gene-expression signatures in patient peripheral blood leukocytes</article-title>
<source/>Ann N Y Acad Sci
          <year>2005</year>
<volume>1062</volume>
<fpage>146</fpage>
<lpage>54</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1196/annals.1358.017">https://doi.org/10.1196/annals.1358.017</ext-link>
</comment>
<pub-id pub-id-type="pmid">16461797</pub-id>
</element-citation>
</ref>
<ref id="R41">
<label>41</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Radich</surname>
<given-names>JP</given-names>
</name>
<name name-style="western">
<surname>Mao</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Stepaniants</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Biery</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Castle</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Ward</surname>
<given-names>T</given-names>
</name>
<name name-style="western">
<surname>Schimmack</surname>
<given-names>G</given-names>
</name>
<name name-style="western">
<surname>Kobayashi</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Carleton</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Lampe</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Linsley</surname>
<given-names>PS</given-names>
</name>
</person-group>
<article-title>Individual-specific variation of gene expression in peripheral blood leukocytes</article-title>
<source/>Genomics
          <year>2004</year>
<volume>83</volume>
<fpage>980</fpage>
<lpage>8</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ygeno.2003.12.013">https://doi.org/10.1016/j.ygeno.2003.12.013</ext-link>
</comment>
<pub-id pub-id-type="pmid">15177552</pub-id>
</element-citation>
</ref>
<ref id="R42">
<label>42</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Whitney</surname>
<given-names>AR</given-names>
</name>
<name name-style="western">
<surname>Diehn</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Popper</surname>
<given-names>SJ</given-names>
</name>
<name name-style="western">
<surname>Alizadeh</surname>
<given-names>AA</given-names>
</name>
<name name-style="western">
<surname>Boldrick</surname>
<given-names>JC</given-names>
</name>
<name name-style="western">
<surname>Relman</surname>
<given-names>DA</given-names>
</name>
<name name-style="western">
<surname>Brown</surname>
<given-names>PO</given-names>
</name>
</person-group>
<article-title>Individuality and variation in gene expression patterns in human blood</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2003</year>
<volume>100</volume>
<fpage>1896</fpage>
<lpage>901</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.252784499">https://doi.org/10.1073/pnas.252784499</ext-link>
</comment>
<pub-id pub-id-type="pmid">12578971</pub-id>
</element-citation>
</ref>
<ref id="R43">
<label>43</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Gasser</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Raulet</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>The DNA damage response, immunity and cancer</article-title>
<source/>Semin Cancer Biol
          <year>2006</year>
<volume>16</volume>
<fpage>344</fpage>
<lpage>7</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.semcancer.2006.07.004">https://doi.org/10.1016/j.semcancer.2006.07.004</ext-link>
</comment>
<pub-id pub-id-type="pmid">16914325</pub-id>
</element-citation>
</ref>
<ref id="R44">
<label>44</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Sharma</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Sahni</surname>
<given-names>NS</given-names>
</name>
<name name-style="western">
<surname>Tibshirani</surname>
<given-names>R</given-names>
</name>
<name name-style="western">
<surname>Skaane</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Urdal</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Berghagen</surname>
<given-names>H</given-names>
</name>
<name name-style="western">
<surname>Jensen</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Kristiansen</surname>
<given-names>L</given-names>
</name>
<name name-style="western">
<surname>Moen</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Sharma</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Zaka</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Arnes</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Sauer</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Early detection of breast cancer based on gene-expression patterns in peripheral blood cells</article-title>
<source/>Breast Cancer Res
          <year>2005</year>
<volume>7</volume>
<fpage>R634</fpage>
<lpage>44</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/bcr1203">https://doi.org/10.1186/bcr1203</ext-link>
</comment>
<pub-id pub-id-type="pmid">16168108</pub-id>
</element-citation>
</ref>
<ref id="R45">
<label>45</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Honma</surname>
<given-names>N</given-names>
</name>
<name name-style="western">
<surname>Takubo</surname>
<given-names>K</given-names>
</name>
<name name-style="western">
<surname>Sawabe</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Arai</surname>
<given-names>T</given-names>
</name>
<name name-style="western">
<surname>Akiyama</surname>
<given-names>F</given-names>
</name>
<name name-style="western">
<surname>Sakamoto</surname>
<given-names>G</given-names>
</name>
<name name-style="western">
<surname>Utsumi</surname>
<given-names>T</given-names>
</name>
<name name-style="western">
<surname>Yoshimura</surname>
<given-names>N</given-names>
</name>
<name name-style="western">
<surname>Harada</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Alternative use of multiple exons 1 of aromatase gene in cancerous and normal breast tissues from women over the age of 80 years</article-title>
<source/>Breast Cancer Res
          <year>2009</year>
<volume>11</volume>
<fpage>R48</fpage>
<lpage>8</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/bcr2335">https://doi.org/10.1186/bcr2335</ext-link>
</comment>
<pub-id pub-id-type="pmid">19589174</pub-id>
</element-citation>
</ref>
<ref id="R46">
<label>46</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Mougeot</surname>
<given-names>JL</given-names>
</name>
<name name-style="western">
<surname>Bahrani-Mostafavi</surname>
<given-names>Z</given-names>
</name>
<name name-style="western">
<surname>Vachris</surname>
<given-names>JC</given-names>
</name>
<name name-style="western">
<surname>McKinney</surname>
<given-names>KQ</given-names>
</name>
<name name-style="western">
<surname>Gurlov</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Naumann</surname>
<given-names>RW</given-names>
</name>
<name name-style="western">
<surname>Higgins</surname>
<given-names>RV</given-names>
</name>
<name name-style="western">
<surname>Hall</surname>
<given-names>JB</given-names>
</name>
</person-group>
<article-title>Gene expression profiling of ovarian tissues for determination of molecular pathways reflective of tumorigenesis</article-title>
<source/>J Mol Biol
          <year>2006</year>
<volume>358</volume>
<fpage>310</fpage>
<lpage>29</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jmb.2006.01.092">https://doi.org/10.1016/j.jmb.2006.01.092</ext-link>
</comment>
<pub-id pub-id-type="pmid">16503337</pub-id>
</element-citation>
</ref>
<ref id="R47">
<label>47</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Shin</surname>
<given-names>JC</given-names>
</name>
<name name-style="western">
<surname>Lee</surname>
<given-names>JH</given-names>
</name>
<name name-style="western">
<surname>Yang</surname>
<given-names>DE</given-names>
</name>
<name name-style="western">
<surname>Moon</surname>
<given-names>HB</given-names>
</name>
<name name-style="western">
<surname>Rha</surname>
<given-names>JG</given-names>
</name>
<name name-style="western">
<surname>Kim</surname>
<given-names>SP</given-names>
</name>
</person-group>
<article-title>Expression of insulin-like growth factor-II and insulin-like growth factor binding protein-1 in the placental basal plate from pre-eclamptic pregnancies</article-title>
<source/>Int J Gynaecol Obstet
          <year>2003</year>
<volume>81</volume>
<fpage>273</fpage>
<lpage>80</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0020-7292(02)00444-7">https://doi.org/10.1016/S0020-7292(02)00444-7</ext-link>
</comment>
<pub-id pub-id-type="pmid">12767569</pub-id>
</element-citation>
</ref>
<ref id="R48">
<label>48</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Hu</surname>
<given-names>VW</given-names>
</name>
<name name-style="western">
<surname>Lai</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Developing a predictive gene classifier for autism spectrum disorders based upon differential gene expression profiles of phenotypic subgroups</article-title>
<source/>N Am J Med Sci (Boston)
          <year>2013</year>
<volume>6</volume>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7156/najms.2013.0603107">https://doi.org/10.7156/najms.2013.0603107</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R49">
<label>49</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Mancini</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Roncaglia</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Brussino</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Stevanin</surname>
<given-names>G</given-names>
</name>
<name name-style="western">
<surname>Buono Lo</surname>
<given-names>N</given-names>
</name>
<name name-style="western">
<surname>Krmac</surname>
<given-names>H</given-names>
</name>
<name name-style="western">
<surname>Maltecca</surname>
<given-names>F</given-names>
</name>
<name name-style="western">
<surname>Gazzano</surname>
<given-names>E</given-names>
</name>
<name name-style="western">
<surname>Stella</surname>
<given-names>AB</given-names>
</name>
<name name-style="western">
<surname>Calvaruso</surname>
<given-names>MA</given-names>
</name>
<name name-style="western">
<surname>Iommarini</surname>
<given-names>L</given-names>
</name>
<name name-style="western">
<surname>Cagnoli</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Forlani</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genome-wide expression profiling and functional characterization of SCA28 lymphoblastoid cell lines reveal impairment in cell growth and activation of apoptotic pathways</article-title>
<source/>BMC Med Genomics
          <year>2013</year>
<volume>6</volume>
<fpage>22</fpage>
<lpage>2</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1755-8794-6-22">https://doi.org/10.1186/1755-8794-6-22</ext-link>
</comment>
<pub-id pub-id-type="pmid">23777634</pub-id>
</element-citation>
</ref>
<ref id="R50">
<label>50</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Choy</surname>
<given-names>E</given-names>
</name>
<name name-style="western">
<surname>Yelensky</surname>
<given-names>R</given-names>
</name>
<name name-style="western">
<surname>Bonakdar</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Plenge</surname>
<given-names>RM</given-names>
</name>
<name name-style="western">
<surname>Saxena</surname>
<given-names>R</given-names>
</name>
<name name-style="western">
<surname>De Jager</surname>
<given-names>PL</given-names>
</name>
<name name-style="western">
<surname>Shaw</surname>
<given-names>SY</given-names>
</name>
<name name-style="western">
<surname>Wolfish</surname>
<given-names>CS</given-names>
</name>
<name name-style="western">
<surname>Slavik</surname>
<given-names>JM</given-names>
</name>
<name name-style="western">
<surname>Cotsapas</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Rivas</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Dermitzakis</surname>
<given-names>ET</given-names>
</name>
<name name-style="western">
<surname>Cahir-McFarland</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genetic analysis of human traits <italic>in vitro</italic>: drug response and gene expression in lymphoblastoid cell lines</article-title>
<source/>PLoS Genet
          <year>2008</year>
<volume>4</volume>
<fpage>e1000287</fpage>
<lpage>7</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pgen.1000287">https://doi.org/10.1371/journal.pgen.1000287</ext-link>
</comment>
<pub-id pub-id-type="pmid">19043577</pub-id>
</element-citation>
</ref>
<ref id="R51">
<label>51</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Duan</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Bleibel</surname>
<given-names>WK</given-names>
</name>
<name name-style="western">
<surname>Huang</surname>
<given-names>RS</given-names>
</name>
<name name-style="western">
<surname>Shukla</surname>
<given-names>SJ</given-names>
</name>
<name name-style="western">
<surname>Wu</surname>
<given-names>X</given-names>
</name>
<name name-style="western">
<surname>Badner</surname>
<given-names>JA</given-names>
</name>
<name name-style="western">
<surname>Dolan</surname>
<given-names>ME</given-names>
</name>
</person-group>
<article-title>Mapping genes that contribute to daunorubicin-induced cytotoxicity</article-title>
<source/>Cancer Res
          <year>2007</year>
<volume>67</volume>
<fpage>5425</fpage>
<lpage>33</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1158/0008-5472.CAN-06-4431">https://doi.org/10.1158/0008-5472.CAN-06-4431</ext-link>
</comment>
<pub-id pub-id-type="pmid">17545624</pub-id>
</element-citation>
</ref>
<ref id="R52">
<label>52</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Huang</surname>
<given-names>RS</given-names>
</name>
<name name-style="western">
<surname>Duan</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Bleibel</surname>
<given-names>WK</given-names>
</name>
<name name-style="western">
<surname>Kistner</surname>
<given-names>EO</given-names>
</name>
<name name-style="western">
<surname>Zhang</surname>
<given-names>W</given-names>
</name>
<name name-style="western">
<surname>Clark</surname>
<given-names>TA</given-names>
</name>
<name name-style="western">
<surname>Chen</surname>
<given-names>TX</given-names>
</name>
<name name-style="western">
<surname>Schweitzer</surname>
<given-names>AC</given-names>
</name>
<name name-style="western">
<surname>Blume</surname>
<given-names>JE</given-names>
</name>
<name name-style="western">
<surname>Cox</surname>
<given-names>NJ</given-names>
</name>
<name name-style="western">
<surname>Dolan</surname>
<given-names>ME</given-names>
</name>
</person-group>
<article-title>A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2007</year>
<volume>104</volume>
<fpage>9758</fpage>
<lpage>63</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.0703736104">https://doi.org/10.1073/pnas.0703736104</ext-link>
</comment>
<pub-id pub-id-type="pmid">17537913</pub-id>
</element-citation>
</ref>
<ref id="R53">
<label>53</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Huang</surname>
<given-names>RS</given-names>
</name>
<name name-style="western">
<surname>Duan</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Shukla</surname>
<given-names>SJ</given-names>
</name>
<name name-style="western">
<surname>Kistner</surname>
<given-names>EO</given-names>
</name>
<name name-style="western">
<surname>Clark</surname>
<given-names>TA</given-names>
</name>
<name name-style="western">
<surname>Chen</surname>
<given-names>TX</given-names>
</name>
<name name-style="western">
<surname>Schweitzer</surname>
<given-names>AC</given-names>
</name>
<name name-style="western">
<surname>Blume</surname>
<given-names>JE</given-names>
</name>
<name name-style="western">
<surname>Dolan</surname>
<given-names>ME</given-names>
</name>
</person-group>
<article-title>Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach</article-title>
<source/>Am J Hum Genet
          <year>2007</year>
<volume>81</volume>
<fpage>427</fpage>
<lpage>37</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1086/519850">https://doi.org/10.1086/519850</ext-link>
</comment>
<pub-id pub-id-type="pmid">17701890</pub-id>
</element-citation>
</ref>
<ref id="R54">
<label>54</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Vaclová</surname>
<given-names>T</given-names>
</name>
<name name-style="western">
<surname>Gómez-López</surname>
<given-names>G</given-names>
</name>
<name name-style="western">
<surname>Setién</surname>
<given-names>F</given-names>
</name>
<name name-style="western">
<surname>Bueno</surname>
<given-names>JM</given-names>
</name>
<name name-style="western">
<surname>Macías</surname>
<given-names>JA</given-names>
</name>
<name name-style="western">
<surname>Barroso</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Urioste</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Esteller</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Benítez</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Osorio</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>DNA repair capacity is impaired in healthy BRCA1 heterozygous mutation carriers</article-title>
<source/>Breast Cancer Res Treat
          <year>2015</year>
<volume>152</volume>
<fpage>271</fpage>
<lpage>82</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10549-015-3459-3">https://doi.org/10.1007/s10549-015-3459-3</ext-link>
</comment>
<pub-id pub-id-type="pmid">26071757</pub-id>
</element-citation>
</ref>
<ref id="R55">
<label>55</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Perou</surname>
<given-names>CM</given-names>
</name>
<name name-style="western">
<surname>Sørlie</surname>
<given-names>T</given-names>
</name>
<name name-style="western">
<surname>Eisen</surname>
<given-names>MB</given-names>
</name>
<name name-style="western">
<surname>van de Rijn</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Molecular portraits of human breast tumours</article-title>
<source/>Nature
          <year>2000</year>
<volume>406</volume>
<fpage>747</fpage>
<lpage>52</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/35021093">https://doi.org/10.1038/35021093</ext-link>
</comment>
<pub-id pub-id-type="pmid">10963602</pub-id>
</element-citation>
</ref>
<ref id="R56">
<label>56</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>van ’t Veer</surname>
<given-names>LJ</given-names>
</name>
<name name-style="western">
<surname>Dai</surname>
<given-names>H</given-names>
</name>
<name name-style="western">
<surname>van de Vijver</surname>
<given-names>MJ</given-names>
</name>
<name name-style="western">
<surname>He</surname>
<given-names>YD</given-names>
</name>
<name name-style="western">
<surname>Hart</surname>
<given-names>AA</given-names>
</name>
<name name-style="western">
<surname>Mao</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Peterse</surname>
<given-names>HL</given-names>
</name>
<name name-style="western">
<surname>van der Kooy</surname>
<given-names>K</given-names>
</name>
<name name-style="western">
<surname>Marton</surname>
<given-names>MJ</given-names>
</name>
<name name-style="western">
<surname>Witteveen</surname>
<given-names>AT</given-names>
</name>
<name name-style="western">
<surname>Schreiber</surname>
<given-names>GJ</given-names>
</name>
<name name-style="western">
<surname>Kerkhoven</surname>
<given-names>RM</given-names>
</name>
<name name-style="western">
<surname>Roberts</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gene expression profiling predicts clinical outcome of breast cancer</article-title>
<source/>Nature
          <year>2002</year>
<volume>415</volume>
<fpage>530</fpage>
<lpage>6</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/415530a">https://doi.org/10.1038/415530a</ext-link>
</comment>
<pub-id pub-id-type="pmid">11823860</pub-id>
</element-citation>
</ref>
<ref id="R57">
<label>57</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Sørlie</surname>
<given-names>T</given-names>
</name>
<name name-style="western">
<surname>Perou</surname>
<given-names>CM</given-names>
</name>
<name name-style="western">
<surname>Tibshirani</surname>
<given-names>R</given-names>
</name>
<name name-style="western">
<surname>Aas</surname>
<given-names>T</given-names>
</name>
<name name-style="western">
<surname>Geisler</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Johnsen</surname>
<given-names>H</given-names>
</name>
<name name-style="western">
<surname>Hastie</surname>
<given-names>T</given-names>
</name>
<name name-style="western">
<surname>Eisen</surname>
<given-names>MB</given-names>
</name>
<name name-style="western">
<surname>van de Rijn</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Jeffrey</surname>
<given-names>SS</given-names>
</name>
<name name-style="western">
<surname>Thorsen</surname>
<given-names>T</given-names>
</name>
<name name-style="western">
<surname>Quist</surname>
<given-names>H</given-names>
</name>
<name name-style="western">
<surname>Matese</surname>
<given-names>JC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2001</year>
<volume>98</volume>
<fpage>10869</fpage>
<lpage>74</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.191367098">https://doi.org/10.1073/pnas.191367098</ext-link>
</comment>
<pub-id pub-id-type="pmid">11553815</pub-id>
</element-citation>
</ref>
<ref id="R58">
<label>58</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Bertucci</surname>
<given-names>F</given-names>
</name>
<name name-style="western">
<surname>Finetti</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Cervera</surname>
<given-names>N</given-names>
</name>
<name name-style="western">
<surname>Charafe-Jauffret</surname>
<given-names>E</given-names>
</name>
<name name-style="western">
<surname>Mamessier</surname>
<given-names>E</given-names>
</name>
<name name-style="western">
<surname>Adélaïde</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Debono</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Houvenaeghel</surname>
<given-names>G</given-names>
</name>
<name name-style="western">
<surname>Maraninchi</surname>
<given-names>D</given-names>
</name>
<name name-style="western">
<surname>Viens</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Charpin</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Jacquemier</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Birnbaum</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers</article-title>
<source/>Cancer Res
          <year>2006</year>
<volume>66</volume>
<fpage>4636</fpage>
<lpage>44</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1158/0008-5472.CAN-06-0031">https://doi.org/10.1158/0008-5472.CAN-06-0031</ext-link>
</comment>
<pub-id pub-id-type="pmid">16651414</pub-id>
</element-citation>
</ref>
<ref id="R59">
<label>59</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Sørlie</surname>
<given-names>T</given-names>
</name>
<name name-style="western">
<surname>Tibshirani</surname>
<given-names>R</given-names>
</name>
<name name-style="western">
<surname>Parker</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Hastie</surname>
<given-names>T</given-names>
</name>
<name name-style="western">
<surname>Marron</surname>
<given-names>JS</given-names>
</name>
<name name-style="western">
<surname>Nobel</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Deng</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Johnsen</surname>
<given-names>H</given-names>
</name>
<name name-style="western">
<surname>Pesich</surname>
<given-names>R</given-names>
</name>
<name name-style="western">
<surname>Geisler</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Demeter</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Perou</surname>
<given-names>CM</given-names>
</name>
<name name-style="western">
<surname>Lønning</surname>
<given-names>PE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Repeated observation of breast tumor subtypes in independent gene expression data sets</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2003</year>
<volume>100</volume>
<fpage>8418</fpage>
<lpage>23</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.0932692100">https://doi.org/10.1073/pnas.0932692100</ext-link>
</comment>
<pub-id pub-id-type="pmid">12829800</pub-id>
</element-citation>
</ref>
<ref id="R60">
<label>60</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Waddell</surname>
<given-names>N</given-names>
</name>
<name name-style="western">
<surname>Arnold</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Cocciardi</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>da Silva</surname>
<given-names>L</given-names>
</name>
<name name-style="western">
<surname>Marsh</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Riley</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Johnstone</surname>
<given-names>CN</given-names>
</name>
<name name-style="western">
<surname>Orloff</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Assie</surname>
<given-names>G</given-names>
</name>
<name name-style="western">
<surname>Eng</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Reid</surname>
<given-names>L</given-names>
</name>
<name name-style="western">
<surname>Keith</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Yan</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Subtypes of familial breast tumours revealed by expression and copy number profiling</article-title>
<source/>Breast Cancer Res Treat
          <year>2010</year>
<volume>123</volume>
<fpage>661</fpage>
<lpage>77</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10549-009-0653-1">https://doi.org/10.1007/s10549-009-0653-1</ext-link>
</comment>
<pub-id pub-id-type="pmid">19960244</pub-id>
</element-citation>
</ref>
<ref id="R61">
<label>61</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Jönsson</surname>
<given-names>G</given-names>
</name>
<name name-style="western">
<surname>Staaf</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Vallon-Christersson</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Ringnér</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Holm</surname>
<given-names>K</given-names>
</name>
<name name-style="western">
<surname>Hegardt</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Gunnarsson</surname>
<given-names>H</given-names>
</name>
<name name-style="western">
<surname>Fagerholm</surname>
<given-names>R</given-names>
</name>
<name name-style="western">
<surname>Strand</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Agnarsson</surname>
<given-names>BA</given-names>
</name>
<name name-style="western">
<surname>Kilpivaara</surname>
<given-names>O</given-names>
</name>
<name name-style="western">
<surname>Luts</surname>
<given-names>L</given-names>
</name>
<name name-style="western">
<surname>Heikkilä</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics</article-title>
<source/>Breast Cancer Res
          <year>2010</year>
<volume>12</volume>
<fpage>R42</fpage>
<lpage>2</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/bcr2596">https://doi.org/10.1186/bcr2596</ext-link>
</comment>
<pub-id pub-id-type="pmid">20576095</pub-id>
</element-citation>
</ref>
<ref id="R62">
<label>62</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Nagel</surname>
<given-names>JH</given-names>
</name>
<name name-style="western">
<surname>Peeters</surname>
<given-names>JK</given-names>
</name>
<name name-style="western">
<surname>Smid</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Sieuwerts</surname>
<given-names>AM</given-names>
</name>
<name name-style="western">
<surname>Wasielewski</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>de Weerd</surname>
<given-names>V</given-names>
</name>
<name name-style="western">
<surname>Trapman-Jansen</surname>
<given-names>AM</given-names>
</name>
<name name-style="western">
<surname>van den Ouweland</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Brüggenwirth</surname>
<given-names>H</given-names>
</name>
<name name-style="western">
<surname>van I Jcken</surname>
<given-names>WF</given-names>
</name>
<name name-style="western">
<surname>Klijn</surname>
<given-names>JG</given-names>
</name>
<name name-style="western">
<surname>van der Spek</surname>
<given-names>PJ</given-names>
</name>
<name name-style="western">
<surname>Foekens</surname>
<given-names>JA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gene expression profiling assigns CHEK2 1100delC breast cancers to the luminal intrinsic subtypes</article-title>
<source/>Breast Cancer Res Treat
          <year>2012</year>
<volume>132</volume>
<fpage>439</fpage>
<lpage>48</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10549-011-1588-x">https://doi.org/10.1007/s10549-011-1588-x</ext-link>
</comment>
<pub-id pub-id-type="pmid">21614566</pub-id>
</element-citation>
</ref>
<ref id="R63">
<label>63</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Hu</surname>
<given-names>Z</given-names>
</name>
<name name-style="western">
<surname>Fan</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Oh</surname>
<given-names>DS</given-names>
</name>
<name name-style="western">
<surname>Marron</surname>
<given-names>JS</given-names>
</name>
<name name-style="western">
<surname>He</surname>
<given-names>X</given-names>
</name>
<name name-style="western">
<surname>Qaqish</surname>
<given-names>BF</given-names>
</name>
<name name-style="western">
<surname>Livasy</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Carey</surname>
<given-names>LA</given-names>
</name>
<name name-style="western">
<surname>Reynolds</surname>
<given-names>E</given-names>
</name>
<name name-style="western">
<surname>Dressler</surname>
<given-names>L</given-names>
</name>
<name name-style="western">
<surname>Nobel</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Parker</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Ewend</surname>
<given-names>MG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The molecular portraits of breast tumors are conserved across microarray platforms</article-title>
<source/>BMC Genomics
          <year>2006</year>
<volume>7</volume>
<fpage>96</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1471-2164-7-96">https://doi.org/10.1186/1471-2164-7-96</ext-link>
</comment>
<pub-id pub-id-type="pmid">16643655</pub-id>
</element-citation>
</ref>
<ref id="R64">
<label>64</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Perou</surname>
<given-names>CM</given-names>
</name>
<name name-style="western">
<surname>Jeffrey</surname>
<given-names>SS</given-names>
</name>
<name name-style="western">
<surname>van de Rijn</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Rees</surname>
<given-names>CA</given-names>
</name>
<name name-style="western">
<surname>Eisen</surname>
<given-names>MB</given-names>
</name>
<name name-style="western">
<surname>Ross</surname>
<given-names>DT</given-names>
</name>
<name name-style="western">
<surname>Pergamenschikov</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Williams</surname>
<given-names>CF</given-names>
</name>
<name name-style="western">
<surname>Zhu</surname>
<given-names>SX</given-names>
</name>
<name name-style="western">
<surname>Lee</surname>
<given-names>JC</given-names>
</name>
<name name-style="western">
<surname>Lashkari</surname>
<given-names>D</given-names>
</name>
<name name-style="western">
<surname>Shalon</surname>
<given-names>D</given-names>
</name>
<name name-style="western">
<surname>Brown</surname>
<given-names>PO</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Distinctive gene expression patterns in human mammary epithelial cells and breast cancers</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>1999</year>
<volume>96</volume>
<fpage>9212</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">10430922</pub-id>
</element-citation>
</ref>
<ref id="R65">
<label>65</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Sørlie</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Molecular portraits of breast cancer: tumour subtypes as distinct disease entities</article-title>
<source/>Eur J Cancer
          <year>2004</year>
<volume>40</volume>
<fpage>2667</fpage>
<lpage>75</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ejca.2004.08.021">https://doi.org/10.1016/j.ejca.2004.08.021</ext-link>
</comment>
<pub-id pub-id-type="pmid">15571950</pub-id>
</element-citation>
</ref>
<ref id="R66">
<label>66</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Nielsen</surname>
<given-names>TO</given-names>
</name>
<name name-style="western">
<surname>Hsu</surname>
<given-names>FD</given-names>
</name>
<name name-style="western">
<surname>Jensen</surname>
<given-names>K</given-names>
</name>
<name name-style="western">
<surname>Cheang</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Karaca</surname>
<given-names>G</given-names>
</name>
<name name-style="western">
<surname>Hu</surname>
<given-names>Z</given-names>
</name>
<name name-style="western">
<surname>Hernandez-Boussard</surname>
<given-names>T</given-names>
</name>
<name name-style="western">
<surname>Livasy</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Cowan</surname>
<given-names>D</given-names>
</name>
<name name-style="western">
<surname>Dressler</surname>
<given-names>L</given-names>
</name>
<name name-style="western">
<surname>Akslen</surname>
<given-names>LA</given-names>
</name>
<name name-style="western">
<surname>Ragaz</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Gown</surname>
<given-names>AM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma</article-title>
<source/>Clin Cancer Res
          <year>2004</year>
<volume>10</volume>
<fpage>5367</fpage>
<lpage>74</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1158/1078-0432.CCR-04-0220">https://doi.org/10.1158/1078-0432.CCR-04-0220</ext-link>
</comment>
<pub-id pub-id-type="pmid">15328174</pub-id>
</element-citation>
</ref>
<ref id="R67">
<label>67</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Abd El-Rehim</surname>
<given-names>DM</given-names>
</name>
<name name-style="western">
<surname>Ball</surname>
<given-names>G</given-names>
</name>
<name name-style="western">
<surname>Pinder</surname>
<given-names>SE</given-names>
</name>
<name name-style="western">
<surname>Rakha</surname>
<given-names>E</given-names>
</name>
<name name-style="western">
<surname>Paish</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Robertson</surname>
<given-names>JF</given-names>
</name>
<name name-style="western">
<surname>Macmillan</surname>
<given-names>D</given-names>
</name>
<name name-style="western">
<surname>Blamey</surname>
<given-names>RW</given-names>
</name>
<name name-style="western">
<surname>Ellis</surname>
<given-names>IO</given-names>
</name>
</person-group>
<article-title>High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses</article-title>
<source/>Int J Cancer
          <year>2005</year>
<volume>116</volume>
<fpage>340</fpage>
<lpage>50</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/ijc.21004">https://doi.org/10.1002/ijc.21004</ext-link>
</comment>
<pub-id pub-id-type="pmid">15818618</pub-id>
</element-citation>
</ref>
<ref id="R68">
<label>68</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Jacquemier</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Ginestier</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Rougemont</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Bardou</surname>
<given-names>VJ</given-names>
</name>
<name name-style="western">
<surname>Charafe-Jauffret</surname>
<given-names>E</given-names>
</name>
<name name-style="western">
<surname>Geneix</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Adélaïde</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Koki</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Houvenaeghel</surname>
<given-names>G</given-names>
</name>
<name name-style="western">
<surname>Hassoun</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Maraninchi</surname>
<given-names>D</given-names>
</name>
<name name-style="western">
<surname>Viens</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Birnbaum</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Protein expression profiling identifies subclasses of breast cancer and predicts prognosis</article-title>
<source/>Cancer Res
          <year>2005</year>
<volume>65</volume>
<fpage>767</fpage>
<lpage>79</lpage>
<pub-id pub-id-type="pmid">15705873</pub-id>
</element-citation>
</ref>
<ref id="R69">
<label>69</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Sørlie</surname>
<given-names>T</given-names>
</name>
<name name-style="western">
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name name-style="western">
<surname>Xiao</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Johnsen</surname>
<given-names>H</given-names>
</name>
<name name-style="western">
<surname>Naume</surname>
<given-names>B</given-names>
</name>
<name name-style="western">
<surname>Samaha</surname>
<given-names>RR</given-names>
</name>
<name name-style="western">
<surname>Børresen-Dale</surname>
<given-names>AL</given-names>
</name>
</person-group>
<article-title>Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms</article-title>
<source/>BMC Genomics
          <year>2006</year>
<volume>7</volume>
<fpage>127</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1471-2164-7-127">https://doi.org/10.1186/1471-2164-7-127</ext-link>
</comment>
<pub-id pub-id-type="pmid">16729877</pub-id>
</element-citation>
</ref>
<ref id="R70">
<label>70</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Sotiriou</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Neo</surname>
<given-names>SY</given-names>
</name>
<name name-style="western">
<surname>McShane</surname>
<given-names>LM</given-names>
</name>
<name name-style="western">
<surname>Korn</surname>
<given-names>EL</given-names>
</name>
<name name-style="western">
<surname>Long</surname>
<given-names>PM</given-names>
</name>
<name name-style="western">
<surname>Jazaeri</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Martiat</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Fox</surname>
<given-names>SB</given-names>
</name>
<name name-style="western">
<surname>Harris</surname>
<given-names>AL</given-names>
</name>
<name name-style="western">
<surname>Liu</surname>
<given-names>ET</given-names>
</name>
</person-group>
<article-title>Breast cancer classification and prognosis based on gene expression profiles from a population-based study</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2003</year>
<volume>100</volume>
<fpage>10393</fpage>
<lpage>8</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.1732912100">https://doi.org/10.1073/pnas.1732912100</ext-link>
</comment>
<pub-id pub-id-type="pmid">12917485</pub-id>
</element-citation>
</ref>
<ref id="R71">
<label>71</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Venables</surname>
<given-names>JP</given-names>
</name>
<name name-style="western">
<surname>Klinck</surname>
<given-names>R</given-names>
</name>
<name name-style="western">
<surname>Bramard</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Inkel</surname>
<given-names>L</given-names>
</name>
<name name-style="western">
<surname>Dufresne-Martin</surname>
<given-names>G</given-names>
</name>
<name name-style="western">
<surname>Koh</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Gervais-Bird</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Lapointe</surname>
<given-names>E</given-names>
</name>
<name name-style="western">
<surname>Froehlich</surname>
<given-names>U</given-names>
</name>
<name name-style="western">
<surname>Durand</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Gendron</surname>
<given-names>D</given-names>
</name>
<name name-style="western">
<surname>Brosseau</surname>
<given-names>JP</given-names>
</name>
<name name-style="western">
<surname>Thibault</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification of alternative splicing markers for breast cancer</article-title>
<source/>Cancer Res
          <year>2008</year>
<volume>68</volume>
<fpage>9525</fpage>
<lpage>31</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1158/0008-5472.CAN-08-1769">https://doi.org/10.1158/0008-5472.CAN-08-1769</ext-link>
</comment>
<pub-id pub-id-type="pmid">19010929</pub-id>
</element-citation>
</ref>
<ref id="R72">
<label>72</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Li</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Kato</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Shiue</surname>
<given-names>L</given-names>
</name>
<name name-style="western">
<surname>Shively</surname>
<given-names>JE</given-names>
</name>
<name name-style="western">
<surname>Ares</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Lin</surname>
<given-names>RJ</given-names>
</name>
</person-group>
<article-title>Cell type and culture condition-dependent alternative splicing in human breast cancer cells revealed by splicing-sensitive microarrays</article-title>
<source/>Cancer Res
          <year>2006</year>
<volume>66</volume>
<fpage>1990</fpage>
<lpage>9</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1158/0008-5472.CAN-05-2593">https://doi.org/10.1158/0008-5472.CAN-05-2593</ext-link>
</comment>
<pub-id pub-id-type="pmid">16488998</pub-id>
</element-citation>
</ref>
<ref id="R73">
<label>73</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>André</surname>
<given-names>F</given-names>
</name>
<name name-style="western">
<surname>Michiels</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Dessen</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Scott</surname>
<given-names>V</given-names>
</name>
<name name-style="western">
<surname>Suciu</surname>
<given-names>V</given-names>
</name>
<name name-style="western">
<surname>Uzan</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Lazar</surname>
<given-names>V</given-names>
</name>
<name name-style="western">
<surname>Lacroix</surname>
<given-names>L</given-names>
</name>
<name name-style="western">
<surname>Vassal</surname>
<given-names>G</given-names>
</name>
<name name-style="western">
<surname>Spielmann</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Vielh</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Delaloge</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Exonic expression profiling of breast cancer and benign lesions: a retrospective analysis</article-title>
<source/>Lancet Oncol
          <year>2009</year>
<volume>10</volume>
<fpage>381</fpage>
<lpage>90</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S1470-2045(09)70024-5">https://doi.org/10.1016/S1470-2045(09)70024-5</ext-link>
</comment>
<pub-id pub-id-type="pmid">19249242</pub-id>
</element-citation>
</ref>
<ref id="R74">
<label>74</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Honrado</surname>
<given-names>E</given-names>
</name>
<name name-style="western">
<surname>Osorio</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Palacios</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Benitez</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations</article-title>
<source/>Oncogene
          <year>2006</year>
<volume>25</volume>
<fpage>5837</fpage>
<lpage>45</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/sj.onc.1209875">https://doi.org/10.1038/sj.onc.1209875</ext-link>
</comment>
<pub-id pub-id-type="pmid">16998498</pub-id>
</element-citation>
</ref>
<ref id="R75">
<label>75</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Vuillaume</surname>
<given-names>ML</given-names>
</name>
<name name-style="western">
<surname>Uhrhammer</surname>
<given-names>N</given-names>
</name>
<name name-style="western">
<surname>Vidal</surname>
<given-names>V</given-names>
</name>
<name name-style="western">
<surname>Vidal</surname>
<given-names>VS</given-names>
</name>
<name name-style="western">
<surname>Chabaud</surname>
<given-names>V</given-names>
</name>
<name name-style="western">
<surname>Jesson</surname>
<given-names>B</given-names>
</name>
<name name-style="western">
<surname>Kwiatkowski</surname>
<given-names>F</given-names>
</name>
<name name-style="western">
<surname>Bignon</surname>
<given-names>YJ</given-names>
</name>
</person-group>
<article-title>Use of gene expression profiles of peripheral blood lymphocytes to distinguish BRCA1 mutation carriers in high risk breast cancer families</article-title>
<source/>Cancer Inform
          <year>2009</year>
<volume>7</volume>
<fpage>41</fpage>
<lpage>56</lpage>
<pub-id pub-id-type="pmid">19352458</pub-id>
</element-citation>
</ref>
<ref id="R76">
<label>76</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Li</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Ge</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Yin</surname>
<given-names>Y</given-names>
</name>
<name name-style="western">
<surname>Luo</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Chen</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Silencing expression of ribosomal protein L26 and L29 by RNA interfering inhibits proliferation of human pancreatic cancer PANC-1 cells</article-title>
<source/>Mol Cell Biochem
          <year>2012</year>
<volume>370</volume>
<fpage>127</fpage>
<lpage>39</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11010-012-1404-x">https://doi.org/10.1007/s11010-012-1404-x</ext-link>
</comment>
<pub-id pub-id-type="pmid">22868929</pub-id>
</element-citation>
</ref>
<ref id="R77">
<label>77</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>McCutchen-Maloney</surname>
<given-names>SL</given-names>
</name>
<name name-style="western">
<surname>Matsuda</surname>
<given-names>K</given-names>
</name>
<name name-style="western">
<surname>Shimbara</surname>
<given-names>N</given-names>
</name>
<name name-style="western">
<surname>Binns</surname>
<given-names>DD</given-names>
</name>
<name name-style="western">
<surname>Tanaka</surname>
<given-names>K</given-names>
</name>
<name name-style="western">
<surname>Slaughter</surname>
<given-names>CA</given-names>
</name>
<name name-style="western">
<surname>DeMartino</surname>
<given-names>GN</given-names>
</name>
</person-group>
<article-title>cDNA cloning, expression, and functional characterization of PI31, a proline-rich inhibitor of the proteasome</article-title>
<source/>J Biol Chem
          <year>2000</year>
<volume>275</volume>
<fpage>18557</fpage>
<lpage>65</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M001697200">https://doi.org/10.1074/jbc.M001697200</ext-link>
</comment>
<pub-id pub-id-type="pmid">10764772</pub-id>
</element-citation>
</ref>
<ref id="R78">
<label>78</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>GTEx Consortium</collab>
</person-group>
<article-title>The Genotype-Tissue Expression (GTEx) project</article-title>
<source/>Nat Genet
          <year>2013</year>
<volume>45</volume>
<fpage>580</fpage>
<lpage>5</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ng.2653">https://doi.org/10.1038/ng.2653</ext-link>
</comment>
<pub-id pub-id-type="pmid">23715323</pub-id>
</element-citation>
</ref>
<ref id="R79">
<label>79</label>
<element-citation publication-type="other">
<person-group person-group-type="author">
<name name-style="western">
<surname>Wan</surname>
<given-names>Q</given-names>
</name>
<name name-style="western">
<surname>Dingerdissen</surname>
<given-names>H</given-names>
</name>
<name name-style="western">
<surname>Fan</surname>
<given-names>Y</given-names>
</name>
<name name-style="western">
<surname>Gulzar</surname>
<given-names>N</given-names>
</name>
<name name-style="western">
<surname>Pan</surname>
<given-names>Y</given-names>
</name>
<name name-style="western">
<surname>Wu</surname>
<given-names>TJ</given-names>
</name>
<name name-style="western">
<surname>Yan</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Zhang</surname>
<given-names>H</given-names>
</name>
<name name-style="western">
<surname>Mazumder</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>BioXpress: an integrated RNA-seq-derived gene expression database for pan-cancer analysis</article-title>
<comment>Database (Oxford). 2015; 2015: bav019. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/database/bav019">https://doi.org/10.1093/database/bav019</ext-link></comment>
</element-citation>
</ref>
<ref id="R80">
<label>80</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>König</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Dedio</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Oess</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Papadakis</surname>
<given-names>T</given-names>
</name>
<name name-style="western">
<surname>Fischer</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Müller-Esterl</surname>
<given-names>W</given-names>
</name>
<name name-style="western">
<surname>Kummer</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>NOSIP and its interacting protein, eNOS, in the rat trachea and lung</article-title>
<source/>J Histochem Cytochem
          <year>2005</year>
<volume>53</volume>
<fpage>155</fpage>
<lpage>64</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1369/jhc.4A6453.2005">https://doi.org/10.1369/jhc.4A6453.2005</ext-link>
</comment>
<pub-id pub-id-type="pmid">15684328</pub-id>
</element-citation>
</ref>
<ref id="R81">
<label>81</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Acharya</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Chen</surname>
<given-names>JJ</given-names>
</name>
<name name-style="western">
<surname>Correia</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Hepatic heme-regulated inhibitor (HRI) eukaryotic initiation factor 2alpha kinase: a protagonist of heme-mediated translational control of CYP2B enzymes and a modulator of basal endoplasmic reticulum stress tone</article-title>
<source/>Mol Pharmacol
          <year>2010</year>
<volume>77</volume>
<fpage>575</fpage>
<lpage>92</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1124/mol.109.061259">https://doi.org/10.1124/mol.109.061259</ext-link>
</comment>
<pub-id pub-id-type="pmid">20071449</pub-id>
</element-citation>
</ref>
<ref id="R82">
<label>82</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Chen</surname>
<given-names>T</given-names>
</name>
<name name-style="western">
<surname>Ozel</surname>
<given-names>D</given-names>
</name>
<name name-style="western">
<surname>Qiao</surname>
<given-names>Y</given-names>
</name>
<name name-style="western">
<surname>Harbinski</surname>
<given-names>F</given-names>
</name>
<name name-style="western">
<surname>Chen</surname>
<given-names>L</given-names>
</name>
<name name-style="western">
<surname>Denoyelle</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>He</surname>
<given-names>X</given-names>
</name>
<name name-style="western">
<surname>Zvereva</surname>
<given-names>N</given-names>
</name>
<name name-style="western">
<surname>Supko</surname>
<given-names>JG</given-names>
</name>
<name name-style="western">
<surname>Chorev</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Halperin</surname>
<given-names>JA</given-names>
</name>
<name name-style="western">
<surname>Aktas</surname>
<given-names>BH</given-names>
</name>
</person-group>
<article-title>Chemical genetics identify eIF2α kinase heme-regulated inhibitor as an anticancer target</article-title>
<source/>Nat Chem Biol
          <year>2011</year>
<volume>7</volume>
<fpage>610</fpage>
<lpage>6</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nchembio.613">https://doi.org/10.1038/nchembio.613</ext-link>
</comment>
<pub-id pub-id-type="pmid">21765405</pub-id>
</element-citation>
</ref>
<ref id="R83">
<label>83</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Lopez-Fanarraga</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Carranza</surname>
<given-names>G</given-names>
</name>
<name name-style="western">
<surname>Bellido</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Kortazar</surname>
<given-names>D</given-names>
</name>
<name name-style="western">
<surname>Villegas</surname>
<given-names>JC</given-names>
</name>
<name name-style="western">
<surname>Zabala</surname>
<given-names>JC</given-names>
</name>
</person-group>
<article-title>Tubulin cofactor B plays a role in the neuronal growth cone</article-title>
<source/>J Neurochem
          <year>2007</year>
<volume>100</volume>
<fpage>1680</fpage>
<lpage>7</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1471-4159.2006.04328.x">https://doi.org/10.1111/j.1471-4159.2006.04328.x</ext-link>
</comment>
<pub-id pub-id-type="pmid">17217416</pub-id>
</element-citation>
</ref>
<ref id="R84">
<label>84</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Vadlamudi</surname>
<given-names>RK</given-names>
</name>
<name name-style="western">
<surname>Barnes</surname>
<given-names>CJ</given-names>
</name>
<name name-style="western">
<surname>Rayala</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Li</surname>
<given-names>F</given-names>
</name>
<name name-style="western">
<surname>Balasenthil</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Marcus</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Goodson</surname>
<given-names>HV</given-names>
</name>
<name name-style="western">
<surname>Sahin</surname>
<given-names>AA</given-names>
</name>
<name name-style="western">
<surname>Kumar</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>p21-activated kinase 1 regulates microtubule dynamics by phosphorylating tubulin cofactor B</article-title>
<source/>Mol Cell Biol
          <year>2005</year>
<volume>25</volume>
<fpage>3726</fpage>
<lpage>36</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/MCB.25.9.3726-3736.2005">https://doi.org/10.1128/MCB.25.9.3726-3736.2005</ext-link>
</comment>
<pub-id pub-id-type="pmid">15831477</pub-id>
</element-citation>
</ref>
<ref id="R85">
<label>85</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Davis</surname>
<given-names>AJ</given-names>
</name>
<name name-style="western">
<surname>Chen</surname>
<given-names>DJ</given-names>
</name>
</person-group>
<article-title>DNA double strand break repair via non-homologous end-joining</article-title>
<source/>Transl Cancer Res
          <year>2013</year>
<volume>2</volume>
<fpage>130</fpage>
<lpage>43</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3978/j.issn.2218-676X.2013.04.02">https://doi.org/10.3978/j.issn.2218-676X.2013.04.02</ext-link>
</comment>
<pub-id pub-id-type="pmid">24000320</pub-id>
</element-citation>
</ref>
<ref id="R86">
<label>86</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Tseng</surname>
<given-names>R-C</given-names>
</name>
<name name-style="western">
<surname>Hsieh</surname>
<given-names>F-J</given-names>
</name>
<name name-style="western">
<surname>Shih</surname>
<given-names>C-M</given-names>
</name>
<name name-style="western">
<surname>Hsu</surname>
<given-names>H-S</given-names>
</name>
<name name-style="western">
<surname>Chen</surname>
<given-names>C-Y</given-names>
</name>
<name name-style="western">
<surname>Wang</surname>
<given-names>Y-C</given-names>
</name>
</person-group>
<article-title>Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study</article-title>
<source/>Cancer
          <year>2009</year>
<volume>115</volume>
<fpage>2939</fpage>
<lpage>48</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/cncr.24327">https://doi.org/10.1002/cncr.24327</ext-link>
</comment>
<pub-id pub-id-type="pmid">19408343</pub-id>
</element-citation>
</ref>
<ref id="R87">
<label>87</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Dombernowsky</surname>
<given-names>SL</given-names>
</name>
<name name-style="western">
<surname>Weischer</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Freiberg</surname>
<given-names>JJ</given-names>
</name>
<name name-style="western">
<surname>Bojesen</surname>
<given-names>SE</given-names>
</name>
<name name-style="western">
<surname>Tybjaerg-Hansen</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Nordestgaard</surname>
<given-names>BG</given-names>
</name>
</person-group>
<article-title>Missense polymorphisms in BRCA1 and BRCA2 and risk of breast and ovarian cancer</article-title>
<source/>Cancer Epidemiol Biomarkers Prev
          <year>2009</year>
<volume>18</volume>
<fpage>2339</fpage>
<lpage>42</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1158/1055-9965.EPI-09-0447">https://doi.org/10.1158/1055-9965.EPI-09-0447</ext-link>
</comment>
<pub-id pub-id-type="pmid">19661094</pub-id>
</element-citation>
</ref>
<ref id="R88">
<label>88</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Pucci</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Mazzarelli</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Rabitti</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Giai</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Gallucci</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Flammia</surname>
<given-names>G</given-names>
</name>
<name name-style="western">
<surname>Alcini</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Altomare</surname>
<given-names>V</given-names>
</name>
<name name-style="western">
<surname>Fazio</surname>
<given-names>VM</given-names>
</name>
</person-group>
<article-title>Tumor specific modulation of KU70/80 DNA binding activity in breast and bladder human tumor biopsies</article-title>
<source/>Oncogene
          <year>2001</year>
<volume>20</volume>
<fpage>739</fpage>
<lpage>47</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/sj.onc.1204148">https://doi.org/10.1038/sj.onc.1204148</ext-link>
</comment>
<pub-id pub-id-type="pmid">11314007</pub-id>
</element-citation>
</ref>
<ref id="R89">
<label>89</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Scully</surname>
<given-names>R</given-names>
</name>
<name name-style="western">
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Plug</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Xiao</surname>
<given-names>Y</given-names>
</name>
<name name-style="western">
<surname>Weaver</surname>
<given-names>D</given-names>
</name>
<name name-style="western">
<surname>Feunteun</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Ashley</surname>
<given-names>T</given-names>
</name>
<name name-style="western">
<surname>Livingston</surname>
<given-names>DM</given-names>
</name>
</person-group>
<article-title>Association of BRCA1 with Rad51 in mitotic and meiotic cells</article-title>
<source/>Cell
          <year>1997</year>
<volume>88</volume>
<fpage>265</fpage>
<lpage>75</lpage>
<pub-id pub-id-type="pmid">9008167</pub-id>
</element-citation>
</ref>
<ref id="R90">
<label>90</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Alshareeda</surname>
<given-names>AT</given-names>
</name>
<name name-style="western">
<surname>Negm</surname>
<given-names>OH</given-names>
</name>
<name name-style="western">
<surname>Albarakati</surname>
<given-names>N</given-names>
</name>
<name name-style="western">
<surname>Green</surname>
<given-names>AR</given-names>
</name>
<name name-style="western">
<surname>Nolan</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Sultana</surname>
<given-names>R</given-names>
</name>
<name name-style="western">
<surname>Madhusudan</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Benhasouna</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Tighe</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Ellis</surname>
<given-names>IO</given-names>
</name>
<name name-style="western">
<surname>Rakha</surname>
<given-names>EA</given-names>
</name>
</person-group>
<article-title>Clinicopathological significance of KU70/KU80, a key DNA damage repair protein in breast cancer</article-title>
<source/>Breast Cancer Res Treat
          <year>2013</year>
<volume>139</volume>
<fpage>301</fpage>
<lpage>10</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10549-013-2542-x">https://doi.org/10.1007/s10549-013-2542-x</ext-link>
</comment>
<pub-id pub-id-type="pmid">23624778</pub-id>
</element-citation>
</ref>
<ref id="R91">
<label>91</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Jia</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Ren</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Yan</surname>
<given-names>D</given-names>
</name>
<name name-style="western">
<surname>Xiao</surname>
<given-names>L</given-names>
</name>
<name name-style="western">
<surname>Sun</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Association between the XRCC6 polymorphisms and cancer risks: a systematic review and meta-analysis</article-title>
<source/>Medicine (Baltimore)
          <year>2015</year>
<volume>94</volume>
<fpage>e283</fpage>
<lpage>3</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/MD.0000000000000283">https://doi.org/10.1097/MD.0000000000000283</ext-link>
</comment>
<pub-id pub-id-type="pmid">25569644</pub-id>
</element-citation>
</ref>
<ref id="R92">
<label>92</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Rajaei</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Saadat</surname>
<given-names>I</given-names>
</name>
<name name-style="western">
<surname>Omidvari</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Saadat</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Association between polymorphisms at promoters of XRCC5 and XRCC6 genes and risk of breast cancer</article-title>
<source/>Med Oncol
          <year>2014</year>
<volume>31</volume>
<fpage>885</fpage>
<lpage>5</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s12032-014-0885-8">https://doi.org/10.1007/s12032-014-0885-8</ext-link>
</comment>
<pub-id pub-id-type="pmid">24615008</pub-id>
</element-citation>
</ref>
<ref id="R93">
<label>93</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Henríquez-Hernández</surname>
<given-names>LA</given-names>
</name>
<name name-style="western">
<surname>Valenciano</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Foro-Arnalot</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Álvarez-Cubero</surname>
<given-names>MJ</given-names>
</name>
<name name-style="western">
<surname>Cozar</surname>
<given-names>JM</given-names>
</name>
<name name-style="western">
<surname>Suárez-Novo</surname>
<given-names>JF</given-names>
</name>
<name name-style="western">
<surname>Castells-Esteve</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Fernández-Gonzalo</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>De-Paula-Carranza</surname>
<given-names>B</given-names>
</name>
<name name-style="western">
<surname>Ferrer</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Guedea</surname>
<given-names>F</given-names>
</name>
<name name-style="western">
<surname>Sancho-Pardo</surname>
<given-names>G</given-names>
</name>
<name name-style="western">
<surname>Craven-Bartle</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association between single-nucleotide polymorphisms in DNA double-strand break repair genes and prostate cancer aggressiveness in the Spanish population</article-title>
<source/>Prostate Cancer Prostatic Dis
          <year>2016</year>
<volume>19</volume>
<fpage>28</fpage>
<lpage>34</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/pcan.2015.63">https://doi.org/10.1038/pcan.2015.63</ext-link>
</comment>
<pub-id pub-id-type="pmid">26754263</pub-id>
</element-citation>
</ref>
<ref id="R94">
<label>94</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Dimberg</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Skarstedt</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Slind Olsen</surname>
<given-names>R</given-names>
</name>
<name name-style="western">
<surname>Andersson</surname>
<given-names>RE</given-names>
</name>
<name name-style="western">
<surname>Matussek</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Gene polymorphism in DNA repair genes XRCC1 and XRCC6 and association with colorectal cancer in Swedish patients</article-title>
<source/>APMIS
          <year>2016</year>
<volume>124</volume>
<fpage>736</fpage>
<lpage>40</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/apm.12563">https://doi.org/10.1111/apm.12563</ext-link>
</comment>
<pub-id pub-id-type="pmid">27328741</pub-id>
</element-citation>
</ref>
<ref id="R95">
<label>95</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Hsu</surname>
<given-names>CM</given-names>
</name>
<name name-style="western">
<surname>Yang</surname>
<given-names>MD</given-names>
</name>
<name name-style="western">
<surname>Chang</surname>
<given-names>WS</given-names>
</name>
<name name-style="western">
<surname>Jeng</surname>
<given-names>LB</given-names>
</name>
<name name-style="western">
<surname>Lee</surname>
<given-names>MH</given-names>
</name>
<name name-style="western">
<surname>Lu</surname>
<given-names>MC</given-names>
</name>
<name name-style="western">
<surname>Chang</surname>
<given-names>SC</given-names>
</name>
<name name-style="western">
<surname>Tsai</surname>
<given-names>CW</given-names>
</name>
<name name-style="western">
<surname>Tsai</surname>
<given-names>Y</given-names>
</name>
<name name-style="western">
<surname>Tsai</surname>
<given-names>FJ</given-names>
</name>
<name name-style="western">
<surname>Bau</surname>
<given-names>DT</given-names>
</name>
</person-group>
<article-title>The contribution of <italic>XRCC6/Ku70</italic> to hepatocellular carcinoma in Taiwan</article-title>
<source/>Anticancer Res
          <year>2013</year>
<volume>33</volume>
<fpage>529</fpage>
<lpage>35</lpage>
<pub-id pub-id-type="pmid">23393345</pub-id>
</element-citation>
</ref>
<ref id="R96">
<label>96</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Zhu</surname>
<given-names>B</given-names>
</name>
<name name-style="western">
<surname>Cheng</surname>
<given-names>D</given-names>
</name>
<name name-style="western">
<surname>Li</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Zhou</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Yang</surname>
<given-names>Q</given-names>
</name>
</person-group>
<article-title>High expression of XRCC6 promotes human osteosarcoma cell proliferation through the β-catenin/Wnt signaling pathway and is associated with poor prognosis</article-title>
<source/>Int J Mol Sci
          <year>2016</year>
<volume>1</volume>
<fpage>1188</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3390/ijms17071188">https://doi.org/10.3390/ijms17071188</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R97">
<label>97</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Yang</surname>
<given-names>H</given-names>
</name>
<name name-style="western">
<surname>Sasaki</surname>
<given-names>T</given-names>
</name>
<name name-style="western">
<surname>Minoshima</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Shimizu</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Identification of three novel proteins (SGSM1, 2, 3) which modulate small G protein (RAP and RAB)-mediated signaling pathway</article-title>
<source/>Genomics
          <year>2007</year>
<volume>90</volume>
<fpage>249</fpage>
<lpage>60</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ygeno.2007.03.013">https://doi.org/10.1016/j.ygeno.2007.03.013</ext-link>
</comment>
<pub-id pub-id-type="pmid">17509819</pub-id>
</element-citation>
</ref>
<ref id="R98">
<label>98</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Nourashrafeddin</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Aarabi</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Modarressi</surname>
<given-names>MH</given-names>
</name>
<name name-style="western">
<surname>Rahmati</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Nouri</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The evaluation of WBP2NL-related genes expression in breast cancer</article-title>
<source/>Pathol Oncol Res
          <year>2015</year>
<volume>21</volume>
<fpage>293</fpage>
<lpage>300</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s12253-014-9820-8">https://doi.org/10.1007/s12253-014-9820-8</ext-link>
</comment>
<pub-id pub-id-type="pmid">25417742</pub-id>
</element-citation>
</ref>
<ref id="R99">
<label>99</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Lindstrom</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Thompson</surname>
<given-names>DJ</given-names>
</name>
<name name-style="western">
<surname>`Paterson</surname>
<given-names>AD</given-names>
</name>
<name name-style="western">
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Gierach</surname>
<given-names>GL</given-names>
</name>
<name name-style="western">
<surname>Scott</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Stone</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Douglas</surname>
<given-names>JA</given-names>
</name>
<name name-style="western">
<surname>Santos Silva Dos</surname>
<given-names>I</given-names>
</name>
<name name-style="western">
<surname>Fernandez-Navarro</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Verghase</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Smith</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Brown</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk</article-title>
<source/>Nat Commun
          <year>2014</year>
<volume>5</volume>
<fpage>5303</fpage>
<lpage>3</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ncomms6303">https://doi.org/10.1038/ncomms6303</ext-link>
</comment>
<pub-id pub-id-type="pmid">25342443</pub-id>
</element-citation>
</ref>
<ref id="R100">
<label>100</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Vachon</surname>
<given-names>CM</given-names>
</name>
<name name-style="western">
<surname>van Gils</surname>
<given-names>CH</given-names>
</name>
<name name-style="western">
<surname>Sellers</surname>
<given-names>TA</given-names>
</name>
<name name-style="western">
<surname>Ghosh</surname>
<given-names>K</given-names>
</name>
<name name-style="western">
<surname>Pruthi</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Brandt</surname>
<given-names>KR</given-names>
</name>
<name name-style="western">
<surname>Pankratz</surname>
<given-names>VS</given-names>
</name>
</person-group>
<article-title>Mammographic density, breast cancer risk and risk prediction</article-title>
<source/>Breast Cancer Res
          <year>2007</year>
<volume>9</volume>
<fpage>217</fpage>
<lpage>7</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/bcr1829">https://doi.org/10.1186/bcr1829</ext-link>
</comment>
<pub-id pub-id-type="pmid">18190724</pub-id>
</element-citation>
</ref>
<ref id="R101">
<label>101</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Pettersson</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Graff</surname>
<given-names>RE</given-names>
</name>
<name name-style="western">
<surname>Ursin</surname>
<given-names>G</given-names>
</name>
<name name-style="western">
<surname>Santos Silva</surname>
<given-names>ID</given-names>
</name>
<name name-style="western">
<surname>McCormack</surname>
<given-names>V</given-names>
</name>
<name name-style="western">
<surname>Baglietto</surname>
<given-names>L</given-names>
</name>
<name name-style="western">
<surname>Vachon</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Bakker</surname>
<given-names>MF</given-names>
</name>
<name name-style="western">
<surname>Giles</surname>
<given-names>GG</given-names>
</name>
<name name-style="western">
<surname>Chia</surname>
<given-names>KS</given-names>
</name>
<name name-style="western">
<surname>Czene</surname>
<given-names>K</given-names>
</name>
<name name-style="western">
<surname>Eriksson</surname>
<given-names>L</given-names>
</name>
<name name-style="western">
<surname>Hall</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mammographic density phenotypes and risk of breast cancer: a meta-analysis</article-title>
<source/>J Natl Cancer Inst
          <year>2014</year>
<volume>106</volume>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/jnci/dju078">https://doi.org/10.1093/jnci/dju078</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R102">
<label>102</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Pettersson</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Hankinson</surname>
<given-names>SE</given-names>
</name>
<name name-style="western">
<surname>Willett</surname>
<given-names>WC</given-names>
</name>
<name name-style="western">
<surname>Lagiou</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Trichopoulos</surname>
<given-names>D</given-names>
</name>
<name name-style="western">
<surname>Tamimi</surname>
<given-names>RM</given-names>
</name>
</person-group>
<article-title>Nondense mammographic area and risk of breast cancer</article-title>
<source/>Breast Cancer Res
          <year>2011</year>
<volume>13</volume>
<fpage>R100</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/bcr3041">https://doi.org/10.1186/bcr3041</ext-link>
</comment>
<pub-id pub-id-type="pmid">22017857</pub-id>
</element-citation>
</ref>
<ref id="R103">
<label>103</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Wang</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Zhao</surname>
<given-names>H</given-names>
</name>
<name name-style="western">
<surname>Zhao</surname>
<given-names>X</given-names>
</name>
<name name-style="western">
<surname>Wan</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Wang</surname>
<given-names>D</given-names>
</name>
<name name-style="western">
<surname>Bi</surname>
<given-names>W</given-names>
</name>
<name name-style="western">
<surname>Jiang</surname>
<given-names>X</given-names>
</name>
<name name-style="western">
<surname>Gao</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Association between an insertion/deletion polymorphism within 3’UTR of SGSM3 and risk of hepatocellular carcinoma</article-title>
<source/>Tumour Biol
          <year>2014</year>
<volume>35</volume>
<fpage>295</fpage>
<lpage>301</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s13277-013-1039-x">https://doi.org/10.1007/s13277-013-1039-x</ext-link>
</comment>
<pub-id pub-id-type="pmid">23918301</pub-id>
</element-citation>
</ref>
<ref id="R104">
<label>104</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Chen</surname>
<given-names>SC</given-names>
</name>
<name name-style="western">
<surname>Kung</surname>
<given-names>ML</given-names>
</name>
<name name-style="western">
<surname>Hu</surname>
<given-names>TH</given-names>
</name>
<name name-style="western">
<surname>Chen</surname>
<given-names>HY</given-names>
</name>
<name name-style="western">
<surname>Wu</surname>
<given-names>JC</given-names>
</name>
<name name-style="western">
<surname>Kuo</surname>
<given-names>HM</given-names>
</name>
<name name-style="western">
<surname>Tsai</surname>
<given-names>HE</given-names>
</name>
<name name-style="western">
<surname>Lin</surname>
<given-names>YW</given-names>
</name>
<name name-style="western">
<surname>Wen</surname>
<given-names>ZH</given-names>
</name>
<name name-style="western">
<surname>Liu</surname>
<given-names>JK</given-names>
</name>
<name name-style="western">
<surname>Yeh</surname>
<given-names>MH</given-names>
</name>
<name name-style="western">
<surname>Tai</surname>
<given-names>MH</given-names>
</name>
</person-group>
<article-title>Hepatoma-derived growth factor regulates breast cancer cell invasion by modulating epithelial--mesenchymal transition</article-title>
<source/>J Pathol
          <year>2012</year>
<volume>228</volume>
<fpage>158</fpage>
<lpage>69</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/path.3988">https://doi.org/10.1002/path.3988</ext-link>
</comment>
<pub-id pub-id-type="pmid">22247069</pub-id>
</element-citation>
</ref>
<ref id="R105">
<label>105</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Hugo</surname>
<given-names>H</given-names>
</name>
<name name-style="western">
<surname>Ackland</surname>
<given-names>ML</given-names>
</name>
<name name-style="western">
<surname>Blick</surname>
<given-names>T</given-names>
</name>
<name name-style="western">
<surname>Lawrence</surname>
<given-names>MG</given-names>
</name>
<name name-style="western">
<surname>Clements</surname>
<given-names>JA</given-names>
</name>
<name name-style="western">
<surname>Williams</surname>
<given-names>ED</given-names>
</name>
<name name-style="western">
<surname>Thompson</surname>
<given-names>EW</given-names>
</name>
</person-group>
<article-title>Epithelial--mesenchymal and mesenchymal--epithelial transitions in carcinoma progression</article-title>
<source/>J Cell Physiol
          <year>2007</year>
<volume>213</volume>
<fpage>374</fpage>
<lpage>83</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/jcp.21223">https://doi.org/10.1002/jcp.21223</ext-link>
</comment>
<pub-id pub-id-type="pmid">17680632</pub-id>
</element-citation>
</ref>
<ref id="R106">
<label>106</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Yang</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Mani</surname>
<given-names>SA</given-names>
</name>
<name name-style="western">
<surname>Donaher</surname>
<given-names>JL</given-names>
</name>
<name name-style="western">
<surname>Ramaswamy</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Itzykson</surname>
<given-names>RA</given-names>
</name>
<name name-style="western">
<surname>Come</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Savagner</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Gitelman</surname>
<given-names>I</given-names>
</name>
<name name-style="western">
<surname>Richardson</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Weinberg</surname>
<given-names>RA</given-names>
</name>
</person-group>
<article-title>Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis</article-title>
<source/>Cell
          <year>2004</year>
<volume>117</volume>
<fpage>927</fpage>
<lpage>39</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cell.2004.06.006">https://doi.org/10.1016/j.cell.2004.06.006</ext-link>
</comment>
<pub-id pub-id-type="pmid">15210113</pub-id>
</element-citation>
</ref>
<ref id="R107">
<label>107</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Chang</surname>
<given-names>KC</given-names>
</name>
<name name-style="western">
<surname>Tai</surname>
<given-names>MH</given-names>
</name>
<name name-style="western">
<surname>Lin</surname>
<given-names>JW</given-names>
</name>
<name name-style="western">
<surname>Wang</surname>
<given-names>CC</given-names>
</name>
<name name-style="western">
<surname>Huang</surname>
<given-names>CC</given-names>
</name>
<name name-style="western">
<surname>Hung</surname>
<given-names>CH</given-names>
</name>
<name name-style="western">
<surname>Chen</surname>
<given-names>CH</given-names>
</name>
<name name-style="western">
<surname>Lu</surname>
<given-names>SN</given-names>
</name>
<name name-style="western">
<surname>Lee</surname>
<given-names>CM</given-names>
</name>
<name name-style="western">
<surname>Changchien</surname>
<given-names>CS</given-names>
</name>
<name name-style="western">
<surname>Hu</surname>
<given-names>TH</given-names>
</name>
</person-group>
<article-title>Hepatoma-derived growth factor is a novel prognostic factor for gastrointestinal stromal tumors</article-title>
<source/>Int J Cancer
          <year>2007</year>
<volume>121</volume>
<fpage>1059</fpage>
<lpage>65</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/ijc.22803">https://doi.org/10.1002/ijc.22803</ext-link>
</comment>
<pub-id pub-id-type="pmid">17487837</pub-id>
</element-citation>
</ref>
<ref id="R108">
<label>108</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Hu</surname>
<given-names>TH</given-names>
</name>
<name name-style="western">
<surname>Huang</surname>
<given-names>CC</given-names>
</name>
<name name-style="western">
<surname>Liu</surname>
<given-names>LF</given-names>
</name>
<name name-style="western">
<surname>Lin</surname>
<given-names>PR</given-names>
</name>
<name name-style="western">
<surname>Liu</surname>
<given-names>SY</given-names>
</name>
<name name-style="western">
<surname>Chang</surname>
<given-names>HW</given-names>
</name>
<name name-style="western">
<surname>Changchien</surname>
<given-names>CS</given-names>
</name>
<name name-style="western">
<surname>Lee</surname>
<given-names>CM</given-names>
</name>
<name name-style="western">
<surname>Chuang</surname>
<given-names>JH</given-names>
</name>
<name name-style="western">
<surname>Tai</surname>
<given-names>MH</given-names>
</name>
</person-group>
<article-title>Expression of hepatoma-derived growth factor in hepatocellular carcinoma</article-title>
<source/>Cancer
          <year>2003</year>
<volume>98</volume>
<fpage>1444</fpage>
<lpage>56</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/cncr.11653">https://doi.org/10.1002/cncr.11653</ext-link>
</comment>
<pub-id pub-id-type="pmid">14508832</pub-id>
</element-citation>
</ref>
<ref id="R109">
<label>109</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Ren</surname>
<given-names>H</given-names>
</name>
<name name-style="western">
<surname>Tang</surname>
<given-names>X</given-names>
</name>
<name name-style="western">
<surname>Lee</surname>
<given-names>JJ</given-names>
</name>
<name name-style="western">
<surname>Feng</surname>
<given-names>L</given-names>
</name>
<name name-style="western">
<surname>Everett</surname>
<given-names>AD</given-names>
</name>
<name name-style="western">
<surname>Hong</surname>
<given-names>WK</given-names>
</name>
<name name-style="western">
<surname>Khuri</surname>
<given-names>FR</given-names>
</name>
<name name-style="western">
<surname>Mao</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Expression of hepatoma-derived growth factor is a strong prognostic predictor for patients with early-stage non-small-cell lung cancer</article-title>
<source/>J Clin Oncol
          <year>2004</year>
<volume>22</volume>
<fpage>3230</fpage>
<lpage>7</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1200/JCO.2004.02.080">https://doi.org/10.1200/JCO.2004.02.080</ext-link>
</comment>
<pub-id pub-id-type="pmid">15310766</pub-id>
</element-citation>
</ref>
<ref id="R110">
<label>110</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Hu</surname>
<given-names>TH</given-names>
</name>
<name name-style="western">
<surname>Lin</surname>
<given-names>JW</given-names>
</name>
<name name-style="western">
<surname>Chen</surname>
<given-names>HH</given-names>
</name>
<name name-style="western">
<surname>Liu</surname>
<given-names>LF</given-names>
</name>
<name name-style="western">
<surname>Chuah</surname>
<given-names>SK</given-names>
</name>
<name name-style="western">
<surname>Tai</surname>
<given-names>MH</given-names>
</name>
</person-group>
<article-title>The expression and prognostic role of hepatoma-derived growth factor in colorectal stromal tumors</article-title>
<source/>Dis Colon Rectum
          <year>2009</year>
<volume>52</volume>
<fpage>319</fpage>
<lpage>26</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/DCR.0b013e31819d1666">https://doi.org/10.1007/DCR.0b013e31819d1666</ext-link>
</comment>
<pub-id pub-id-type="pmid">19279430</pub-id>
</element-citation>
</ref>
<ref id="R111">
<label>111</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Wu</surname>
<given-names>D</given-names>
</name>
<name name-style="western">
<surname>Niu</surname>
<given-names>X</given-names>
</name>
<name name-style="western">
<surname>Pan</surname>
<given-names>H</given-names>
</name>
<name name-style="western">
<surname>Zhang</surname>
<given-names>Z</given-names>
</name>
<name name-style="western">
<surname>Zhou</surname>
<given-names>Y</given-names>
</name>
<name name-style="western">
<surname>Qu</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Zhou</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>MicroRNA-497 targets hepatoma-derived growth factor and suppresses human prostate cancer cell motility</article-title>
<source/>Mol Med Rep
          <year>2016</year>
<volume>13</volume>
<fpage>2287</fpage>
<lpage>92</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3892/mmr.2016.4756">https://doi.org/10.3892/mmr.2016.4756</ext-link>
</comment>
<pub-id pub-id-type="pmid">26780929</pub-id>
</element-citation>
</ref>
<ref id="R112">
<label>112</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Yamamoto</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Tomita</surname>
<given-names>Y</given-names>
</name>
<name name-style="western">
<surname>Hoshida</surname>
<given-names>Y</given-names>
</name>
<name name-style="western">
<surname>Takiguchi</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Fujiwara</surname>
<given-names>Y</given-names>
</name>
<name name-style="western">
<surname>Yasuda</surname>
<given-names>T</given-names>
</name>
<name name-style="western">
<surname>Doki</surname>
<given-names>Y</given-names>
</name>
<name name-style="western">
<surname>Yoshida</surname>
<given-names>K</given-names>
</name>
<name name-style="western">
<surname>Aozasa</surname>
<given-names>K</given-names>
</name>
<name name-style="western">
<surname>Nakamura</surname>
<given-names>H</given-names>
</name>
<name name-style="western">
<surname>Monden</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Expression of hepatoma-derived growth factor is correlated with lymph node metastasis and prognosis of gastric carcinoma</article-title>
<source/>Clin Cancer Res
          <year>2006</year>
<volume>12</volume>
<fpage>117</fpage>
<lpage>22</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1158/1078-0432.CCR-05-1347">https://doi.org/10.1158/1078-0432.CCR-05-1347</ext-link>
</comment>
<pub-id pub-id-type="pmid">16397032</pub-id>
</element-citation>
</ref>
<ref id="R113">
<label>113</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Yuen</surname>
<given-names>BT</given-names>
</name>
<name name-style="western">
<surname>Knoepfler</surname>
<given-names>PS</given-names>
</name>
</person-group>
<article-title>Histone H3.3 mutations: a variant path to cancer</article-title>
<source/>Cancer Cell
          <year>2013</year>
<volume>24</volume>
<fpage>567</fpage>
<lpage>74</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ccr.2013.09.015">https://doi.org/10.1016/j.ccr.2013.09.015</ext-link>
</comment>
<pub-id pub-id-type="pmid">24229707</pub-id>
</element-citation>
</ref>
<ref id="R114">
<label>114</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Behjati</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Tarpey</surname>
<given-names>PS</given-names>
</name>
<name name-style="western">
<surname>Presneau</surname>
<given-names>N</given-names>
</name>
<name name-style="western">
<surname>Scheipl</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Pillay</surname>
<given-names>N</given-names>
</name>
<name name-style="western">
<surname>Van Loo</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Wedge</surname>
<given-names>DC</given-names>
</name>
<name name-style="western">
<surname>Cooke</surname>
<given-names>SL</given-names>
</name>
<name name-style="western">
<surname>Gundem</surname>
<given-names>G</given-names>
</name>
<name name-style="western">
<surname>Davies</surname>
<given-names>H</given-names>
</name>
<name name-style="western">
<surname>Nik-Zainal</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Martin</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>McLaren</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone</article-title>
<source/>Nat Genet
          <year>2013</year>
<volume>45</volume>
<fpage>1479</fpage>
<lpage>82</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ng.2814">https://doi.org/10.1038/ng.2814</ext-link>
</comment>
<pub-id pub-id-type="pmid">24162739</pub-id>
</element-citation>
</ref>
<ref id="R115">
<label>115</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Ayoubi</surname>
<given-names>HA</given-names>
</name>
<name name-style="western">
<surname>Mahjoubi</surname>
<given-names>F</given-names>
</name>
<name name-style="western">
<surname>Mirzaei</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Investigation of the human H3.3B (H3F3B) gene expression as a novel marker in patients with colorectal cancer</article-title>
<source/>J Gastrointest Oncol
          <year>2017</year>
<volume>8</volume>
<fpage>64</fpage>
<lpage>9</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.21037/jgo.2016.12.12">https://doi.org/10.21037/jgo.2016.12.12</ext-link>
</comment>
<pub-id pub-id-type="pmid">28280610</pub-id>
</element-citation>
</ref>
<ref id="R116">
<label>116</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Shadeo</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Lam</surname>
<given-names>WL</given-names>
</name>
</person-group>
<article-title>Comprehensive copy number profiles of breast cancer cell model genomes</article-title>
<source/>Breast Cancer Res
          <year>2006</year>
<volume>8</volume>
<fpage>R9</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/bcr1370">https://doi.org/10.1186/bcr1370</ext-link>
</comment>
<pub-id pub-id-type="pmid">16417655</pub-id>
</element-citation>
</ref>
<ref id="R117">
<label>117</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Ganss</surname>
<given-names>B</given-names>
</name>
<name name-style="western">
<surname>Jheon</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Zinc finger transcription factors in skeletal development</article-title>
<source/>Crit Rev Oral Biol Med
          <year>2004</year>
<volume>15</volume>
<fpage>282</fpage>
<lpage>97</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1177/154411130401500504">https://doi.org/10.1177/154411130401500504</ext-link>
</comment>
<pub-id pub-id-type="pmid">15470266</pub-id>
</element-citation>
</ref>
<ref id="R118">
<label>118</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Divisato</surname>
<given-names>G</given-names>
</name>
<name name-style="western">
<surname>Formicola</surname>
<given-names>D</given-names>
</name>
<name name-style="western">
<surname>Esposito</surname>
<given-names>T</given-names>
</name>
<name name-style="western">
<surname>Merlotti</surname>
<given-names>D</given-names>
</name>
<name name-style="western">
<surname>Pazzaglia</surname>
<given-names>L</given-names>
</name>
<name name-style="western">
<surname>Del Fattore</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Siris</surname>
<given-names>E</given-names>
</name>
<name name-style="western">
<surname>Orcel</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Brown</surname>
<given-names>JP</given-names>
</name>
<name name-style="western">
<surname>Nuti</surname>
<given-names>R</given-names>
</name>
<name name-style="western">
<surname>Strazzullo</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Benassi</surname>
<given-names>MS</given-names>
</name>
<name name-style="western">
<surname>Cancela</surname>
<given-names>ML</given-names>
</name>
<etal></etal>
</person-group>
<article-title>ZNF687 mutations in severe paget disease of bone associated with giant cell tumor</article-title>
<source/>Am J Pathol
          <year>2016</year>
<volume>98</volume>
<fpage>275</fpage>
<lpage>86</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ajhg.2015.12.016">https://doi.org/10.1016/j.ajhg.2015.12.016</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R119">
<label>119</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Katoh</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>FGFR2 abnormalities underlie a spectrum of bone, skin, and cancer pathologies</article-title>
<source/>J Invest Dermatol
          <year>2009</year>
<volume>129</volume>
<fpage>1861</fpage>
<lpage>7</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/jid.2009.97">https://doi.org/10.1038/jid.2009.97</ext-link>
</comment>
<pub-id pub-id-type="pmid">19387476</pub-id>
</element-citation>
</ref>
<ref id="R120">
<label>120</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Turner</surname>
<given-names>N</given-names>
</name>
<name name-style="western">
<surname>Grose</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Fibroblast growth factor signalling: from development to cancer</article-title>
<source/>Nat Rev Cancer
          <year>2010</year>
<volume>10</volume>
<fpage>116</fpage>
<lpage>29</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nrc2780">https://doi.org/10.1038/nrc2780</ext-link>
</comment>
<pub-id pub-id-type="pmid">20094046</pub-id>
</element-citation>
</ref>
<ref id="R121">
<label>121</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Kelleher</surname>
<given-names>FC</given-names>
</name>
<name name-style="western">
<surname>O’Sullivan</surname>
<given-names>H</given-names>
</name>
<name name-style="western">
<surname>Smyth</surname>
<given-names>E</given-names>
</name>
<name name-style="western">
<surname>McDermott</surname>
<given-names>R</given-names>
</name>
<name name-style="western">
<surname>Viterbo</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Fibroblast growth factor receptors, developmental corruption and malignant disease</article-title>
<source/>Carcinogenesis
          <year>2013</year>
<volume>34</volume>
<fpage>2198</fpage>
<lpage>205</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/carcin/bgt254">https://doi.org/10.1093/carcin/bgt254</ext-link>
</comment>
<pub-id pub-id-type="pmid">23880303</pub-id>
</element-citation>
</ref>
<ref id="R122">
<label>122</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Helsten</surname>
<given-names>T</given-names>
</name>
<name name-style="western">
<surname>Schwaederle</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Kurzrock</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implications</article-title>
<source/>Cancer Metastasis Rev
          <year>2015</year>
<volume>34</volume>
<fpage>479</fpage>
<lpage>96</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10555-015-9579-8">https://doi.org/10.1007/s10555-015-9579-8</ext-link>
</comment>
<pub-id pub-id-type="pmid">26224133</pub-id>
</element-citation>
</ref>
<ref id="R123">
<label>123</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Suvannasankha</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Tompkins</surname>
<given-names>DR</given-names>
</name>
<name name-style="western">
<surname>Edwards</surname>
<given-names>DF</given-names>
</name>
<name name-style="western">
<surname>Petyaykina</surname>
<given-names>KV</given-names>
</name>
<name name-style="western">
<surname>Crean</surname>
<given-names>CD</given-names>
</name>
<name name-style="western">
<surname>Fournier</surname>
<given-names>PG</given-names>
</name>
<name name-style="western">
<surname>Parker</surname>
<given-names>JM</given-names>
</name>
<name name-style="western">
<surname>Sandusky</surname>
<given-names>GE</given-names>
</name>
<name name-style="western">
<surname>Ichikawa</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Imel</surname>
<given-names>EA</given-names>
</name>
<name name-style="western">
<surname>Chirgwin</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>FGF23 is elevated in multiple myeloma and increases heparanase expression by tumor cells</article-title>
<source/>Oncotarget
          <year>2015</year>
<volume>6</volume>
<fpage>19647</fpage>
<lpage>60</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18632/oncotarget.3794">https://doi.org/10.18632/oncotarget.3794</ext-link>
</comment>
<pub-id pub-id-type="pmid">25944690</pub-id>
</element-citation>
</ref>
<ref id="R124">
<label>124</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Degirolamo</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Sabbà</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Moschetta</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23</article-title>
<source/>Nat Rev Drug Discov
          <year>2016</year>
<volume>15</volume>
<fpage>51</fpage>
<lpage>69</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nrd.2015.9">https://doi.org/10.1038/nrd.2015.9</ext-link>
</comment>
<pub-id pub-id-type="pmid">26567701</pub-id>
</element-citation>
</ref>
<ref id="R125">
<label>125</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Kazemi</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Mounir</surname>
<given-names>Z</given-names>
</name>
<name name-style="western">
<surname>Baltzis</surname>
<given-names>D</given-names>
</name>
<name name-style="western">
<surname>Raven</surname>
<given-names>JF</given-names>
</name>
<name name-style="western">
<surname>Wang</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Krishnamoorthy</surname>
<given-names>JL</given-names>
</name>
<name name-style="western">
<surname>Pluquet</surname>
<given-names>O</given-names>
</name>
<name name-style="western">
<surname>Pelletier</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Koromilas</surname>
<given-names>AE</given-names>
</name>
</person-group>
<article-title>A novel function of eIF2alpha kinases as inducers of the phosphoinositide-3 kinase signaling pathway</article-title>
<source/>Mol Biol Cell
          <year>2007</year>
<volume>18</volume>
<fpage>3635</fpage>
<lpage>44</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1091/mbc.E07-01-0053">https://doi.org/10.1091/mbc.E07-01-0053</ext-link>
</comment>
<pub-id pub-id-type="pmid">17596516</pub-id>
</element-citation>
</ref>
<ref id="R126">
<label>126</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Gardino</surname>
<given-names>AK</given-names>
</name>
<name name-style="western">
<surname>Yaffe</surname>
<given-names>MB</given-names>
</name>
</person-group>
<article-title>14-3-3 proteins as signaling integration points for cell cycle control and apoptosis</article-title>
<source/>Semin Cell Dev Biol
          <year>2011</year>
<volume>22</volume>
<fpage>688</fpage>
<lpage>95</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.semcdb.2011.09.008">https://doi.org/10.1016/j.semcdb.2011.09.008</ext-link>
</comment>
<pub-id pub-id-type="pmid">21945648</pub-id>
</element-citation>
</ref>
<ref id="R127">
<label>127</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Paplomata</surname>
<given-names>E</given-names>
</name>
<name name-style="western">
<surname>O’Regan</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers</article-title>
<source/>Ther Adv Med Oncol
          <year>2014</year>
<volume>6</volume>
<fpage>154</fpage>
<lpage>66</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1177/1758834014530023">https://doi.org/10.1177/1758834014530023</ext-link>
</comment>
<pub-id pub-id-type="pmid">25057302</pub-id>
</element-citation>
</ref>
<ref id="R128">
<label>128</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Durocher</surname>
<given-names>F</given-names>
</name>
<name name-style="western">
<surname>Labrie</surname>
<given-names>Y</given-names>
</name>
<name name-style="western">
<surname>Soucy</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Sinilnikova</surname>
<given-names>O</given-names>
</name>
<name name-style="western">
<surname>Labuda</surname>
<given-names>D</given-names>
</name>
<name name-style="western">
<surname>Bessette</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Chiquette</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Laframboise</surname>
<given-names>R</given-names>
</name>
<name name-style="western">
<surname>Lépine</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Lespérance</surname>
<given-names>B</given-names>
</name>
<name name-style="western">
<surname>Ouellette</surname>
<given-names>G</given-names>
</name>
<name name-style="western">
<surname>Pichette</surname>
<given-names>R</given-names>
</name>
<name name-style="western">
<surname>Plante</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families</article-title>
<source/>BMC Cancer
          <year>2006</year>
<volume>6</volume>
<fpage>230</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1471-2407-6-230">https://doi.org/10.1186/1471-2407-6-230</ext-link>
</comment>
<pub-id pub-id-type="pmid">17010193</pub-id>
</element-citation>
</ref>
<ref id="R129">
<label>129</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Guénard</surname>
<given-names>F</given-names>
</name>
<name name-style="western">
<surname>Pedneault</surname>
<given-names>CS</given-names>
</name>
<name name-style="western">
<surname>Ouellette</surname>
<given-names>G</given-names>
</name>
<name name-style="western">
<surname>Labrie</surname>
<given-names>Y</given-names>
</name>
<name name-style="western">
<surname>Simard</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Durocher</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Evaluation of the contribution of the three breast cancer susceptibility genes CHEK2, STK11, and PALB2 in non-BRCA1/2 French Canadian families with high risk of breast cancer</article-title>
<source/>Genet Test Mol Biomarkers
          <year>2010</year>
<volume>14</volume>
<fpage>515</fpage>
<lpage>26</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1089/gtmb.2010.0027">https://doi.org/10.1089/gtmb.2010.0027</ext-link>
</comment>
<pub-id pub-id-type="pmid">20722467</pub-id>
</element-citation>
</ref>
<ref id="R130">
<label>130</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Litim</surname>
<given-names>N</given-names>
</name>
<name name-style="western">
<surname>Labrie</surname>
<given-names>Y</given-names>
</name>
<name name-style="western">
<surname>Desjardins</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Ouellette</surname>
<given-names>G</given-names>
</name>
<name name-style="western">
<surname>Plourde</surname>
<given-names>K</given-names>
</name>
<name name-style="western">
<surname>Belleau</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Durocher</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Polymorphic variations in the FANCA gene in high-risk non-BRCA1/2 breast cancer individuals from the French Canadian population</article-title>
<source/>Mol Oncol
          <year>2013</year>
<volume>7</volume>
<fpage>85</fpage>
<lpage>100</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.molonc.2012.08.002">https://doi.org/10.1016/j.molonc.2012.08.002</ext-link>
</comment>
<pub-id pub-id-type="pmid">23021409</pub-id>
</element-citation>
</ref>
<ref id="R131">
<label>131</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Desjardins</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Belleau</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Labrie</surname>
<given-names>Y</given-names>
</name>
<name name-style="western">
<surname>Ouellette</surname>
<given-names>G</given-names>
</name>
<name name-style="western">
<surname>Bessette</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Chiquette</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Laframboise</surname>
<given-names>R</given-names>
</name>
<name name-style="western">
<surname>Lépine</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Lespérance</surname>
<given-names>B</given-names>
</name>
<name name-style="western">
<surname>Pichette</surname>
<given-names>R</given-names>
</name>
<name name-style="western">
<surname>Plante</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Durocher</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Genetic variants and haplotype analyses of the ZBRK1/ZNF350 gene in high-risk non BRCA1/2 French Canadian breast and ovarian cancer families</article-title>
<source/>Int J Cancer
          <year>2008</year>
<volume>122</volume>
<fpage>108</fpage>
<lpage>16</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/ijc.23058">https://doi.org/10.1002/ijc.23058</ext-link>
</comment>
<pub-id pub-id-type="pmid">17764113</pub-id>
</element-citation>
</ref>
<ref id="R132">
<label>132</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Trapnell</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Pachter</surname>
<given-names>L</given-names>
</name>
<name name-style="western">
<surname>Salzberg</surname>
<given-names>SL</given-names>
</name>
</person-group>
<article-title>TopHat: discovering splice junctions with RNA-Seq</article-title>
<source/>Endocrinol Metabol Syndrome
          <year>2009</year>
<volume>25</volume>
<fpage>1105</fpage>
<lpage>11</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/bioinformatics/btp120">https://doi.org/10.1093/bioinformatics/btp120</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R133">
<label>133</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Yuan</surname>
<given-names>Y</given-names>
</name>
<name name-style="western">
<surname>Tian</surname>
<given-names>L</given-names>
</name>
<name name-style="western">
<surname>Lu</surname>
<given-names>D</given-names>
</name>
<name name-style="western">
<surname>Xu</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Analysis of genome-wide RNA-sequencing data suggests age of the CEPH/Utah (CEU) lymphoblastoid cell lines systematically biases gene expression profiles</article-title>
<source/>Sci Rep
          <year>2015</year>
<volume>5</volume>
<fpage>7960</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/srep07960">https://doi.org/10.1038/srep07960</ext-link>
</comment>
<pub-id pub-id-type="pmid">25609584</pub-id>
</element-citation>
</ref>
<ref id="R134">
<label>134</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>DePristo</surname>
<given-names>MA</given-names>
</name>
<name name-style="western">
<surname>Banks</surname>
<given-names>E</given-names>
</name>
<name name-style="western">
<surname>Poplin</surname>
<given-names>R</given-names>
</name>
<name name-style="western">
<surname>Garimella</surname>
<given-names>KV</given-names>
</name>
<name name-style="western">
<surname>Maguire</surname>
<given-names>JR</given-names>
</name>
<name name-style="western">
<surname>Hartl</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Philippakis</surname>
<given-names>AA</given-names>
</name>
<name name-style="western">
<surname>del Angel</surname>
<given-names>G</given-names>
</name>
<name name-style="western">
<surname>Rivas</surname>
<given-names>MA</given-names>
</name>
<name name-style="western">
<surname>Hanna</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>McKenna</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Fennell</surname>
<given-names>TJ</given-names>
</name>
<name name-style="western">
<surname>Kernytsky</surname>
<given-names>AM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A framework for variation discovery and genotyping using next-generation DNA sequencing data</article-title>
<source/>Nat Genet
          <year>2011</year>
<volume>43</volume>
<fpage>491</fpage>
<lpage>8</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ng.806">https://doi.org/10.1038/ng.806</ext-link>
</comment>
<pub-id pub-id-type="pmid">21478889</pub-id>
</element-citation>
</ref>
<ref id="R135">
<label>135</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Bray</surname>
<given-names>N</given-names>
</name>
<name name-style="western">
<surname>Pimentel</surname>
<given-names>H</given-names>
</name>
<name name-style="western">
<surname>Melsted</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Pachter</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Near-optimal RNA-Seq quantification</article-title>
<source/>arXiv.org
          <year>2015</year>
</element-citation>
</ref>
<ref id="R136">
<label>136</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Robinson</surname>
<given-names>MD</given-names>
</name>
<name name-style="western">
<surname>McCarthy</surname>
<given-names>DJ</given-names>
</name>
<name name-style="western">
<surname>Smyth</surname>
<given-names>GK</given-names>
</name>
</person-group>
<article-title>edgeR: a bioconductor package for differential expression analysis of digital gene expression data</article-title>
<source/>Bioinformatics
          <year>2010</year>
<volume>26</volume>
<fpage>139</fpage>
<lpage>40</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/bioinformatics/btp616">https://doi.org/10.1093/bioinformatics/btp616</ext-link>
</comment>
<pub-id pub-id-type="pmid">19910308</pub-id>
</element-citation>
</ref>
<ref id="R137">
<label>137</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Anders</surname>
<given-names>S</given-names>
</name>
<name name-style="western">
<surname>Huber</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Differential expression analysis for sequence count data</article-title>
<source/>Genome Biol
          <year>2010</year>
<volume>11</volume>
<fpage>R106</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/gb-2010-11-10-r106">https://doi.org/10.1186/gb-2010-11-10-r106</ext-link>
</comment>
<pub-id pub-id-type="pmid">20979621</pub-id>
</element-citation>
</ref>
<ref id="R138">
<label>138</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>Young</surname>
<given-names>MD</given-names>
</name>
<name name-style="western">
<surname>Wakefield</surname>
<given-names>MJ</given-names>
</name>
<name name-style="western">
<surname>Smyth</surname>
<given-names>GK</given-names>
</name>
<name name-style="western">
<surname>Oshlack</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Gene ontology analysis for RNA-seq: accounting for selection bias</article-title>
<source/>Genome Biol
          <year>2010</year>
<volume>11</volume>
<fpage>R14</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/gb-2010-11-2-r14">https://doi.org/10.1186/gb-2010-11-2-r14</ext-link>
</comment>
<pub-id pub-id-type="pmid">20132535</pub-id>
</element-citation>
</ref>
<ref id="R139">
<label>139</label>
<element-citation publication-type="other">
<person-group person-group-type="author">
<name name-style="western">
<surname>Fox</surname>
<given-names>J</given-names>
</name>
<name name-style="western">
<surname>Weisberg</surname>
<given-names>S</given-names>
</name>
</person-group>
<comment>An R Companion to Applied Regression. SAGE; 2010. 1 p</comment>
</element-citation>
</ref>
<ref id="R140">
<label>140</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name name-style="western">
<surname>Core Team</surname>
<given-names>R</given-names>
</name>
</person-group>
<source/>R: A language and environment for statistical computing. R Foundation for Statistical Computing
          <publisher-loc>Vienna, Austria</publisher-loc>
<year>2016</year>
<comment>Available from <ext-link ext-link-type="uri" xlink:href="https://www.r-project.org/">https://www.r-project.org/</ext-link></comment>
</element-citation>
</ref>
<ref id="R141">
<label>141</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name name-style="western">
<surname>De Mendiburu</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Agricolae: Statistical procedures for agricultural research</article-title>
<source/>R package version 12-3
          <year>2015</year>
<comment>Available from <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/agricolae/index.html">https://cran.r-project.org/web/packages/agricolae/index.html</ext-link></comment>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>